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Abstract 
The purpose of this thesis was to develop methodology by which treatments for the 
cognitive impairments in Huntington’s disease (HD) could be tested.  As such, the thesis focused 
mainly on evaluating rats with quinolinic acid (QA) lesions of the striatum, as this manipulation 
mimics some aspects of the neural damage in Huntington’s disease, to try to identify cognitive 
deficits of HD resulting from cell loss in the striatum.   
In the first part (Chapters 3-5), the role of the striatum in implicit memory was 
investigated.  Chapter 3 compared the performance of rats and humans on a reaction time task 
that evaluated implicit memory by presenting visual stimuli with differing probabilities which 
change over time.  Although rats made higher percentage of incorrect responses and late errors, 
both groups showed a similar pattern of reaction times.  Chapter 4 investigated whether implicit 
memory (the computation of probabilities to predict the location of a stimulus) was affected by 
selective blockade of dopaminergic transmission at the D1 or D2 receptors by SCH-23390 and 
raclopride, respectively.  Reaction times were slower with SCH-23390 and raclopride, but only 
SCH-23390 reduced errors to the least probable target location.  Chapter 5 used the same task to 
evaluate implicit memory in rats with QA lesions of the dorsomedial striatum (DMS).  Implicit 
memory was not affected by lesions of the DMS, which suggested that once a task that requires 
implicit memory has been learned, the DMS was not involved in sustaining the performance of 
the task.  The second part of this thesis (Chapter 6), explored the contribution of the DMS in 
habit formation.  DMS lesioned rats did not show habitual responding, and were not impaired in 
learning a new goal-directed behaviour.  The third part (Chapters 7 and 8), investigated the role 
of the dorsal striatum in reversal learning, attentional set-formation, and set-shifting.  Dorsal 
striatum lesioned rats were not impaired in reversal learning, but had a diminished shift-cost, 
which suggested that dorsal striatum lesions disrupted the formation of attentional sets.   
These results showed that although QA lesions of the dorsal striatum mimic some aspects 
of the neural damage in HD, they did not result in the same cognitive deficits observed in 
patients with HD, at least using the tasks presented in this thesis.  However, other animal models 
of HD could be evaluated using the different tasks presented in this thesis to continue the search 
of a reliable animal model of HD in which treatments for the disease could be evaluated. 
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Huntington’s disease 
1.1 Introduction 
Huntington’s disease (HD) is a hereditary, autosomal dominant neurodegenerative 
disorder that is progressive and that it is characterised by a triad of motor, cognitive, and 
psychiatric symptoms (Novak and Tabrizi, 2010; Novak and Tabrizi, 2011; Petersén and 
Brundin, 2002; Ross and Margolis, 2001; Wagner et al., 2008).   
The disease was named after George Huntington (1850-1916), a physician, who in 1872 
presented his manuscript, “On chorea”, in which he described the choreiform movement 
disorder, the psychiatric symptoms associated with the disease, the inheritance pattern, and the 
progressive and fatal course of the disease (Huntington, 1872; reprinted in Huntington, 2003).  
Although he was not the first to describe the disease (Hayden, 2012, for a review), his description 
was so concise and accurate that his name became attached to the disease (Berg, 1948; Hayden, 
2012; Heathfield, 1973; Rüb et al., 2015).  
1.2 Epidemiology 
Studies that incorporated genetic and clinical diagnostic standards have shown that the 
prevalence of HD in western populations is 10.6-13.7 individuals per 100,000 (or 1 in 7,300) are 
affected (Bates et al., 2015). 
In the United Kingdom, the prevalence of HD is 12.3 per 10,000: the London region had 
the lowest prevalence (5.4 per 100,000); while the North East of England (18.3 per 10,000) and 
Scotland (16.1 per 10,000) had the highest prevalence (Evans et al., 2013).   
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1.3 Genetics 
HD is caused by an expanded cytosine-adenine-guanine (CAG) trinucleotide repeat in 
exon 1 of the huntingtin gene (or IT-15, interesting transcript 15), encoding Huntingtin protein 
(HTT), which is located on chromosome 4 (Gusella et al., 1983; MacDonald et al., 1993).  The 
disease is an autosomal dominant inheritance disease (i.e., there is 50% chance that each child of 
an affected parent will inherit the abnormal gene).  A normal gene contains between 6 to 35 
polyglutamine (PolyQ) repeats; however, increased CAG repeats can vary from 36 to 180.  
Symptoms of HD have not been reported in individuals with fewer than 36 CAG repeats; 
however, an abnormal gene containing more than 40 repeats will ultimately result in symptoms 
of HD.  Patients with genes containing between 36 to 39 CAG repeats show reduced penetrance 
(i.e., some would develop HD and others will not; Snell et al., 1993).  Since the causative gene 
mutation was discovered (MacDonald et al., 1993), genetic testing for HD has become available.  
A blood sample (or other tissues, even autopsy material) can determine the CAG repeat length in 
the HTT gene (Nance et al., 2011).  Testing could be performed in three clinical situations: to 
diagnose if the symptoms observed in a patient are due to HD, to predict if a person with a parent 
with HD has an expanded CAG and will develop HD, or prenatally to evaluate if the foetus has 
an expanded HTT gene (Rosenblatt et al., 1999; See, 1994).  
The mean age of onset of symptoms is between 35 and 45 years of age; but, depending on 
the severity of the genetic mutation (i.e., number of repeats), there may be juvenile (< 20 years) 
or late (> 70 years) onset of symptoms.  The onset of the disease is inversely proportional to the 
length of the PolyQ repeats (i.e., the longer the CAG repeat length, the earlier the onset of 
symptoms; a genetic phenomenon known as “anticipation”).  Juvenile HD is commonly seen 
with 60 or more CAG repeats; in adult onset, the average number of CAG repeats is 44 and in 
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patients with late onset, the number of CAG repeats varies from 42 to 46.  In adult onset, death 
generally occurs within 15 to 20 years after onset (Novak and Tabrizi, 2011).  Patients diagnosed 
with a repeat expansion that do not exhibit the full clinical syndrome yet are in the prodromal, 
preclinical, asymptomatic or pre-symptomatic phase of HD (Nance et al., 2011; Paulsen, 2011). 
1.4 Neuropathology 
Although HD affects many regions of the brain, the most prominent neuropathological 
characteristic of HD is the selective atrophy and neuronal loss of the striatum (i.e., caudate 
nucleus and putamen).  The earliest and most affected area by the disease is the caudate nucleus, 
but as the disease progresses there is a dorsal to ventral, anterior to posterior, and medial to 
lateral direction of striatal degeneration (Vonsattel et al., 2008).  Within the striatum, neuron 
populations are divided into two groups.  One group consists of aspiny neurons, which are 
interneurons whose connections are contained within the striatum.  The other group consists of 
spiny neurons, which are the projection neurons that use gamma-aminobutyric acid (GABA) as 
their principal neurotransmitter, and are often referred to as GABAergic projection neurons.  
Spiny neurons constitute 90-95% of striatal neurons (Kita and Kitai, 1988).  In patients with HD, 
almost all types of interneurons in the striatum show evidence of dysfunction.  However, the 
neuropathological hallmark of HD is the premature and progressive degeneration of medium 
spiny projection neurons, while the large aspiny interneurons in the striatum are relatively 
preserved (Ferrante et al., 1987; Ferrante et al., 1985; Ferrante et al., 1986). 
In addition to the striatum, the cortex also suffers from atrophy and the cortical neuronal 
degeneration leads to excessive thinning of the cerebral mantle of the entire brain (Hedreen et al., 
1991).  Similar to the striatum, while the cortical interneurons are preserved, the projection 
neurons in the cortex are the ones that are more vulnerable to degeneration (Vonsattel et al., 
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2008).  It also appears that the large cortical neurons are the most affected; most of the neuronal 
loss is seen in projections to the thalamus, while there is a significant loss in neurons that project 
to the caudate nucleus and putamen (Ross and Margolis, 2001).  Other nuclei such as the globus 
pallidus (GP), thalamus, hypothalamus, subthalamic nucleus (STN), substantia nigra (SN), and 
cerebellum also are affected in HD (Vonsattel et al., 2008, for a review).   Vonsattel et al. (1985) 
introduced a neuropathological five-point grading system that stages the extent of neuronal 
degeneration in the striatum, gliosis, and cell loss as the disease progresses.  Depending on the 
progression of the disease, other common neuronal changes in HD include thinning of the 
cortical mantle, ventricle enlargements, and decreased brain weights and volume.  During the last 
stages of the disease, with the combined reduction in the striatal volume (60%), and the atrophy 
of the neocortex (20%), the HD brain may lose nearly 25-30% of its weight (Roze et al., 2011). 
In order to understand the mechanisms by which degeneration of neurons in the basal 
ganglia produce symptoms in HD, the neuronal circuitry of the normal basal ganglia first needs 
to be examined in more detail. 
1.4.1 Organisation of the basal ganglia 
The basal ganglia are a group of interconnected subcortical nuclei incorporating the 
striatum (caudate nucleus and putamen), the GP, which is divided into internal (GPi) and external 
(GPe) segments, the STN, and the SN, divided  into the pars reticulata (SNpr) and the pars 
compacta (SNpc; Albin et al., 1989). 
Albin et al. (1989) proposed a model in which specific types of basal ganglia disorders 
are associated with changes in the function of striatal projection neurons.  In this model, the 
caudate nucleus and the putamen integrate the input compartment, since they receive inputs from 
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the cerebral cortex, intralaminar thalamic nuclei, and the SNpc.  The STN, SNpr, and GPi, 
integrate the output compartment, their target nuclei are in the thalamus, which has excitatory 
effects on the cortex.  The input and the output compartments are integrated in two major 
pathways: the direct pathway, which facilities movement by disinhibition, and the indirect 
pathway, which inhibits movements.  In this model, dopaminergic innervations of striatal 
neurons originate in the SNpc.  When dopamine is realised into the striatum, it inhibits the 
indirect pathway by acting on D2 receptors and stimulates the direct pathway by acting on D1 
receptors.  Figure 1.1 shows the location and circuitry of the basal ganglia. 
The direct pathway consists of medium spiny neurons (MSNs) that mostly express D1 
receptors (Gerfen et al., 1990) and substance-P (Haber and Nauta, 1983) that project to the GPi 
and SNpr.  The GPi and the SNpr then project to the thalamus, which then projects to the cortex 
to initiate movements (Albin et al., 1989).  To initiate movements, the cortex sends excitatory 
(glutamatergic) input to the putamen and caudate nucleus; this process increases the activity of 
the neurons of the striatum, which are inhibitory (GABAergic).  The striatum then sends this 
increased inhibitory signal to the GPi and the SNpr.  The GPi and the SNpr normally send 
inhibitory (GABAergic) signals to the thalamus; however, since the GPi and the SNpr are briefly 
suppressed, the thalamus is disinhibited; permitting the thalamus to send excitatory 
(glutamatergic) signals to the cortex, the activation of the cortex ultimately facilitates movement. 
The indirect pathway consists of MSNs that mostly express D2 receptors (Gerfen et al., 
1990) and enkephalin (Haber and Nauta, 1983), and project to the GPe.  The GPe projects to the 
STN, which projects to the GPi or to the SNpr.  The GPi and the SNpr then project to the 
thalamus, which then projects to the cortex to inhibit movements (Albin et al., 1989).  To inhibit 
movements, the cortex sends excitatory (glutamatergic) input to the putamen and caudate 
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nucleus; this process increases the activity of the neurons of the striatum, which are inhibitory 
(GABAergic).  The striatum then sends this increased inhibitory signal to the GPe and the SNpr.  
The role of the GPe is to inhibit (via GABA) the STN; however, since the striatum is inhibiting 
the GPe, the STN is disinhibited.  The STN sends increased excitatory (glutamatergic) signals to 
the GPi and the SNpr.  The GPi and the SNpr normally send inhibitory (GABAergic) signals to 
the thalamus; however, since the GPi and the SNpr are more active, they send an increased 
inhibitory (GABAergic) signal to the thalamus.  Leading to a decrease in the excitatory 
(glutamatergic) signals that the thalamus sends to the cortex, this effect results in inhibition of 
movement. 
1.4.1.1 The basal ganglia in HD 
MSNs of the indirect pathway are the most affected neurons in HD.  In early and middle 
stages of the disease, striatal spiny projection neurons containing enkephalin, which project to the 
GPe (a reliable marker for the indirect pathway), are more affected than substance-P neurons, 
that project to the GPi (a reliable marker for the direct pathway).  At the most advanced stages of 
the disease, almost all striatal projections are depleted (Reiner et al., 1988). 
Disruption of the afferent pathways in the striatum results in the motor dysfunction 
observed in HD (Vonsattel et al., 2008).  The degeneration of the striatal inhibitory neurons of 
the indirect pathway leads to a reduced inhibitory output of the GPe upon the subthalamic 
nucleus (STN).  Thus, the STN becomes hypo functional, reducing the inhibitory action of the 
GPi upon the thalamus, which increases the excitation of the cortex, causing chorea (Albin et al., 
1990).  Thus, Albin et al. (1990) hypothesised that chorea, which occurs early in the disease, 
results from preferential dysfunction and loss of striatal MSNs projecting to the GPe (indirect 
pathway), and that akinesia and dystonia, which occurs later in HD, is a result from the additional 
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loss of striatal MSNs projecting to the GPi direct pathway.  Additionally, it has been suggested 
that the imbalance within the two GP also impairs voluntary movements (Chesselet and Delfs, 
1996; Matsumura et al., 1995).  Figure 1.1 shows a summary explanation of the hyperkinetic 
disorder seen in HD. 
It has been reported that loss of basal ganglia volume begins many years prior to 
diagnosable HD (Aylward et al., 1996).  Patients in the prodromal phase present loss of 
corticostriatal connectivity and striatal atrophy (Tabrizi et al., 2012; Tabrizi et al., 2011).  Using 
magnetic resonance imaging (MRI) scans, Aylward et al. (2004) measured the volumes of the 
caudate nucleus and the putamen on asymptomatic preclinical subjects with the HD gene 
expansion (i.e., people that have more than 36 CAG repeats but that had not developed the 
characteristic motor deficits of the disease) and reported that they had smaller volumes of the 
basal ganglia than aged matched control subjects.  These results suggested that atrophy in the 
striatum begins long before onset of the disease.  An increasing number of studies using positron 
emission tomography (PET) and functional MRI (fMRI) in prodromal HD carriers have provided 
evidence that clinical impairments and brain atrophy can be detected prior to a clinical diagnosis 
(Paulsen, 2009, for a review). 
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1.5 Symptoms 
HD is characterised by a triad of progressive clinical symptoms: motor dysfunction, 
psychiatric disturbances, and cognitive decline.  Although the onset of HD is generally defined as 
the time when motor symptoms become evident (Siesling et al., 1998), it has been reported that 
mood changes and cognitive deficits appear before the motor symptoms manifest (Aylward, 
Figure 1.1.  Schematic representation of the direct/indirect pathway in the normal 
brain (left) and in HD (right). Red lines indicate the direct pathway (facilitates movement); 
blue lines, the indirect pathway (inhibits movement).  The inhibitory connections are marked 
with “–”; the excitatory with “+“. 
Left: basic circuit in the normal brain.  
Right: In HD, in the indirect pathway (blue lines) the projection from the putamen (and 
caudate, not shown) to the GPe is diminished (thinner line).  This increases the inhibition 
from the GPe to the STN (thicker line), which makes the excitatory STN less effective in 
opposing the action of the direct pathway (thinner line between the STN-Gpi, STN-SNpr, and 
between GPi-thalamus and SNpr-thalamus).  Resulting in an increased activation (thicker 
arrow) from the thalamus to the cortex, this leads to increased motor activity.  
Abbreviations: GPe = external segment of the globus pallidus; GPi = internal segment of the 
globus pallidus; SNpc = substantia nigra pars compacta; SNpr = substantia nigra pars 
reticulata; STN = subthalamic nucleus. 
(Redrawn from Calabresi, Picconi, Tozzi, Ghiglieri, & Di Filippo, 2014) 
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2007; Aylward et al., 2000; Duff et al., 2007; Paulsen, 2011; Paulsen et al., 2006; Paulsen et al., 
2008; Paulsen et al., 2001b). 
1.5.1 Motor symptoms. 
There are two main categories of motor symptoms: increased involuntary movements 
(e.g., chorea, dystonia) and impaired ability to sustain voluntary muscular effort (e.g., dysphagia, 
dysarthria, spasticity, rigidity, bradykinesia).  The most common motor manifestation of HD is 
chorea, which is defined as involuntary, quick irregular movements.  The most prominent regions 
where chorea manifests are the orofacial regions and the distal musculature of hands and feet.  
Chorea can be an early manifestation of HD (Berardelli et al., 1999), may manifest in individuals 
at risk of HD (McCusker et al., 2000), and, in late onset of HD, may be the only symptom 
(Myers et al., 1985).  It has been reported that early in the disease, patients may not be aware of 
the presence of chorea, but as the disease progresses, larger muscle groups are involved which 
interferes with voluntary movements; the incorporation of chorea into purposeful movements is 
known as parakinesia (Novak and Tabrizi, 2011). 
Dystonia (slower movements caused by increased muscle tone and involuntary 
contraction of muscles) is also seen in most patients with HD.  Different displays of dystonia 
include: twisting, tilting, turning of the neck (torticollis), involuntary arching of the back 
(opisthotonos), rotatory dystonic movements of the shoulder, hands, and arching of the feet 
(Ghosh and Tabrizi, 2015; Novak and Tabrizi, 2011).  Cervical dystonia has been proposed as an 
initial manifestation of HD  and is more prominent in juvenile onset of HD (Ashizawa and 
Jankovic, 1996).  Bradykinesia (slowness in execution of movements), clumsiness, and akinesia 
(slowness of initiation of movements) are also common in patients with HD.  Patients with 
juvenile onset tend to have more bradykinesia, rigidity, dystonia and little or no chorea, while 
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later onset patients predominantly manifest chorea (Louis et al., 2000).  The combination of 
bradykinesia, dystonia, and chorea, which is observed in many patients with HD, leads to gait 
disorders, which is a major and disabling feature of HD that leaves patients highly prone to falls.  
Some of the characteristics of gait dysfunctions that are observed in patients with HD are a 
decrease in gait velocity and stride length, spontaneous flection of the knees and broad based 
gait; these symptoms are commonly confused which drunkenness by people unaware of the 
disease (Koller and Trimble, 1985).  Eye movement abnormalities are also present in patients 
with HD.  These manifest through significant abnormalities of saccades, difficulty maintaining 
fixation and smooth pursuit.  Oculomotor abnormalities manifest early in the disease and persist 
throughout the course of it (Lasker et al., 1987).  Severe myoclonus (sudden brief jerkin of 
groups of muscles) and tics may also be present in patients with HD.  Tics can be stereotyped 
movements such as blinking, nose twitching, head jerking, or transient abnormal postures; they 
can also cause sounds like sniffs, snorts, grunts, coughs, and sucking through involvement of 
respiratory and vocal structures and may be severe enough to cause significant speech difficulties 
(dysarthria), problems with swallowing (dysphagia), and balance, causing frequent falls 
(Jankovic and Ashizawa, 1995).  
1.5.2 Psychiatric and mood symptoms. 
Psychiatric and mood symptoms are common in HD and precede motor dysfunctions by 
many years (Duff et al., 2007).  Around 72-98% of HD patients exhibit psychiatric symptoms 
(Paulsen et al., 2001a; Van Duijn et al., 2007).  A review by Van Duijn et al. (2007) showed that 
the most common psychiatric symptoms that HD gene carriers will experience before 
establishing the diagnosis and during the course of the disease include: depression, suicide risk, 
apathy, anxiety, irritability and agitation, obsessive-compulsive behaviours, and psychosis.   
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While depression is common in HD, it is not clear if it is an intrinsic feature of the 
disease, if it is a response to being diagnosed with a terminal disease with increase disability, or 
if it is a combination of both (Wahlin and Byrne, 2012).  A survey conducted in 2,835 patients 
with HD found that 40% presented symptoms of depression and more than 10% had made at 
least one suicide attempt (Paulsen et al., 2005a).  Suicide risk is higher in HD patients (Di Maio 
et al., 1993; Schoenfeld et al., 1984), patients at risk for HD (Sørensen and Fenger, 1992), and 
even in people without the disease but with a family history of HD (Robins Wahlin et al., 2000).  
The suicide rate in HD is 4-6 times higher than in the general population, and it was the cause of 
death in 7.8% of HD patients in one study (Di Maio et al., 1993).  Schoenfeld et al. (1984) noted 
that half of the suicides occurred in individuals who showed early signs of the illness but who 
had not been diagnosed, which suggested that suicide risk is greater in early stages of the illness.  
Further examination by Paulsen et al. (2005a) reported that there are two critical periods for 
increased risk of suicide in patients with HD: before receiving a formal diagnosis, but when they 
start showing motor symptoms of HD, and when their independence decreases as a result of the 
onset of the disease.  Novak and Tabrizi (2010) suggested that some of the risk factors for suicide 
are depression and the idea that it is the rational response to their fear of loss of independence.  
But in some other cases, patients without depression also attempted suicide, especially if they 
had no offspring (Lipe et al., 1993).   
Apathy, which is characterised by diminish energy and activity, lack of drive, and 
impaired performance of daily tasks (Van Duijn et al., 2007), can sometimes be confused as a 
symptom of depression.  However, it has been reported that apathy is not correlated with 
depression (Levy et al., 1998) and that it is a separate clinical symptom in neuropsychiatric 
disorders (Levy et al., 1998; Marin, 1991).  Different studies have reported that apathy is another 
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symptom observed in patients with HD (Craufurd et al., 2001; Kulisevsky et al., 2001; Paulsen et 
al., 2001a; Van Duijn et al., 2007), with a prevalence varying between 36-76% depending on the 
scale used, and it has been reported to increase as the disease progresses (Levy et al., 1998). 
Other psychological problems are also apparent in HD patients.  For example, anxiety has 
also been reported in patients with HD (Craufurd et al., 2001; Kulisevsky et al., 2001; Murgod et 
al., 2001; Paulsen et al., 2005b; Paulsen et al., 2001a; Van Duijn et al., 2007).  The highest 
prevalence of anxiety (61%) has been reported after showing the first motor symptoms of the 
disease (Murgod et al., 2001).  Irritability, a mood disorder characterised by a diminishes control 
over temper, that may result in verbal or physical altercations (Snaith and Taylor, 1985), has a 
prevalence of 38-73% in patients with HD (Craufurd et al., 2001; Kulisevsky et al., 2001; 
Murgod et al., 2001; Paulsen et al., 2001a; Van Duijn et al., 2007).  There has also been reported 
a prevalence of 10-52% of obsessive and compulsive thoughts and behaviours in HD (Anderson 
et al., 2001; Craufurd et al., 2001; Murgod et al., 2001).  The three most common obsessions in 
HD are related to other people, to the self, and ritualistic behaviours (Novak and Tabrizi, 2010).  
Psychotic symptoms, such as delusions and hallucinations, are rare in HD, but low prevalence (3-
10%) has been reported (Craufurd et al., 2001; Kulisevsky et al., 2001; Murgod et al., 2001; 
Paulsen et al., 2001a; Van Duijn et al., 2007). 
1.5.3 Cognitive symptoms. 
It was previously believed that cognitive deficits began only after the motor symptoms 
were apparent.  However, recent studies have reported that by the time diagnostic tests confirms 
the disease, there is already significant cognitive impairment, and subtle cognitive impairment 
could be among the earliest manifestations of the disease (Aylward, 2007; Aylward et al., 2000; 
Hahn-Barma et al., 1998; Paulsen, 2011; Paulsen et al., 2006; Paulsen et al., 2008; Paulsen et al., 
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2001b).  Additionally, it has been proposed that cognitive changes might be one of the first 
symptoms of HD (Hahn-Barma et al., 1998), and it has also been reported that cognitive and 
motor impairments in HD are independent from each other (Rothlind et al., 1993).   
1.5.3.1 Cognitive Diagnoses in HD 
Even though there are several rating scales to assess features of HD, there is no universal 
battery that has been used for cognitive assessment of HD.  Some HD centres rely on the Unified 
Huntington Disease Rating Scale (UHDRS; Kremer and Group, 1996), a battery that combines 
different tests to measure four domains of clinical features of HD: motor function, cognitive 
function, behavioural abnormalities (psychiatric symptoms), and functional capacity.  Motor 
function is assessed by rating oculomotor function, dysarthria, chorea, dystonia, gait, and 
postural stability.  Higher scores, indicate more severe motor impairments.  Cognitive function is 
evaluated by using a series of tests: the phonetic verbal fluency test, where participants have to 
say as many words as possible from a category in a given time (Ho et al., 2002); the Symbol 
Digit Modalities Test, where using a reference key, subjects have 90 seconds to pair specific 
numbers with given geometric figures (Smith, 2002); and the Stroop Interference Test (Stroop, 
1935).  In this section of the battery, higher scores, indicate better cognitive performance.  
Behavioural assessment, which is more related to a psychiatric assessment, is evaluated by rating 
both the severity and frequency of symptoms related to mood, self-esteem, anxiety, suicidal 
thoughts, aggressive behaviour, irritable behaviour, obsession, compulsion, delusions, and 
hallucinations.  Higher scores in this section of the battery indicate more severe disturbance.  
Finally, the functional assessment include the Huntington’s Disease Functional Capacity Scale 
(HDFCS), which assesses a patient’s capacity in functional domains including employability, 
financial tasks, domestic capacities, and self-care skills (Shoulson and Fahn, 1979); the 
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independence scale and a checklist of common daily tasks. Higher scores on the functional scales 
indicate better functioning.  Nevertheless, although there have been some studies that have found 
the scale useful for monitoring the progression of motor deficits in patients with HD, the changes 
observed on the scale during longitudinal follow-up studies have not been reported for all of the 
patients (Marder et al., 2000; Siesling et al., 1998).  In other cases, no change on the motor scores 
of the UHDRS (except rigidity) was observed during a 3-year follow-up study (Reilmann et al., 
2001).  Likewise, Pavese et al. (2003) did not find a correlation between the progression of 
striatal loss of D2 receptors and the individual changes in UHDRS motor scores in a longitudinal 
study over 3 years, which suggests that the UHDRS does not reflect progression of striatal 
reduction of dopaminergic receptors alone.  Other limitations of the UHDRS is that the cognitive 
assessment throughout this rating scale is very limited (Beglinger et al., 2010) and, that it is only 
designed as a screening tool (Paulsen et al., 2001b).  Therefore, other cognitive tests should be 
conducted to evaluate the specific cognitive mechanisms that are impaired in HD.  
Another cognitive screening battery that has been used for cognitive assessment in HD is 
the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS; Randolph et 
al., 1998).  The battery was developed to identify and characterise abnormal cognitive decline in 
older adults and to perform neuropsychological screening in younger patients.  The battery 
evaluates five cognitive domains: 1) Immediate Memory (measured through two subtests: list 
learning and story memory); 2) Visuospatial/Constructional (consisting of two subtests: figure 
copy and line orientation), 3) Language (structured with the following two subsets: picture 
naming and semantic fluency), 4) Attention (including two subtests: Digit Span and Coding), and 
5) Delay Memory (evaluated through four subtests: list recall, list recognition, story recall, and 
figure recall.  Randolph et al. (1998) reported that HD patients were impaired on the Attention 
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and the Visuospatial/Constructional subsections.  A limitation of this battery is that it has not 
been extensively explored, as it has only been reported in three published studies (Beglinger et 
al., 2010; Duff et al., 2010; Randolph et al., 1998) and two of the studies had small sample sizes.  
Randolph et al. (1998) only tested 20 HD patients and Beglinger et al. (2010) had a sample of 38 
patients with HD, which questions the generalisability of the data to other patients with HD.  For 
example, when the sample size was increased to 75 patients, Duff et al. (2010) reported that HD 
patients were impaired on all the five cognitive domains (on 11 of the 12 subtests), which were 
different from the results reported from the two other experiments (Beglinger et al., 2010; 
Randolph et al., 1998).  Another limitation is that only Beglinger et al. (2010) retested the 
patients to evaluate if the task measured the cognitive decline as the disease progressed.  After 16 
months, when the patients were retested, they showed a decline in performance on the attentional 
index and on the subtest scores on coding, digit span, list recognition, figure copy, and figure 
recall (Beglinger et al., 2010).  However, further research will be needed to evaluate if the battery 
continues measuring cognitive decline as the disease progresses.  Another limitation is that the 
battery does not provide information about the other characteristics of the patients (e.g., severity 
of motor dysfunction and psychiatric symptoms); therefore, it should be used with other batteries 
that examine other markers of HD to better characterise the sample of HD patients that are being 
evaluated.  
 Given the absence of valid batteries for cognitive assessment of HD, new cognitive tasks 
should be considered.  The next section summarises the cognitive impairments that have been 
reported in patients with HD in an attempt to identify those areas that have the most potential to 
yield a cognitive biomarker of HD.  
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1.5.3.2 Cognitive changes in HD 
The major feature of the cognitive deficits in HD is a progressive decline of executive 
functions, defined as the set of processes that serves to optimise performance in complex tasks 
with many cognitive or behavioural components (Lawrence et al., 1998b).  The abilities to plan, 
organise, show mental flexibility, switch from one way of responding to another (e.g., shifting of 
attention), and multitask are impaired in patients with HD; furthermore, organisation of time, 
thoughts, and activities become harder resulting in significant problems in daily functioning and 
as the disease progresses, patients lose their independence (Ghosh and Tabrizi, 2015).  Some of 
the tests that require executive functions in which patients with HD are impaired are: the 
Wisconsin Card Sorting Test (Paulsen et al., 1995b) and the computerised Intra-
Dimensional/Extra-Dimensional (ID/ED) attentional set-shifting task  (Josiassen et al., 1983; 
Lange et al., 1995), which have been used to evaluate cognitive flexibility and shifting attentional 
set.  Also, HD patients showed impaired planning in the Tower of London test, which requires 
the ability to plan a sequence of actions to solve the test (Lange et al., 1995).  Likewise, patients 
with HD perform poorly on verbal fluency tasks, which involve generation of words belonging to 
a specified category or beginning with a specified letter (Monsch et al., 1994).   
The first cognitive changes in HD may appear 12-15 years before the clinical (i.e., motor 
symptoms) onset of the disease (Stout et al., 2011).  Paulsen (2011) reported that the earliest 
cognitive deficit detected in HD patients is emotional recognition.  Compared to healthy controls, 
patients at the prodromal stage of HD were not able to identify facial expressions or verbal tones 
representing fear, anger, or disgust (Snowden et al., 2008).  A review of the literature showed 
that using different tests of emotion recognition varying from facial expressions, vocal 
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expressions, and short verbal vignettes, recognition of emotions of disgust and anger associated 
with social disapproval were the most frequently impaired in HD (Calder et al., 2010).  
Impaired timing (e.g., perception of time and the production of timed output) has also 
been reported in pre-symptomatic carriers of HD 15 years before the motor diagnosis, as well as 
in patients with HD (Hinton et al., 2007; Rowe et al., 2010; Zimbelman et al., 2007).  These 
studies are consistent with the animal research showing that interval timing depends on the intact 
striatum (Buhusi and Meck, 2005, for a review).   
Changes in psychomotor speed have also been reported as an early sign of cognitive 
changes in prodromal HD patients.  For example, completion of ordinary mental tasks become 
more tiring and requires more time.  Thus, cognitive or motor tasks that require speed are 
sensitive to the detection and progression of prodromal HD and HD patients (Paulsen, 2011).  
Some of the tasks that have been used to detect psychomotor slowing in patients with HD are the 
Stroop, Symbol Digit Modalities Test, and Trail Making tests (Ho et al., 2003).  Slower reaction 
times have also been reported in patients with HD (Jahanshahi et al., 1993; Sprengelmeyer et al., 
1995).   
Changes in psychomotor speed also affect communication, as patients with HD have 
reported that they required increased effort and concentration to communicate (Hartelius et al., 
2010).  Although patients with HD have language difficulties, they are not aphasic.  They 
understand words and speak grammatically correct sentences; early in the disease, language 
difficulties in HD are primarily related to muscle control impairments that make patients unable 
to articulate and speak clearly.  As the disease progresses, the ability to speak is limited, but 
language comprehension may remain (Paulsen, 2011). 
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Learning and memory dysfunction is a symptom frequently reported in HD that may 
precede the onset of motor symptoms (Montoya et al., 2006a; Solomon et al., 2007).  Although 
several studies have reported that patients with HD may have difficulty learning new information 
and retrieving previously learned information (i.e., explicit memory; Montoya et al., 2006a; 
Solomon et al., 2007), procedural learning is more likely to be impaired in HD (i.e., implicit 
memory; Redondo-Verge, 2000; Sprengelmeyer et al., 1995).  In comparison to patients with 
severe amnesia or Alzheimer’s disease (who may be able to learn new motor procedures even 
though they are unable to retrieve previously learned information), older memories are often 
unaffected in patients with HD, even when they have implicit learning impairments and are 
unable to learn new motor skills or procedures (Paulsen et al., 1995a).  This dissociation between 
learning a skill and an explicit recall of learning episodes suggested that the distinct cognitive 
profiles are associated with the different underlying pathologies of the two dementias.  In the 
case of HD, some deficits in implicit learning are associated with the neuronal loss of the 
striatum (Paulsen et al., 1995a).   
Until recently, the implications of the areas affected in HD were poorly understood and it 
was even believed that neuronal loss in the striatum was only responsible for the motor 
impairments in HD, while the cognitive symptoms resulted from atrophy in the neocortex.  
However, a number of studies have shown a relationship between cognitive performance and 
changes in the striatum, and have shown that the progressive neurodegeneration of the striatum 
produce both cognitive and motor symptoms in HD (Montoya et al., 2006b).  Additionally, 
selective cortical thinning and semi-independent of striatal atrophy have been correlated with 
cognitive deficits in HD (Rosas et al., 2005).  Furthermore, different lines of research have 
shown that many of the cognitive changes in HD result from the atrophy and neuronal loss in the 
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corticostriatal circuit, leading to the hypothesis that executive function depends on circuits of 
multiple interconnected neural structures that code for specialised subprocesses (Lawrence et al., 
1998b). 
1.6 Treatment 
Even though the first clinical description of HD was reported in 1872, currently, there are 
no treatments to cure, or even to slow the progression of the disease.  The medications available 
merely ameliorate the motor and psychiatric symptoms (see Rosenblatt et al., 1999 for a detailed 
handbook of HD treatment options) but do not treat the cognitive decline that is observed in HD.  
Several studies have reported that cognitive and psychiatric functions are better predictors of 
impaired functioning than the movement disorder, and they are closely related to HD patients’ 
independence and quality of life (Hamilton et al., 2003; Nehl et al., 2004).  For this reason, it is 
widely accepted that clinical research and drug trials should focus on targeting cognitive 
treatments of HD.  The use of animal models of HD is an essential step in drug-discovery, before 
the pursuit of a full-scale human trial, for preclinical validation of the therapeutic targets and/or 
compounds (Yang and Gray, 2011).  
1.7 Choosing an animal model for the study of Huntington's disease 
Even though clinical studies in patients with HD have shown that cognitive changes 
precede motor symptoms, mechanistic studies are difficult to perform.  In this respect, animal 
models of HD have become an important tool for mechanistic examination.   
Although there is no animal model that simulates all the aspects of HD, models that 
presents some aspects of the disease are often more valuable in exploring specific domains (e.g., 
cognitive) without contamination from other impairments of the disorder (e.g., motor).  
Therefore, partial models are often accepted as appropriate (Willner, 1991) and sometimes 
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superior.  Nevertheless, it is common approach to require that an animal model resembles the 
clinical disorder in many details as possible, including symptomatic expression, treatment 
responses, pathophysiology, and, ideally, aetiology.  The validity of animal models has been 
evaluated using three main criteria: face, predictive, and construct validity (Willner, 1986).  More 
specifically, an adequate model of HD should resemble the fundamental motor, psychiatric, and 
cognitive symptoms, as well as the pathophysiology, found in HD patients (face validity).  
Should conform to a theoretical rationale, such as the known genetics of HD (construct validity), 
and allow us to make predictions about HD, based on the performance of the model (predictive 
validity).  From a pharmacological perspective, predictive validity is the ability of an animal 
model to respond to treatments in the same manner that humans respond to the treatment and 
vice versa (Willner, 1984).  Currently there are no effective treatments available for HD, and thus 
this criterion cannot be used to validate the existing animal models of HD.   
In an attempt to gain a better understanding of the progression of HD and its treatments, 
various animal models that try to resemble the neuropathology, genetic mutation, and symptoms 
of HD have been proposed.  In general terms, these animal models have been divided into two 
broad categories: toxin and genetic models.  
Before the mutation that causes HD was discovered (MacDonald et al., 1993), the animal 
models of HD relied on neurotoxic lesions of the striatum (Beal et al., 1986; McGeer and 
McGeer, 1976; Schwarcz et al., 1984).  However, after the discovery of the HTT mutation in 
1993 (MacDonald et al., 1993), a number of genetic approaches have been used to generate 
animal models with a similar genetic background to HD.  There are several genetic models of 
HD which vary on the number of CAG repeat expansion, the behavioural phenotype, the level of 
neuropathology affected, and the time course of the disease (Ferrante, 2009; Menalled, 2005; 
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Menalled and Chesselet, 2002; Pouladi et al., 2013; Ramaswamy et al., 2007, for a review).  In 
general, the different genetic mouse lines fall into three broad categories: knockout, transgenic, 
and knock-in models.   
The first genetic mouse models were the huntingtin knockout models.  However, the 
homozygous knockout of this gene in mice is embryonic lethal (Duyao et al., 1995; Nasir et al., 
1995), which diverges to the late onset of the disease in humans.  Therefore, although this early 
mouse models have demonstrated that huntingtin has an important role in embryonic 
development, they are not good models of the disease (Menalled, 2005; Menalled and Chesselet, 
2002).  
The transgenic models are those in which the human mutant huntingtin (HD) gene, or a 
fragment of the gene, is inserted randomly into the mouse genome.  Therefore, this mouse model 
will express the two normal copies of the endogenous mouse huntingtin (Hdh) gene and the 
additional mutant gene inserted (Menalled, 2005; Menalled and Chesselet, 2002).  This category 
includes the R6/1, R6/2 and N171-82Q lines.  The main differences between R6/1 and R6/2 lines 
are the number of CAG repeat expansion.  The R6/1 has 116, while the R6/2 has 144-150 CAG 
repeats.  The R6/2 was the first transgenic mouse model and has been the most studied.  These 
mice present body weight loss, diabetes, dystonia with limp clasping, reduced limp performance, 
tremors and seizures (Carter et al., 1999; Hurlbert et al., 1999; Mangiarini et al., 1996).  In 
addition, they also have an early death at 12-18 weeks and although the brain volume is reduced, 
the neuronal loss is minimal and delayed in comparison to the behavioural symptoms 
(Mangiarini et al., 1996; Turmaine et al., 2000).  The N171-82Q mice have 82 polyglutamines 
(Schilling et al., 1999).  Between the behavioural changes that are observed, these mice present 
body weight loss, and motor performance deficits that include loss of coordination, gait 
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abnormalities, hypokinesia, hind limb clasping behaviour, and muscle weakness (Schilling et al., 
1999; Yu et al., 2003).  The neuropathology of the model is similar to that observed in humans, 
as the model presents neuronal loss of the striatum and enlarged ventricles (Yu et al., 2003).  
However, the model has a short life span which ranges between 130-180 days.  In addition, it has 
been reported that the phenotype of this model is more variable than that of R6/2 mice; therefore, 
a larger sample of mice are required for drug trials (Ferrante, 2009).   
The knock-in mouse models have a CAG repeat expansion inserted into the mouse 
huntingtin gene.  Given that the mutation is genomically correct and under the endogenous Hdh 
promoter, they have been suggested as the closest genetic models of the human disease (Ferrante, 
2009; Menalled, 2005; Menalled and Chesselet, 2002).  However, some of the lines do not show 
behavioural phenotypes that are characteristic of HD (Wheeler et al., 2000; White et al., 1997), 
making these models inappropriate for investigating treatments for the symptoms observed in 
HD.  Some knock-in models are the chimeric HdhQ lines, which, depending on the model, can 
contain 48-111 CAG repeats.  Other knock-in models with greater CAG repeats are the CAG140 
HD mice and the Hdh
(CAG)150
, with 140 and 150 CAG repeats respectively.  These models have 
been suggested for investigating early mechanisms and preclinical biomarkers of HD (Ferrante, 
2009; Menalled, 2005; Menalled and Chesselet, 2002).  
As these genetic animal models of HD have only recently begun being investigated, they 
present some disadvantages that should be considered when choosing an animal model for 
studying HD.  For example, the motor impairments that some of the genetic models have are so 
severe that the animals are unable to control neither their voluntary movements or their 
involuntary movements, which prevent them from performing certain behavioural tasks (Brooks 
et al., 2004).  Additionally, the long polyglutamine repeats in some of the genetic models have 
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been suggested to replicate the juvenile form of the disease instead of the adult onset form of HD 
(Ferrante, 2009).  Likewise, another relevant characteristic to consider when designing an 
experiment is the lifespan of the model, which can limit the duration of the research that could be 
conducted in these animal models.  Hence, most of the research that has been conducted in 
genetic models has predominantly evaluated motor phenotypes (Brooks and Dunnett, 2009), 
while the cognitive aspects of the models still remain unknown.  The neuropathology of these 
models should also be considered, as it has been reported that in some genetic modified mice, 
there is no evidence of neuronal loss in the striatum or other regions (Ferrante, 2009, for a 
review).  Without neuronal cell loss, these animal models are inadequate for investigating 
treatments for the neuropathology observed in HD; thus they will not be discussed further.  
Excitotoxic lesions of the striatum offer an alternative model for the study of HD (Beal et 
al., 1986; Kim et al., 2011; Schwarcz et al., 1984).  Although the excitotoxic models do not 
mimic the pathogenesis of HD, and thus they are less effective for investigating the development 
of the disease, as noted above, there are some advantages over the genetic models.  For example, 
excitotoxic lesions are not limited to mouse models.  Using rats rather than mice, has the 
advantage that they tend to live longer, and there is a richer repertoire of behavioural tasks 
available for the rat, which can help to pinpoint the dysfunction and degeneration of neurons in 
HD.   
In addition, lesions of the striatum are a controlled and rapid method to induce HD 
neuropathology, as well as cognitive and motor phenotypes, which allows validating tests in 
which the striatum might be involved.  By controlling the “onset” of the disease, comparisons 
between pre- and post-surgery can be done to understand the cognitive and behavioural 
phenotypes caused by the neuronal loss in the striatum.  This direct comparison cannot be done 
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in neurodegenerative models, as the disease will not be diagnosed until the first motor symptoms 
appear, even though cognitive and psychiatric symptoms may precede the motor dysfunctions 
(Aylward, 2007; Aylward et al., 2000; Duff et al., 2007; Paulsen, 2011; Paulsen et al., 2006; 
Paulsen et al., 2008; Paulsen et al., 2001b).  Besides providing information about the role of the 
striatum in behaviour, the excitotoxic models have been proposed as “first pass” model systems 
in order to evaluate therapeutic compounds, cell replacement therapies and other interventions 
before the use of genetic modified models (Brooks and Dunnett, 2013).  Given the strengths and 
limitations of the currently available animal models of HD, this thesis investigated an excitotoxic 
model of HD. 
1.7.1 Quinolinic acid (QA) lesions of the rat striatum: an animal model of Huntington’s 
disease 
Among the most important neurotoxin-based models of HD is the quinolinic acid (QA) 
lesion of the striatum.  As previously mentioned, the most prominent neuropathological feature 
of HD is selective neuronal degeneration in the striatum, where medium spiny neurons with 
GABAergic striatal projection neurons are affected early and most severely (Ferrante et al., 1987; 
Ferrante et al., 1985; Ferrante et al., 1986).  QA is an excitatory amino acid acting via N-methyl-
D-aspartate (NMDA) receptors (DiFiglia, 1990).  Injections of QA in the striatum results in a 
depletion of GABA, which induces apoptotic cell death of the striatal MSNs while leaving aspiny 
neurons with somatostatin unaffected.  Similarly as in patients with HD, QA lesions also show 
marked gliosis (Björklund et al., 1986), produce a loss in GABAA receptors in the striatum and 
an increase in the GP (Faull et al., 1993), and a decrease of substance-P and enkephalin 
GABAergic striatal projection neurons (Beal et al., 1986; Ferrante et al., 1993).  Therefore, the 
model resembles the most similar pattern of striatal neuropathology and receptor changes of HD 
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(Beal et al., 1986; Kim et al., 2011; Wang et al., 2012).  QA cannot cross the blood-brain barrier; 
thus, in order to create the excitotoxic animal model of HD, it needs to be injected directly into 
the striatum (Foster et al., 1984).  In rats (Brasted et al., 1998; Dunnett et al., 2012; Shear et al., 
1998), mice (McLin et al., 2006), and non-human primates (Emerich et al., 2006; Ferrante et al., 
1993), excitotoxic lesions of the striatum produce anatomical changes that resemble the 
pathology of HD (face validity). 
In addition, striatal lesions produce behavioural changes that, whilst might not be 
identical to the symptoms observed in HD, are analogous (Brasted et al., 1998).  In this sense, the 
face validity of the model has focused on similarity of impaired behaviours that have been 
established as behaviours affected in HD.  For example, performance in reaction time tasks has 
been shown to be impaired by QA lesions of the rodent striatum (Brasted et al., 1998; Brooks et 
al., 2007; Hauber and Schmidt, 1994; Jay and Dunnett, 2007), which are also characteristics of 
patients with HD (Jahanshahi et al., 1993; Kim et al., 2004; Knopman and Nissen, 1991; 
Sprengelmeyer et al., 1995).    
In order to evaluate the effects of lesions of the striatum in reaction time tasks, rodents 
have been tested in nine-hole operant chambers.  In basic reaction time tasks, the three central 
holes are used, and the rat is required to sustain a nose poke in the central hole until a brief visual 
stimulus is presented in one of the two holes (on the left or right side).  In order to receive a 
reward, the rat must withdraw its nose from the central hole (reaction time) and nose poke into 
the signalled hole (movement time).  Using this task, different studies have reported that reaction 
time, but not movement time (i.e., the initiation but not the execution of a learned response), is 
affected by lesions of the striatum (Brasted et al., 1997; Brown and Robbins, 1989; Mittleman et 
al., 1988). 
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In reaction time tasks, when regular patterns of stimuli appear in random sequences, 
human subjects normally show progressive improvements in speed and accuracy to the 
sequences, without being consciously aware of them (Nissen and Bullemer, 1987).  It is not clear 
if this type of implicit learning is impaired in patients with HD.  While some studies have found 
that HD patients showed implicit learning deficits in the serial reaction time task (Kim et al., 
2004; Knopman and Nissen, 1991; Willingham and Koroshetz, 1993), several others have failed 
to replicate these deficits (Brown et al., 2001; Ghilardi et al., 2008; Maki et al., 2000; Schneider 
et al., 2010).  Differences in data analysis may account for some of the discrepancy in results.  To 
evaluate this type of implicit learning, a form of procedural learning, in rodent models of HD, the 
serial implicit learning task (SILT) was developed (Trueman et al., 2005).  Using the operant 
nine-hole box, the SILT adapted the methodology used in the 5-choice serial reaction time task 
(5-CSRTT; Robbins, 2002), where rodents have to nose poke into one of the five holes that 
presented a light stimulus in order to receive a reward.  On the SILT, rodents needed to respond 
to two consecutive light stimuli, presented at two of the five holes, before receiving a reward.  
The light stimuli at the holes were randomly presented; however, amongst these random two-
sequence stimuli presentations, an implicit learning probe trial was introduced.  On these trials, 
an embedded two-sequence combination was presented, where a light stimulus at the second hole 
was always followed by a light stimulus at the fourth hole.  Implicit learning was measured by 
faster reaction time and greater accuracy to the predictable stimuli (light presented at the second 
hole followed by the presentation of the light at the fourth hole) and then compared to the 
performance to the corresponding mirrored unpredictable stimuli (light presented at the fourth 
hole followed by the presentation of the light on the second hole).  Rats with QA lesions of the 
striatum did not show implicit learning deficits on the SILT (i.e., there was no evidence that rats 
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utilised the predictable information embedded within the task; Jay and Dunnett, 2007).  The same 
results were observed in mice with QA lesions of the striatum (Trueman et al., 2005), and it was 
also reported that acquisition of the task was not impaired with QA lesions of the striatum 
(Brooks et al., 2007).  Since the SILT is the only task available to evaluate implicit learning in 
rodents, and it has been suggested that implicit learning is mediated by the striatum (Kim et al., 
2004; Knopman and Nissen, 1991; Knowlton et al., 1996b; Wilkinson and Jahanshahi, 2007), 
new tasks for rodents that assess implicit learning, and other behavioural impairments after cell 
loss in the striatum, should be designed.  
Despite the numerous animal models of HD available, most research has evaluated the 
motor impairments of the models, while the characterisation of the cognitive impairments 
remains poorly investigated.  The reduced number of tasks available for evaluating cognitive 
impairments in animal models of HD, which are caused by cell loss in the striatum, has slowed 
the progress for testing treatments for the disease.  Currently, the only treatments available for 
HD ameliorate the motor and psychiatric symptoms, but there are no treatments available for the 
cognitive decline observed in HD.  This suggests the necessity to develop and validate new tests 
of striatal function in which the effectiveness of treatments for HD could be evaluated.  
Accordingly, the present thesis examines three different tasks that measured implicit learning, 
habit formation, and attentional set-shifting in rats with QA lesions of the striatum in order to 
assess the validity of these tasks and to evaluate the effectiveness of potential treatments for HD. 
1.8 Behavioural paradigms used in this thesis to evaluate QA lesioned rats 
Considering the cognitive deficits that have been previously reported in HD, this thesis 
uses three tasks to evaluate QA lesioned rats to try to identify cognitive biomarkers of HD caused 
by cell loss in the striatum.  Having valid cognitive tasks is necessary for evaluating the 
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effectiveness of potential treatments for HD.  The remainder of this section summarises the 
relevant principles, theories, and previous studies of implicit memory tasks, habit formation 
tasks, and attentional set-shifting tasks. 
1.8.1 Implicit memory tasks 
As previously mentioned in section 1.5.3.2, older memories are often unaffected in 
patients with HD; however, they have implicit learning impairments, as they are unable to learn 
new motor skills or procedures.  Some of the deficits in implicit memory have been attributed to 
the neuronal loss of the striatum and other basal ganglia structures (Paulsen et al., 1995a).  The 
basal ganglia is connected to motor and premotor areas of the frontal lobe, regions that have been 
implicated in the planning of movements as well as their execution (Alexander et al., 1986).  
These corticostriatal connections, as the connectivity in the striatum, have suggested that the 
basal ganglia are not only involved in the motor execution, but also in motor learning (Graybiel 
et al., 1994).  In particular, within the striatum, it has been suggested that motor and cognitive 
skill learning are mediated by the caudate nucleus.  In effect, patients with HD are impaired in 
learning and retaining certain motor and cognitive skills, which in healthy patients improve 
through practice and are not expressed verbally, which suggested that the neuronal loss in the 
striatum in HD impairs implicit memory (Knowlton et al., 1996b).  Implicit memory is a 
descriptive label that refers to the performance that has been influenced by past experiences, 
without conscious recollection of a learning episode.  In this sense, it is assumed that 
performance on implicit tests reflects unconscious or unaware expression of retention (i.e., 
although the performance of the task improves through practice, participants cannot verbalise 
how they solve the task).  Other terms that have been used instead of implicit memory are: 
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memory without awareness, indirect memory, and non-declarative memory (Schacter et al., 
1993).    
Patients with HD were impaired on a number of implicit memory tasks.  For example, 
patients with HD were impaired in rotor-pursuit perceptual-motor learning, a task that requires 
tracking a rotatory object with a stylus (Heindel et al., 1988) and impaired in learning to read 
mirror-reversed text (Martone et al., 1984).  In the weight judgement study, where subjects lift a 
set of weights (heavy or light) and then later judge the heaviness of a new set of weights.  Prior 
experience with the weights affects the weight judgements in healthy controls (e.g., the standard 
set of weights are perceived heavier if subjects were exposed to the light weights, but the weights 
are perceived lighter if they were exposed to the heavy weights).  However, patients with HD 
showed impaired adaptation-level effects for weight judgements, as they were not influenced by 
the prior exposure of the weights (Heindel et al., 1991).  Another task in which patients with HD 
showed impairments is in the prism adaptation task, where participants wear distorting prism 
goggles that displace the perceived location of objects to the right or left while being required to 
point to a target.  With practice, healthy participants improved their performance on the task, 
whereas HD patients showed impaired prism adaptation (Paulsen et al., 1993).  The results from 
these studies have suggested that impairments in motor skill leaning are related to neostriatal 
dysfunction.  
In addition, as previously mentioned, some studies have reported that patients with HD 
have difficulty learning the repeated sequence in a serial reaction time task, as their reaction time 
is not faster in the embedded sequence in comparison to the random sequence (Heindel et al., 
1988; Heindel et al., 1989; Kim et al., 2004; Knopman and Nissen, 1991; Willingham and 
Koroshetz, 1993).  Additionally, functional imaging studies have shown increased metabolic 
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activity in the striatum when subjects are performing a serial reaction time task, which suggests 
that the striatum is involved in implicit learning (Kim et al., 2004).  Nevertheless, others studies 
have not reported a performance deficit in patients with HD in learning the embedded sequences 
in the serial reaction time task (Brown et al., 2001; Ghilardi et al., 2008; Maki et al., 2000; 
Schneider et al., 2010).  The contradictory results on the performance of this task call into 
question its validity for investigating deficits in implicit memory in patients with HD.  These 
conflicting results should be considered before using this behavioural paradigm as a means of 
testing the animal models of HD.  
Although the findings from the previously described tasks suggest that the striatum and 
its cortical connections may be critical for implicit memory tasks, it is important to mention that 
all of these tasks are restricted to motor components (e.g., pursuit rotor learning) or require 
changes in motor programs in response to perceptual information (e.g., prism adaptation, weight 
judgements, mirror reading).  To investigate if the implicit memory deficits in HD are not only 
limited to motor learning, Knowlton et al. (1994) investigated implicit memory in the 
probabilistic classification task, a task that was not restricted to motor components, but that 
required learning a cognitive skill with practice.  Briefly, the probabilistic classification task 
involves predicting the weather with a set of cards.  There are four cues in the task (i.e., cards 
with geometric shapes), which predict sun or rain 60-85% of the time.  Even though the 
participants report that they feel they are guessing, generally, they learn to choose the more 
highly associated outcome after 50-100 trials.  Knowlton et al. (1996b) reported that patients 
with HD were impaired in learning this task, which suggested that the basal ganglia is related to 
incrementally learned cognitive skill tasks that require trial-by-trial practice and that are not 
conscious (i.e., implicit memory); also, that the striatum is not limited to only motor skill tasks.  
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However, Gluck et al. (2002) reported that the task could be solved using at least three different 
strategies.  First, a one-cue strategy, which involves responding in the presence of absence of a 
single cue, regardless of all the other cues.  The second approach uses an optimal multiple-cue 
strategy, which involves responding to each pattern based on the associations of all four cues 
with each outcome.  The third strategy that could be used is a singleton strategy, which requires 
learning only about the four patterns that have only one cue present and all others absent.  Given 
the variability of strategies to solve the task, it has been argued that different brain regions are 
involved in solving this task.  Thus, the task is not a reliable measure to evaluate cognitive 
impairments related to neuronal cell loss in the striatum.  
The tasks that have been used to evaluate implicit memory in HD (e.g., rotor-pursuit 
perceptual-motor learning, weight judgement, prism adaptation, mirror reading, weather 
probabilistic classification task) were designed for humans, and the behaviours that they require 
cannot be evaluated in rats.  Therefore, the first aim of this thesis was to develop a valid task that 
could be performed by rats and humans to evaluate implicit memory.  Because it has been 
suggested that the striatum is involved in the calculation of probabilities that predict an outcome 
(Knowlton et al., 1996b), a reaction time task was modified to allow the study of implicit 
memory by incorporating the computation of probabilities to predict the location of the stimuli.  
In this reaction time task, the location of the target (spatial probability) changed as a function of 
the length of the foreperiod (temporal probability).  Thus, at shorter foreperiods, targets on the 
left side were more probable than targets on the right side, but at longer foreperiods, targets on 
the right side became more probable than the targets on the left side.  If implicit learning 
occurred it was expected that, during the task, the subjects would gradually have faster reaction 
times on the left side at shorter foreperiods, and have faster reaction times on the right side at 
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longer foreperiods (the more probable location of the targets), even though they would not have 
conscious knowledge of the location where the stimuli were more likely to appear.   
To summarise, this section has presented a series of implicit memory tasks in which 
patients with HD were impaired.  The results from these studies have suggested that these 
impairments are related to striatal dysfunction.  However, this has not been investigated in 
animal models of HD, as there are no tasks available for rats.  Chapter 3 describes a task 
developed to evaluate implicit memory (the computation of probabilities to predict the location 
of a stimulus) in rats and humans.  
1.8.1.1 Dopamine D1 and D2 Receptors in HD 
As previously mentioned in section 1.4.1.1 the basal ganglia in HD, it has been suggested 
that altered dopamine receptors contribute to the pathophysiology of HD.  In the direct pathway, 
the striatum projects to the SNpr and the GPi.  In the indirect pathway, the striatum projects to 
the GPe, then the SNT, and finally to the GPi (Albin et al., 1989).  In the striatum, D1 receptors 
are mostly expressed by the substance-P neurons of the direct pathway, while D2 receptors are 
mostly expressed by the enkephalin neurons of the indirect pathway.  Dopamine inhibits the 
indirect pathway by acting on D2 receptors and stimulates the direct pathway by acting on D1 
receptors.  The direct pathway facilities movement, and the indirect pathway inhibits movements 
(Ferré et al., 1997).  Albin et al. (1989) proposed that the chorea observed in HD results from the 
selective loss of D2 receptors enkephalin neurons of the indirect pathway.  However, recent 
results from PET studies argue against the differential loss of D1 and D2 receptors in HD.  These 
new studies have observed a parallel reduction of both caudate and putamen D2 and D1 receptor 
binding in pre-symptomatic mutation carriers of HD (Andrews et al., 1999; Weeks et al., 1996) 
and in HD patients regardless if chorea or rigidity is predominant (Turjanski et al., 1995).  
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Although these findings have not found a selective loss of striatal dopamine receptor in HD for 
chorea, Turjanski et al. (1995) found that HD patients with rigidity present an increased loss of  
striatal D1 and D2 receptor compared to those patients without rigidity.  In addition, Andrews et 
al. (1999) found that the annual percentage reduction in D1 and D2 binding were not related to 
each other and proposed that in pre-symptomatic mutation carriers of HD striatal D2 measures 
were more sensitive for detecting disease progression.  Thus, suggesting that differential loss and 
dysfunction of the neurons that express these two dopamine receptors may contribute to the 
different symptoms of the disease.   
Correlations between striatal dysfunction and cognitive performance have also been 
found using functional studies of neurotransmission systems.  Different PET studies have found 
reductions in dopamine binding in the striatum in patients with HD (Backman et al., 1997; Berent 
et al., 1988; Bohnen et al., 2000; Ginovart et al., 1997).  
Changes in cognitive performance induced by reduction of dopamine binding have also 
been observed in patients with HD.  Brandt et al. (1990)  showed that HD patients with reduced 
D2 receptor binding in the caudate nucleus presented impairments in tasks that required rapid 
coordination and set alternation.  Reductions in D1 and D2 receptor density in the striatum in HD 
patients have also been correlated with the severity of impairments of executive function, 
perceptual speed, visuospatial skill, verbal fluency, episodic memory, and reasoning (Backman et 
al., 1997).  These correlations between reduced D1 and D2 receptor binding and cognitive deficits 
have also been reported in preclinical carriers of HD (Lawrence et al., 1998b; Lawrence et al., 
1998c).  The relationship between D1 and D2 receptors in the striatum and cognition in HD are an 
area of inquiry that requires further research.   
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Previous research has reported that in addition to motor deficits, dopaminergic receptor 
blockade of the brain dopamine (DA) system also induces cognitive deficits (Amalric et al., 
1993; Baunez et al., 1995; Courtière et al., 2003; Domenger and Schwarting, 2006; Mayfield et 
al., 1993).  However, the functional differences between D1 and D2 receptors in different 
behaviours are not clear.  In order to evaluate the differences between these two receptors, DA 
antagonist drugs that selectively block D1 or D2 have been used.  SCH-23390 is a DA antagonist 
with high affinity for the D1 DA receptor (Billard et al., 1984; Hietala et al., 1992). 
Contrastingly, raclopride is a DA antagonist with a high affinity for the D2 DA receptor and has 
no effect on D1 receptors (Hall et al., 1988; Ögren et al., 1986).  Differential role of the D1 and 
D2 DA receptors in the execution of a reaction time motor task have been reported.  While D1 
receptor antagonist SCH-23390 did not affect the performance on a reaction time task, D2 
receptor antagonist raclopride increased the number of incorrect responses, which suggests that 
reaction time could be differentially affected by a selective dopamine receptor blockade (Amalric 
et al., 1993).  Research in HD could benefit if the PET studies also incorporate a cognitive task 
that could detect differences between the loss of striatal D1 and D2 receptors.  Incorporating both 
methodologies could be useful for monitoring the effects of new treatment interventions in HD.  
The experiment in Chapter 4 was designed to investigate if the performance on a 
probabilistic serial reaction time task was differently affected by the dopamine D1 receptor 
antagonist SCH-23390 or the D2 receptor antagonist raclopride.  Given that changes in cognitive 
performance induced by reductions in D1 and D2 receptor density in the striatum in HD patients 
and preclinical carriers of HD have been observed (Backman et al., 1997; Berent et al., 1988; 
Bohnen et al., 2000; Brandt et al., 1990; Ginovart et al., 1997; Lawrence et al., 1998b), it was 
hypothesised that selective blockade of dopaminergic transmission at the D1 or the D2 receptor 
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would affect implicit memory (the computation of probabilities to predict the location of a 
stimulus).   
1.8.1.2 QA lesions of the rat striatum in an implicit task 
The results presented in section 1.8.1 show that patients with HD are impaired in 
acquiring new motor skills, which suggests that the striatum is necessary for learning implicit 
tasks.  However, the question of whether the striatum, once a task that requires implicit memory 
has been learned, is necessary for continuing performance in the task, has yet to be addressed.  
This will be investigated in Chapter 5 using an animal model of HD with QA lesions of the 
striatum.  If the striatum is necessary for continuing performance in the task once it has been 
learned, it would be predicted that post-surgery the performance on the Spatiotemporal Target 
Probability Signal Reaction Time Task would be affected.   
1.8.2 Habit formation tasks 
In addition to having a general role in the initiation and patterning of different behaviours, 
the striatum has also been associated with habit formation (Packard and Knowlton, 2002; Yin 
and Knowlton, 2006).   
Goal-directed behaviours (i.e., flexible, deliberate actions) are controlled by their 
consequences; thus, they require an association of an action and an expected outcome (A-O).  
When the value of the expected outcome changes, the action should consequently be affected.  
Conversely, habits (i.e., inflexible, automatic actions) are regulated by antecedent stimuli from 
the environment and are behaviours that have become routine and predictable.  Thus, action 
selection is controlled through association of stimulus-response (S-R) without associating the 
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outcome to those actions; therefore, changes in the value of the expected outcome should not 
affect the behaviour (Adams and Dickinson, 1981).   
To evaluate if the behaviour is goal-directed or habitual, the value of the outcome could 
be decreased (devalued) or increased (inflated).  For example, to devaluate the value of a reward, 
animals are given access to the reward before the task.  If the performance of the task is 
unaffected after the value of the outcome is manipulated, then the behaviour is habitual.  
Conversely, if the performance is affected after the value of the outcome is manipulated (e.g., the 
rate of responding decreases after the reward is devalued), then the behaviour is goal-directed.  In 
addition, if degrading the contingency between action-outcome (e.g., rewards are delivered 
regardless of the behaviour), has no effect on the performance of the task, then the behaviour is 
habitual and not goal-directed (Dickinson, 1985; Dickinson and Balleine, 1994).    
Whereas S-R associations mediating automatic habitual behaviours require implicit 
memory, it has been suggested that deliberate actions (i.e., goal-directed behaviours) are encoded 
in declarative memory (Dickinson, 1980; Knowlton et al., 1996a).   
As previously mentioned (section 1.8.1),  it has been suggested that the basal ganglia 
mediates some forms of implicit or automatic (habit) learning, and the dorsal striatum, in 
particular, has been reported as a critical brain structure for implicit tasks that require motor 
skills (Graybiel, 1995; Salmon and Butters, 1995).  In rats, the DMS have been suggested to be 
involved in A-O learning.  To assess the role of the striatum in habit learning, rats were trained to 
press a lever in order to receive a reward under a variable interval schedule.  They then received 
a devaluation of the reward using conditional taste aversion, which consisted of pairing of the 
reward with administration of lithium chloride (which makes rats sick).  Rats with lesions of the 
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DMS responded habitually (i.e., the effects of devaluating the outcome did not affect the 
performance), which suggests that lesions of the DMS do not affect habit learning (Yin et al., 
2004).   Yin et al. (2005) continued this line of research by investigating the effects of lesions of 
the DMS in the performance of goal-directed instrumental actions.  Using a procedure with two 
actions and two outcomes under variable ratio schedules, the authors found that lesions of the 
posterior DMS (pDMS), as well as local inactivation of this area, abolished sensitivity to 
devaluation and degradation, which suggested that the pDMS was necessary for the acquisition 
and expression of goal-directed actions.   
The role of the dorsal striatum in habits has also been investigated using the place and 
response learning task.  In this task, the rats were always placed in the same starting point, and 
they were trained to retrieve the reward from a consistent arm in a cross-maze.  Probe trials 
consist of moving the starting point to the opposite side of the maze and allowing them to 
approach a maze arm.  If the rats turned to the opposite side to the one that was learned during 
training, they were considered place learners.  Accordingly, it was suggested that the behaviour 
was flexible as they were incorporating spatial cues to decide the side to turn.  Conversely, if rats 
continued performing the same response (i.e., continued turning to the same side) as in the 
training phase, they were considered response learners, which shows that the behaviour was 
inflexible and response specific.  At the beginning, most rats used the place strategy, but after 
repeated testing, they switched to a response strategy (inflexible and response specific 
behaviour).  Rats with inactivation of the dorsal striatum continued using the place strategy, 
independently of the number of trials, which suggests that the dorsal striatum was required to 
switch between goal-directed actions to habitual responding (Packard and Knowlton, 2002; 
Packard and McGaugh, 1996).  
Chapter 1 
54 
 
Instead of characterising habitual behaviours as associations between stimulus and 
response, another approach in the study of habits has defined them as a stereotypic, ritualistic 
behaviour that consists of sequential movements (Graybiel, 1998).  To study the formation of 
sequential habits, Desrochers et al. (2010) designed a task in which monkeys were presented with 
a grid of four or nine dots, one of which was randomly baited after a variable delay.  Once the 
monkey captured the baited target by fixating or saccading through the target dot, a reward 
became available.  However, given that the baited dot changed every trial, it was unpredictable 
where and when the target would become baited.  Therefore, no particular response or sequence 
of responses would produce a reward, and no fixed S-R habit would be required to solve the task.  
Using this task, Desrochers et al. (2010) found that even though the monkeys were free to move 
their eyes in any direction to find the target, there was no explicit training to develop a pattern of 
saccades to scan the grid.  Monkeys developed a dot-looking visual habit to scan the target grids 
without training and without explicit S-R associations.  However, even though Desrochers et al. 
(2010) described the scanning pattern as habitual behaviour, it remains to be investigated if the 
behaviour is affected by the outcome.  As Dickinson (1985) suggested, if the performance of the 
task is unaffected after the value of the outcome is manipulated, then the behaviour is considered 
habitual.  Chapter 6 implemented a task, adapted from that of Desrochers et al. (2010) in which 
rats nose poked a row of five holes to find a target hole selected randomly on each trial (no cue 
would indicate which hole would produce the reward) to evaluate habit formation in rats with 
QA lesions of the DMS.   
Changes in goal value were assessed by using a devaluation of the reward, in which rats 
had free access to the reinforcement in their home cages before testing and the reward was not 
delivered during the session.  It was hypothesised that if habits were formed, the performance on 
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the task would not be affected even though the value of the reward was devalued.  In addition, to 
evaluate if lesions of the DMS would impair goal-directed behaviour (i.e., the association of an 
action and an expected outcome), in the last phase all of the conditions remained the same, but 
the central hole never produced a reward.  Since there were no cues to indicate the change, the rat 
had to learn through the task that nose poking into the central hole would never produce a 
reward.  Habit responding would consist of continuing responding to the central hole.  Thus,  it 
was hypothesised that if the DMS is required to learn goal-directed behaviours, rats with DMS 
lesions would show habit responding and would continue responding to the central hole 
regardless of no further reinforcement for that response.   
1.8.3 Attentional set-shifting tasks 
One of the cognitive deficits in patients with Huntington’s disease is a decrement in 
behavioural flexibility (i.e., the ability to adjust responses according to the specified context and 
requirements of varying situations).  Attentional set-shifting, which is a process of shifting 
attention from one perceptual dimension to another, is an aspect of behavioural flexibility that 
has been assessed in humans using the Wisconsin Card Sorting Test (WCST; Berg, 1948).  In 
this test, the participants are given 60 response cards.  Each card has one to four identical figures 
of a single colour.  There are four different figures (stars, crosses, triangles, and circles) and four 
different colours (red, yellow, blue, and green).  The participants are presented with four stimulus 
cards that differ in number, form and colour and they are asked to match the response cards to 
one of the four stimulus cards.  Each card could be sorted according to number, form, or colour 
of the figures; however, the participants are not told the stimulus dimension to use in order to sort 
the cards.  They only receive feedback when a particular match is right or wrong; therefore, the 
strategy to sort the cards must be inferred from the feedback provided.  After five consecutive 
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correct responses, the sorting rules are changed and the participants not only need to discover the 
new sorting rule, but they also need to stop responding to the old rule for the newly sorted cards.  
The WCST measures the ability to make this shift by analysing the errors, time to complete the 
task, and the amount of perseveration (i.e., previously rewarded responses that persist when they 
are no longer beneficial).   
Although the prefrontal cortex (PFC) mediates different forms of behavioural flexibility 
(Chase et al., 2012; Dias et al., 1996a), flexible behaviour is not only supported by this structure 
but by a larger neural network which includes the prefrontal-basal ganglia circuits.  The striatum 
is one of the brain structures that has been suggested to interact with the PFC to mediate 
behavioural flexibility (Ragozzino, 2007).  Ragozzino et al. (2002b) examined the effects of 
inactivating the dorsomedial striatum in a task that required rats to switch from a response 
discrimination to a visual cue discrimination and vice versa.  Rats were trained either on a 
response or on a visual cue discrimination task.  On the response discrimination task, regardless 
of where a white visual cue was placed, rats always had to make a 90° turn to the right to receive 
cereal reinforcement.  Alternatively, rats on the visual cue discrimination always had to enter the 
visual cued arm, which required making turns to the right or to the left.  Inactivation of the DMS 
by infusing 2% tetracaine, a local anaesthetic, when rats were changed between the conditions, 
impaired switching from a response to a visual cue discrimination and vice versa.  This impaired 
behavioural flexibility was due to an inability to maintain the new task strategy.  Likewise, 
excitotoxic lesions of the DMS impaired rats in reversing an instrumental spatial discrimination 
(the previously correct lever became incorrect and the previously incorrect lever became correct).  
The reversal deficits were present because rats failed to suppress perseverative responding from 
the previous contingency (Castañé et al., 2010). 
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Impaired performances on reversal learning after lesions of the dorsomedial striatum have 
suggested that this region is important for flexible alternation of strategies or for response 
patterns when environmental conditions change (Castañé et al., 2010; Ragozzino, 2007; 
Ragozzino et al., 2002b).  To support the idea that the striatum plays a critical role in behavioural 
flexibility, it has been reported that in diseases where the striatum is affected, such as HD, 
patients manifest flexible behaviour deficits on the WCST.  Josiassen et al. (1983) compared the 
performance of patients with recently diagnosed HD (diagnosed for one year or less) with 
moderate HD patients (diagnosed for more than a year to eight years) on the WCST.  While both 
groups were able to infer the first sorting rule without difficulty, changing the sorting rule 
showed that patients with moderate HD had deficits in behavioural flexibility (i.e., they 
perseverated in using the past sorting rule).  Various imaging studies have suggested that the 
deficits seen in HD patients in the WCST result from changes in striatal function rather than in 
the frontal cortex (Lawrence et al., 1998b, for a review).  For example, using high resolution 
single photon emission computerised tomography (SPECT), Hasselbalch et al. (1992) showed 
that blood flow is reduced in the caudate nucleus of patients with HD and that there is a positive 
linear relationship between blood flow in the caudate nucleus and performance of the WCST and 
in patients with HD. 
Although the WCST examines the transference from perceptual dimensions between 
stimuli (colour to shape, shape to number, number to colour, etc.) when the sorting rule changes, 
the task can be solved using different strategies, including matching to sample.  Furthermore, 
given the structure of the task, successful completion of the WCST is not only limited to 
behavioural flexibility.  Other executive processes such as: remembering the goal of the task, the 
ability to respond to feedback to infer the sorting rule, recognizing that new sorting rules are 
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required along the task, flexibility to change strategies to find the new sorting rule, maintaining 
that response and stopping to respond to the previous sorting rules, are required to successfully 
complete the task.  However, deficits in any of these cognitive processes are not accounted in the 
scoring system, which makes it impossible to identify if the impaired performance on the WCST 
are limited to deficits in behavioural flexibility.  Therefore, attentional set-shifting abilities 
become difficult to assess.   
To address some of these issues, Roberts et al. (1988) modified the task so that the early 
stages could identify these executive functioning deficits and would prevent the subject to 
progress to the stages that evaluate set-formation and shifting.  The Intra-Dimensional/Extra-
Dimensional attentional set-shifting task is a computerised test that displays white lines 
superimposed onto blue-filled shapes on a touch screen as the two perceptual dimensions.  The 
ID/ED attentional set-shifting task, studies the formation, maintenance and shifting of cognitive 
sets.  In this task, humans and marmosets were required to learn a series of two-choice 
discriminations in which one stimulus from one of the two dimensions (shape or line) was 
correct.  Feedback of incorrect and correct responses was provided by the computer.  The ID/ED 
attentional set-shifting task consisted of a series of stages.  The first stage was the simple 
discrimination (SD) stage in which subjects had to choose one of two stimuli which are equal of 
the same dimensions (i.e., either shape or line).  For example, from the shape dimension, two 
different shapes were presented, but only one was the correct stimulus.  Subjects completed 60 
trials per day for a given stage until they reached a criterion of 90% correct responses in one 
session.  At the following stage, the simple reversal (SR) stage, the contingencies were changed 
and the previously correct shape stimulus became incorrect and vice versa.  The criterion for the 
reversal stage was 18 correct responses out of the last 20 trials.  At the third stage, the compound 
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discrimination (CD) stage, stimuli from the alternative dimension were introduced.  The lines 
(i.e., irrelevant stimuli) were superimposed over the shapes (i.e., relevant stimuli) to form a 
compound stimulus.  Therefore, there were four compound stimuli: Line-A/Shape-A, Line-
A/Shape-B, Line-B/Shape-A, and Line-B/Shape-B.  On any one trial, the lines and shapes were 
intermixed.  On some trials, Line-A/Shape-A was combined with Line-B/Shape-B; on others, 
Line-A/Shape-B was presented with Line-B/Shape-A.  In order to respond correctly, subjects had 
to stay with the previously relevant stimulus (shape) and ignore the irrelevant stimulus (line).  
Therefore, if Shape-B had been reinforced in the previous stage, it remained reinforced 
regardless of whether it formed a compound stimulus with Line-A or Line-B.  Given that each 
shape was paired with each line, an irrelevant dimension stimulus only predicted a reward 50% 
of the time, whereas the relevant dimension stimulus predicted reward 100% of the time.  This 
stage continued until 90% correct responses were made in a session of 60 trials.  At the fourth 
stage, the compound discrimination reversal (CDR) stage, the compound stimulus containing the 
previously incorrect shape became the correct choice and vice versa.  The criterion to move to 
the next stage was 18 correct responses out of 20.  At the fifth stage, the probe test, new 
exemplars of the irrelevant dimension were introduced (Line-C and Line-D), but the relevant 
dimension stimuli did not change (Shape-A and Shape-B were used) and the reinforcement 
contingencies were similarly unaltered.  The previously rewarded shape remained reinforced 
regardless of whether it formed a compound stimulus with Line-C or Line-D.  This stage was 
used only for one session to measure if the subject had learned to ignore the irrelevant dimension 
in the compound stimuli.  In the next stage, subjects were returned to the previous compound 
stimuli used in the CDR stage.  This stage continued until 90% correct responses were made over 
60 trials over the course of two consecutive days.  For the final stage, subjects received either an 
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Intra-, or Extra-dimensional shift stage.  For these stages, new compound stimuli were introduced 
which were composed of new shapes and lines.  In the ID stage, the relevant dimension was the 
same from the previous stages (e.g., shape).  Thus, subjects had to continue to ignore the line 
dimension and base their choices solely on the shape’s dimension.  In the ED shift stage, subjects 
needed to shift their attention between the different stimuli dimensions.  In this stage, the shape’s 
dimension became irrelevant, and the line became the relevant stimuli dimension.  It has been 
suggested that this stage is analogous to the change in category in the WCST (Grant and Berg, 
1948), whereby the experimenter introduces an ED shift by changing the sorting rule and the 
subject has to learn to shift to the new sorting rule (Grant and Berg, 1948).  Finally, the last stage 
was a reversal stage.  The group that had an ID stage, received an ID reversal (IDR), whereby the 
compound stimulus containing the previously incorrect shape became the correct choice and vice 
versa.  For the group that received the ED stage, they received an ED reversal (EDR), whereby 
the compound stimulus containing the previously incorrect line became the correct choice and 
vice versa.   
The ID/ED attentional set-shifting task showed that the subjects that had to distinguish 
between stimuli varying along a different dimension (ED) from the previous stage (i.e., lines to 
shapes or shapes to lines) made more errors than those required to distinguish between stimuli 
varying along the same dimension (ID) from the previous stage (i.e., shapes to shapes or lines to 
lines).  Suggesting that humans and marmosets were able to learn to attend to the relevant 
dimension of a stimulus (Roberts et al., 1988).  It is important to note that the example used to 
describe the test was based on shapes being the initial relevant dimension.  However, in the test, 
the conditions are counterbalanced so that half of the subjects receive a line as the initial relevant 
dimension and the other half receive a shape as the relevant dimension.  
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The Intra-Extra Dimensional Set Shift (IED) task from the Cambridge 
Neuropsychological Test Automated Battery (CANTAB; 2002) is a modified version of the task 
that has been used to measure behavioural flexibility.  As in the ID/ED attentional set-shifting 
task from Roberts et al. (1988), participants are told that there is a rule that they can learn in 
order to find the correct stimulus each time; however, this rule will change once it is apparent 
that they have understood the currently correct rule.  In this version of the task, subjects are 
tested in both the ID and the ED shift stages.  The test consists of nine stages: SD, SR, C_D (first 
compound discrimination, where the irrelevant stimuli are introduced and are paired side by side 
with the relevant stimuli), CD, CDR, ID, IDR, ED, and EDR.  After six consecutive correct 
choices at one stage, the test automatically proceeds to the next stage.  If the criterion of six 
correct choices is not reached within 50 trials, the test is discontinued.  Since the task is designed 
as a series of stages, executive functioning deficits in learning from feedback, maintain a 
response over time or keeping a future goal in mind, are detected in the early stages and prevent 
the subject to progress to the next stages.  So, any impairment in performance on the ID or ED 
shift stages, which are the last stages, cannot be attributed to deficits to those cognitive processes.  
Therefore, the structure of the ID/ED attentional set-shifting task provides a more controlled 
measure than the WCST for the cognitive processes that are involved to successfully complete 
the task.   
Patients with damage to the striatum arising from HD, exhibit deficits in the ID/ED 
attentional set-shifting task (Lawrence et al., 1998b).  Depending on the progression of the 
disease, patients with HD had shown different impairments in the ID/ED attentional set-shifting 
task.  Patients in the early stage of HD showed impairments in the ED shift (i.e., they had deficits 
when the task required them to shift responding from stimuli of one perceptual dimension to 
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stimuli of another dimension) and they made more perseverative than non-perseverative errors 
(i.e., they kept on responding to the previous relevant stimuli dimension, when it was no longer 
relevant).  However, they were not impaired in set-formation or reversal learning.  Less than 20% 
of the participants in early stage HD were able to complete all the stages of the task (Lawrence et 
al., 1996).  To investigate the impaired ED shift performance in HD patients, Lawrence et al. 
(1999b) used two modified versions of the ID/ED attentional set-shifting task.  Until the ED 
stage, the initial stages were the same for both tasks.  However, the ED stage for the 
perseveration condition replaced the irrelevant dimension with a new dimension (which became 
the relevant dimension) and the learned irrelevance condition replaced the previously relevant 
dimension with a new dimension (which was irrelevant for task performance).  Perseveration was 
described as the inability to release attention from relevant perceptual dimension, and learned 
irrelevance was defined as the inability to reengage attention to the previously irrelevant 
dimension (Owen et al., 1993).  Results showed that early stage HD patients were able to learn 
that the previously irrelevant dimension became relevant.  Accordingly, their set-shifting 
impairments resulted from perseverative responding (i.e., inability to stop responding) to the 
stimulus dimension that was relevant in the stages before the ED (Lawrence et al., 1999b).  These 
results are consistent with previous data that shows that HD patients are impaired in shifting sets  
(Josiassen et al., 1983).    However, patients in advanced HD showed reversal impairments (i.e., 
they continued selecting the previously reinforced stimuli even though it was no longer correct) 
and also failed to complete the task.  Patients in advanced stages of HD cannot complete the 
reversal stages and rarely reach the ED stage (Lange et al., 1995).  It has also been reported that 
preclinical carriers of the HD mutation, before the onset of any clinical movement disorder, 
showed specific deficits in the ED stage of the ID/ED attentional set-shifting task.  Therefore, the 
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ID/ED attentional set-shifting task seems to be a tool that is capable of detecting subtle 
impairments earlier than many other cognitive tasks and before the development of the 
movement disorders in HD (Lawrence et al., 1998a). 
 Birrell and Brown (2000) adapted the ID/ED attentional set-shifting task for rodents.  
Like the human version, the rodent ID/ED attentional set-shifting task consists of multiple stages 
(simple and compound discrimination, reversals, ID and ED shifts) in which the shifting rules 
change.  Using different digging medium and odour stimuli as the stimulus modalities, rats are 
presented with a pair of bowls in which only one is baited.  Rats need to dig in the bowl that 
contains the correct stimulus exemplar to retrieve the hidden food reinforcement.  In this task, the 
rats perform a series of seven stages that are analogous to those in the human task.   
Mice have also been tested on the rodent ID/ED attentional set-shifting task (Brigman et 
al., 2005; Colacicco et al., 2002; Garner et al., 2006).  However, even though there are several 
transgenic rodent models of HD (Menalled and Chesselet, 2002, for a review), at present, there is 
only one study that had tested a knock-in model of HD in the attentional set-shifting task (Brooks 
et al., 2006).  A 24 week old HD homozygous Hdh
(CAG)150
 knock-in mouse line was tested in a 
modified version of the rodent ID/ED task.  This version consisted of only five discrimination 
stages (simple discrimination, compound discrimination, compound reversal, intradimensional 
acquisition, and extradimensional shift).  Each stage was tested on separate days.  Although there 
was no difference between the Wild type (Wt) mice and the knock-in mouse model of HD on the 
reversal stage, the knock-in line required more trials to complete the ED shift stage.  However, 
this difference might be the result from the decreased number of trials of the Wt mice at the ED 
stage compared to the ID stage, which suggests that the Wt mice formed no attentional set.  Two 
other characteristics of the mouse line that was used were that they present only mild HD-like 
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behavioural symptoms and they lack striatal atrophy; therefore, the role of the striatum in the 
rodent ID/ED task remains unknown. 
Given that the ID/ED task has been able to identify cognitive deficits in HD patients even 
before any motor symptoms manifest (Lawrence et al., 1998a), and since different studies have 
suggested that the striatum is essential for effective set-shifting (Castañé et al., 2010; Ragozzino 
et al., 2002b), Chapter 7 evaluates if rats with bilateral quinolinic acid lesion of the dorsomedial 
striatum present similar cognitive deficits in the attentional set-shifting task as those seen in 
patients with HD.  Based on the performance on the ED/ID task of HD patients (Josiassen et al., 
1983; Lange et al., 1995; Lawrence et al., 1998a; Lawrence et al., 1996; Lawrence et al., 1999b), 
it was hypothesised that rats with QA lesions of the DMS would show impairments in the ED 
shift (i.e., they would have deficits when the task requires them to shift responding from stimuli 
of one perceptual dimension to stimuli of another dimension), would make more perseverative 
than non-perseverative errors (i.e., they would kept on responding to the previous relevant 
stimuli dimension, when it would no longer be relevant), and would have reversal impairments 
(i.e., they would continue selecting the previously reinforced stimuli even though it would no 
longer be correct). 
To test if attentional set-formation is impaired in rats with lesions of the DMS Chapter 8 
presents a series of behavioural tasks designed to further elucidate set-shifting performance with 
the possibility of drawing conclusions on set-formation.  In addition, differences between DMS 
and the dorsolateral striatum (DLS) in reversal performance have been reported using an 
instrumental two-lever spatial discrimination task in rats.  While rats with DLS lesions showed 
no reversals impairments, rats with lesions of the DMS showed a significant impairment in 
reversal learning (Castañé et al., 2010).  Therefore, given that it has been suggested that different 
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striatal sub-regions may be implicated in different forms of flexible behaviour (Castañé et al., 
2010) to assess the specificity of the role of the DMS in set-shifting performance, a group with 
lesions of the DLS was added. 
Thus, Chapter 8 evaluates the contributions of the DMS and the DLS in reversal learning, 
set-formation, and set-shifting in rats.   
1.9 Outline of experimental work in this thesis 
This thesis focused mainly on evaluating the behaviour of rats with QA lesions of the 
striatum, which mimic some aspects of the neural damage in HD, in order to try to identify 
cognitive deficits of HD caused by cell loss in the striatum.   
The experiments described in this thesis may be divided into three parts.  
In the first part (Chapters 3-5), the role of the striatum in implicit memory is investigated.  
Chapter 3 reports on the development of a new task in rats and humans for examining reaction 
time and computation of probabilities of a location of a target.  The task presents lateralised 
visual stimuli with differing probabilities that change over time.  At short foreperiods (i.e., the 
interval between a warning signal and the stimulus to which the subject was to respond), the 
stimuli were more likely on the left side but, as time elapsed, presentation of the stimuli on the 
right side became more likely.  It was expected that with practice, reaction times would be faster 
on the side in which the stimulus was more likely to appear (left side at shorter foreperiods and 
right side at longer foreperiods).  The aim of this experiment was to find a task that could detect 
deficits in implicit memory (computation of probabilities of a location of a target) in rodents that 
were transitional to humans, so potential treatments for HD could be tested.  Since a loss of 
striatal D1 and D2 receptors in HD has been reported.  Chapter 4 uses the same task used in 
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Chapter 3 in order to investigate if implicit memory (the computation of probabilities to predict 
the location of a stimulus) is affected by a selective blockade of dopaminergic transmission at the 
D1 or D2 receptors by SCH-23390 and raclopride, respectively.  Chapter 5 also uses the task 
described in Chapter 3 as a means of evaluating the role of the striatum in computation of 
probabilities of a location of a target in rats with bilateral QA lesions of the dorsomedial striatum 
(an animal model of HD). 
In the second part (Chapter 6), the contribution of the dorsomedial striatum (DMS) in 
habit formation is explored.  Chapter 6 implements a task, adapted from that of Desrochers et al. 
(2010), in order to evaluate habit formation in rats with QA lesions of the DMS. 
 In the third part (Chapters 7 and 8), the role of the dorsal striatum in attentional set-
shifting is investigated.  Chapter 7 tests rats with bilateral QA lesions of the DMS in the 
attentional set-shifting task in order to determine if the animal model presents similar cognitive 
deficits in behavioural flexibility as those seen in patients with HD.  Chapter 8 presents a series 
of experiments as a means of investigating the role of the dorsolateral or the dorsomedial 
striatum in reversal learning, attentional set-formation, and set-shifting in rats with QA lesions. 
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Chapter 2 
2 General Methods 
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2.1.1 Animals  
The animals used in Chapters 3, 4, and 8 were experimentally-naïve male hooded Lister 
rats (Charles River, UK Ltd).  While the animals used in Chapter 6 were experimentally-näive 
male hooded Lister rats (Harlan, UK Ltd).  Table 2.1 shows the start and finish weights of all the 
rats used in this thesis.  The rats were housed, in groups of up to four, in plastic box cages (50 x 
25 x 30 cm) and handled five days a week.  After habituation to the conditions of the animal 
colony, food was restricted to 15-20 g per rat, per day, of standard laboratory rat chow (Special 
Diet Services, Essex, UK).  Body weight was monitored weekly to ensure steady gain.  Water 
was available ad libitum in the home cage.  Lights were on a 12:12 hr light-dark cycle with lights 
on at 7 a.m.  Testing was conducted during the light phase.  All experimental and welfare 
practices described herein complied with the Animal (Scientific Procedures) Act 1986, and were 
carried out under the authority of project licenses approved by the United Kingdom Home Office 
and the University of St Andrews Animal Welfare and Ethics Committee.  
 
Table 2.1. 
Start and finish weights of all the rats used in this thesis 
Chapter Number of rats Start weights (range) End weights (range) 
Chapters 3, 5 & 7 24 276 – 307 g 473 – 599 g 
Chapter 4 8 289 – 315 g 447 – 520 g 
Chapter 6 16 256 – 321 g 407 – 572 g 
Chapter 8 36 288 – 330 g 417 – 580 g 
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2.1.2 Surgery 
The surgical protocol was based on that previously described by Castañé et al. (2010).  
Anaesthesia was induced by inhalation of 5% isoflurane (Abbott Laboratories Ltd) in oxygen, 
and was maintained between 1-2% throughout the surgery at a flow rate of 2L/min delivered by a 
nosecone fitted on the incisor bar of the stereotaxic frame.  Once anaesthetised, the rats were 
administered a 0.05ml injection (SC) of the anti-inflammatory carprofen (Carprieve, Norbrook 
Laboratories LTD, Newry, N. Ireland, UK), and then secured in a stereotaxic frame (David Kopf 
Instruments, Tujunga, CA, USA).  Rats were fitted with atraumatic ear bars and with the incisor 
tooth bar set at -3.3 mm relative to the interaural line for a level skull position.  A midline 
incision was made along the scalp, and skin and tissues were retracted.  Once the skull surface 
was exposed, small holes in the skull were made above the appropriate stereotaxic coordinates 
using a dental drill.   
Bilateral lesions of the DMS or DLS were made by infusions (0.125µl per site; 1 min 40 
sec infusion time per site) of 0.09M quinolinic acid (Sigma Aldrich) buffered to pH 7.3-7.4 in 
0.1M phosphate-buffered saline (PBS) using a 0.5µl Hamilton syringe with a 30-gauge round-
tipped needle.  Stereotaxic coordinates for DMS were: AP +1.2, ML ±2.0, DV -4.5 and -5.5; and 
AP +0.2, DV ±2.0, DV -4.5 and -5.5.  Stereotaxic coordinates for DLS were: AP +0.7, ML ±3.6, 
DV -5.5 and -6.0; and AP -0.3, DV ±3.6, DV -6.0 and -6.5.  The needle was left in situ for a 
further 1 min 40 sec after infusion, before being slowly moved to the next DV coordinate, or 
withdrawn.  Coordinates were taken from the skull surface using the bregma as the point of 
origin.  Coordinates for all the surgery are presented in Table 2.2 (based on Castañé et al., 2010) 
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Surgery for control rats was identical to that described above, with the exception that the 
infusions were 0.01M PBS.  After surgery, animals were individually housed; body weight, food 
intake, wound condition, and general health was monitored. 
 
Table 2.2.   
Injection parameters for dorsomedial striatum lesions. 
Lesion 
area 
Injections 
per site 
Excitotoxin Coordinates 
 
Injection 
 
Diffusion 
AP L DV Vol (µl) Time 
(min:s) 
Time 
(min:s) 
DMS 1 0.09 M Quinolinic acid +0.2 ±2.0 -5.5 0.125 1:40 1:40 
     -4.5 0.125 1:40 1:40 
   +1.2 ±2.0 -5.5 0.125 1:40 1:40 
     -4.5 0.125 1:40 1:40 
 
DLS 1 0.09 M Quinolinic acid -0.3 ±3.6 -6.5 0.125 1:40 1:40 
     -6.0 0.125 1:40 1:40 
   +0.7 ±3.6 -6.0 0.125 1:40 1:40 
     -5.5 0.125 1:40 1:40 
Note.  Abbreviations: DMS, dorsomedial striatum; DLS, dorsolateral striatum; AP 
anteroposterior; L, lateral from midline; DV, dorsoventral.  DV coordinates were taken 
from the skull surface (table adapted from Castañé et al., 2010). 
 
2.1.3 Histology 
Once the behavioural testing was completed, rats were anaesthetised with a lethal dose of 
0.8 ml Dolethal (intraperitoneal, IP; Univet, Bicester, UK) and perfused transcardially with 4% 
paraformaldehyde in 0.1M phosphate buffer (PB; disodium hydrogen orthophosphate and sodium 
dihydrogen orthophosphate in distilled water).  Brains were removed and stored overnight at 4°C 
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in a 20% sucrose solution, then washed three times in distilled water and allowed to dry.  Brains 
were placed in individual wells and surrounded with egg yolk, before being placed in a 40% 
formaldehyde bath for five days to allow the tissue to fix.  Brains were then cut to 50m sections 
on a microtome (Jung Histoslide 2000, Reichert-Jung, Cambridge Instruments GmbH) into 0.1M 
PBS (0.9%).  Brain sections were double-stained for neuronal nuclei (NeuN) and with cresyl 
violet to visualise cell nuclei and cytoarchitecture in order to map lesion extent. 
For NeuN, sections were washed 5 times for three minutes in 0.1M PBS, then placed on a 
stirrer for 1 hour in blocking solution (0.1M PBS, 20% normal goat serum, 0.1% triton).  
Sections were washed, as previously in 0.1M PBS, then incubated in anti-NeuN (1:4000; 
Chemicon International, Temecula, CA, USA) in antibody diluting solution (ADS; 0.1M PBS, 
1% normal goat serum, 0.1% triton) on a stirrer for 1 night.  Subsequently sections were washed 
in 0.1M PBS as before, then incubated in a stirrer in vector IgG solution (anti-mouse IgG at 
5l/ml ADS; Vector Laboratories Ltd, Peterborough, UK) for 1 hour.  After being washed in 
0.1M PBS again, sections were incubated in a stirrer in Vectastain ABC complex (Vector 
Laboratories Ltd, Peterborough, UK; reagents A and B at 10l/ml ADS) for a further hour.  
Sections were then washed in 0.1M PBS again and finally immersed in Sigma Fast 3.3-
Diaminobenzidine tablets (DAB; Sigma Chemical Company, St Louis, MO, USA) for 
approximately 10 minutes, with the time being determined by visual inspection of the tissue.  The 
tissue was removed during the point at which background staining was minimal but neurons were 
clearly visible.  Sections were washed again in 0.1M PBS and then mounted on treated glass 
slides. 
Sections were then de-fatted with xylene, and re-hydrated with ethanol, then 50% ethanol 
solution, then water.  Sections were immersed in cresyl violet solution (cresyl fast violet acetate 
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dissolved in distilled water and glacial acetic acid, pH adjusted to 3.5 with sodium acetate) for 2 
minutes then washed in running water for 5 minutes.  Sections were subsequently dehydrated in 
50% ethanol solution, ethanol and finally xylene before being cover slipped with DPX mountant 
(BDH Laboratory Supplies, Poole, UK). 
Lesions were verified by light microscope examination of areas and cell damage was 
noted by lack of neuronal staining.  The extent of lesions was mapped onto standardised sections 
of the rat brain using a stereotaxic atlas by Paxinos and Watson (2007). 
2.1.4 Data analyses 
Statistical analyses.  All analyses were conducted in IBM SPSS (v 21, SPSS Inc., 
Chicago, IL).  The criterion for significance (alpha level) was p < .05 in all cases.  Sidak’s-
corrected pairwise comparisons were calculated, which is less conservative than Bonferroni’s 
correction, and there is no loss of power associated with Bonferroni corrected values; it controls 
the family wise error only when the comparisons are independent (Field, 2013). 
Effect size was computed to gain an index of the strength of the contribution of the 
manipulated variable.  A partial eta
2
 (ηp2) statistic was used to determine the variance accounted 
for by an effect and that effect plus its associated error variance: 𝜂𝑝𝑎𝑟𝑡𝑖𝑎𝑙
2 =
𝑆𝑆𝑒𝑓𝑓𝑒𝑐𝑡
𝑆𝑆𝑒𝑓𝑓𝑒𝑐𝑡+𝑆𝑆𝑒𝑟𝑟𝑜𝑟
 , 
where 𝑆𝑆𝑒𝑓𝑓𝑒𝑐𝑡 was the sum of squares associated with each effect in the model and 𝑆𝑆𝑒𝑟𝑟𝑜𝑟 was 
the sum of squares for the error term associated with that effect.  
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Chapter 3 
3 Spatiotemporal Target Probability Signal 
Reaction Time Task: Performance of Rats and 
Humans  
 
Rats and humans were tested in the Spatiotemporal Target Probability Signal Reaction 
Time Task: a reaction time task that presented visual stimuli with differing probabilities which 
changed over time.  At shorter foreperiods, the stimuli were more likely to appear on the left 
side, but at longer foreperiods, the stimuli were more likely to appear on the right side.  Having a 
task that detects deficits in the computation of probabilities of the location of stimuli in rats, on 
which humans can also be tested, will allow further investigation of animal models of HD to 
evaluate potential treatments for the disease. 
 
Do rats and humans have faster reaction times to stimuli presented in a more probable 
location, even when the location changes as a function of time-in-trial? 
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3.1 Introduction 
Prediction of future events is a pervasive function of the brain.  However, in order to 
make accurate predictions, time-based patterns need to be recognised, stored and recalled 
(Hawkins et al., 2009).  Most predictions are based on the implicit learning that occurs when 
information is acquired from an environment of complex stimuli, without conscious access either 
to what was learned or to the fact that the learning occurred (Janacsek and Nemeth, 2012).  
Implicit learning has been defined as the knowledge that is acquired with practice but without 
awareness of the process or the product of the acquisition (Reber et al., 1991).  It has been 
suggested that a great variety of everyday situations require the retrieval of previous implicit 
learning.  For example, operations of appliance, computer applications, and even playing an 
instrument require implicit memory (Romano et al., 2010).  Some social situations that require 
the prediction of emotions, or prediction of others’ behaviour based on previous verbal and 
nonverbal social communication have also been considered to require implicit memory (Janacsek 
and Nemeth, 2012).  Therefore, it has been suggested that implicit memory is not only related to 
motor skills, but also to cognitive and social skills (Kaufman et al., 2010), which are important 
aspects across life.  
The basal ganglia have been reported as a critical brain structure for implicit learning 
(Paulsen et al., 1995a); in effect, deficits in implicit learning have been observed in diseases in 
which there is neuronal loss of the striatum, such as HD (Knowlton et al., 1996b).  While the 
performance of HD patients is normal on implicit memory tasks that involve lexical, semantic 
and pictorial priming, their performance is impaired on implicit tasks that require the generation 
and modification of central motor programs to guide behaviour (Butters et al., 1994).  For 
example, some of the implicit learning tasks in which HD patients have shown impairments 
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include rotor-pursuit perceptual-motor learning, weight judgement, prism adaptation, mirror 
reading and weather probabilistic classification task (see section 1.8.1 from the General 
Introduction).  However, as previously mentioned, these tasks were designed for humans, and the 
behaviours required to perform the tasks cannot be tested in animals.  Thus, implicit learning in 
animal models of HD has been restricted.  This suggests the necessity to develop and validate 
new tests of striatal function in which the effectiveness of treatments for HD could be evaluated.   
Therefore, the aim of this experiment was to develop a valid task that measured implicit 
memory which could be performed by both rats and humans.  Because it has been suggested that 
the striatum is involved in the calculation of probabilities that predict an outcome (Knowlton et 
al., 1996b), a reaction time task was modified to allow the study of implicit memory by 
incorporating the computation of probabilities to predict the location of the stimuli.  In this 
reaction time task, the location of the target (spatial probability) changed as a function of the 
length of the foreperiod (temporal probability).  Thus, at shorter foreperiods, targets on the left 
side were more probable than targets on the right side, but at longer foreperiods, targets on the 
right side became more probable than the targets on the left side.  If implicit learning occurred it 
was expected that, during the task, subjects would gradually have faster reaction times on the left 
side at shorter foreperiods, and have faster reaction times on the right side at longer foreperiods 
(the more probable location of the targets), even though they would not have conscious 
knowledge of the location where the stimuli were more likely to appear.   
3.2 Method 
3.2.1 Subjects 
Twenty four experimentally-naïve male hooded Lister rats (Charles River, UK Ltd) with a 
mean ad libitum weight of 290 g (range = 276 - 307 g) at the beginning of the experiment.  The 
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rats were housed in pairs in plastic box cages (see the General Methods sections in Chapter 2 for 
more details).  Housing and husbandry conditions were described in the General Methods in 
Chapter 2.   
In addition, 35 human adults (11 males, 24 females; with an age range of 18-40 years) 
students at the University of St Andrews participated in the study for a fee of £5.  All participants 
had normal or corrected-to-normal vision and were recruited through the University of St 
Andrews SONA experiment participation scheme.  The study was approved by the University of 
St Andrews University Teaching and Research Ethics Committee (UTREC; see Appendix). 
3.2.2 Apparatus 
For rats.  All phases of the experiment were conducted in a set of four nine-hole operant 
chambers (Paul Fray Ltd, Cambridge, UK; see left image of Figure 3.1).  Each chamber was 
enclosed in a ventilated, sound-attenuating cubicle.  An extractor fan provided a constant low-
level of background noise and a continuous airflow.  The floor of the chamber was comprised of 
a stainless steel grid.  The rear wall of each chamber was concave and had a horizontal array of 
nine holes; however, only the three central holes were used for this study (holes 4, 5 and 6 from 
left to right) and the other three holes located on the left (holes 1, 2 and 3) and on the right (holes 
7, 8 and 9) of the three central holes were blocked with metal covers.  Visual stimuli were 
presented by the illumination of a white bulb placed at the rear of each hole.  Each hole contained 
a vertical photocell beam located at the front of each hole to detect nose entries.  In the opposite 
wall, a 5.1 cm × 5.1 cm pellet hopper with a hinged panel was located 2.5 cm above the floor, 
and this received, according to the schedule, 45-mg TestDiet precision food pellets (Richmond, 
IN, USA) from a magazine pellet dispenser.  The panel occluding the hopper was connected to a 
micro-switch that indicated its opening and contained a 28-volt cue light.  A 3-W yellow house 
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light was located on the ceiling of the chamber.  Auditory stimuli were produced from a tone 
generator, connected to a loudspeaker, located in the centre of the ceiling of the chamber.  The 
presentation of stimuli and the collection of data were controlled by computers with a custom 
built interface, programmed in a version of BBC Basic (SPIDER; Paul Fray Ltd, Cambridge, 
UK).  The temporal resolution of the instrumental set-up was 0.1 sec. 
For humans.  One of the nine-hole operant chambers was modified by removing the front 
wall, sterilising the apparatus, and adding a button outside the box to initiate the trials (see right 
image of Figure 3.1). 
 
3.2.3 Procedure 
3.2.3.1 Behavioural protocol for rats. 
Pre-training.  In the initial session, rats were habituated to the operant boxes during one 
30 min session, in which the house light was turned on and there were about 60 pellets available 
in the pellet hopper.  Habituation was completed when the rat had eaten all the pellets in the 
designated time.  During the next sessions, a pellet was dispensed every time the rat pushed the 
Figure 3.1.  Nine-hole operant chamber.  
Left: Operant box used for rats.  Right: Modified operant box for humans. 
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hinged panel of the hopper.  When rats earned 100 reinforcers in a 30 min session within this 
procedure, which typically required five sessions, the pre-training phase finished. 
Instrumental conditioning.  During the subsequent sessions, the animals were trained to 
poke their nose into the illuminated central hole to receive food.  The trial began with the house 
light and the hopper light on.  Once the rat pushed the panel of the hopper, the light of the hopper 
was turned off and the light inside the central hole was illuminated to serve as a signal of trial 
commencement.  The hole light remained lit until the rat poked its nose; once this occurred, the 
light was turned off and the rat was required to sustain the nose poke in the hole until a tone was 
presented.  The duration of the tone was 100 ms and was delivered from the speaker located in 
the ceiling of the chamber.  The duration of time between the nose poke and the tone onset was 
gradually increased across sessions, according to the individual rat’s performance (rats needed to 
complete 120 correct responses within 30 min session), from 100 to 600 ms.  If the animal held 
the nose poke until the onset of the tone a single pellet reinforcer was delivered and a correct 
response was counted; however, if the animal withdrew its nose from the hole before the tone 
was turned on, no pellet was delivered, and a time-out interval was initiated, wherein the house 
light was turned off for 1 sec, and an anticipatory error was registered.  To initiate a new trial the 
rat needed to press the pellet panel.  Sessions finished when the rats received 120 reinforcers in 
total.  Once the animals had a low rate of anticipatory errors (fewer than 20 per session) in the 
600 ms foreperiod and completed at least 120 trials within the 30 min session, they progressed to 
a simple two choice discrimination task in the next session.  This phase was carried out over 14 
training sessions. 
Simple two choice discrimination task.  During the next sessions, all the rats were trained 
in a reaction time task to respond to lateralised visual stimuli to receive food.  Each trial was 
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initiated once the rat pushed the panel of the hopper.  The beginning of a trial was indicated by 
the illumination of the central hole which remained lit until the rat made a nose poke.  In this 
phase, the rat was required to sustain the nose poke for a variable, unpredictable, foreperiod 
delay of 200, 300, 400, 500 or 600 ms.  The end of the foreperiod was indicated by the onset of a 
continuous tone and a target light stimulus on either the right or the left hole (50% to each side 
through a complete session).  The tone was turned off once the animal removed its nose from the 
central hole, but the target light remained on until the rat responded by making a nose poke into 
one of the side holes.  The duration of the target light was initially 5 sec, but it was gradually 
reduced to 3, then 2, and finally 1 sec during the following sessions.  If the animal removed its 
nose from the central hole after the onset of the tone, and the target light, and poked its nose into 
the illuminated side opening while the light was on, a food pellet was delivered and a correct 
response was counted; however, if there was no response on either of the side holes within 2 sec, 
a late error was recorded.  An incorrect response was registered when the animal removed its 
nose from the central hole after the onset of the target stimuli but poked its nose into the side 
opening that was not illuminated.  If the rat failed to hold the nose poke in the central hole for the 
duration of the foreperiod, an anticipatory error was counted.  Late, incorrect and anticipatory 
errors initiated a time-out interval where no pellet was delivered and, after the rat pushed the 
hopper panel, the same trial was restarted.  The session was terminated after either 120 correct 
responses or after 40 min.  A stable baseline of about 80% correct responses was achieved in 14 
training sessions, after which they progressed to the next phase. 
Spatiotemporal Target Probability Signal Reaction Time Task.  The final behavioural 
task differed from the previous one in terms of the probability of the target location cues.  During 
the early foreperiods, the stimuli were more likely to appear on the left, but as time elapsed, 
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presentation of the stimuli became more likely to appear on the right.  A complete schematic 
representation of the Spatiotemporal Target Probability Signal Reaction Time Task is shown in 
Figure 3.2.   
In each session, there were 24 trials for each of the five different foreperiods (200, 300, 
400, 500 or 600 ms), which were pseudo-randomly distributed in a 45 min session (120 trials in 
total).   
 
 
 
Training in this condition continued until the rats were able to complete 120 correct trials 
and had fewer than 25% incorrect responses within a 45 minutes session, for 5 consecutive days.  
 Figure 3.2.  Schematic representation of the Spatiotemporal Target 
Probability Signal Reaction Time Task.  Foreperiods could have durations 
of 200, 300, 400, 500 or 600 ms and were followed by a light stimulus of 
100 ms on either left or right side.  At the early foreperiods, the stimuli 
were more likely on the left side; as time elapsed, presentation of the stimuli 
became more likely on the right.  
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Data was collected for another 10 additional days (1200 trials) and were used for the analysis.  
On average, this phase required 140 sessions.   
3.2.3.2 Behavioural protocol for humans. 
Participants sat in front of the apparatus and were instructed to press the button outside 
the box to initiate the trials.  This would turn off the light on top of the box and would turn on the 
light on the central hole.  Participants were instructed to insert their index finger into the middle 
hole when it was lit, wait until a light on either the right or the left adjacent holes appeared and to 
move their finger as fast as possible to the hole where the light appeared.  They were informed 
that, when an incorrect response was made, a time-out interval, during which time no lights 
would be on, would initiate for 1 sec.  No further information about the structure of the task was 
given to the participants.  After completing five trials correctly, the experiment would begin.  
Trials were initiated by poking a finger into the central hole.  After a foreperiod of 200, 300, 400, 
500 or 600 ms a target light on the right or the left (left more likely at short foreperiods and right 
more likely at longer foreperiods) was turned on.  Subjects were required to respond to the 
location of the light.  A new trial was initiated by pressing the button outside the box for humans.  
The data were collected in one session that consisted of 1000 trials.  
Two factors could influence the performance of the task: location (spatial probability of 
the target), and time (foreperiod).  The relative contribution of each of these two factors to the 
overall performance of the task is shown in Table 3.1 to illustrate the information available at any 
given point in time during the task.  A priori temporal probability is the likelihood of the stimuli 
appearing at the different foreperiods.  Conditional temporal probability shows that, as time 
elapses, the likelihood of a target to appear increases.  For example, the probability of occurrence 
of the signal is 20% before 200 ms (as there are 5 foreperiods in which the stimulus could 
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appear), 25% before 300 ms (as there are now only 4 foreperiods left in which the stimulus could 
appear), 33% before 400 ms (with only 3 foreperiods left), 50% before 500 ms (as there are now 
only 2 foreperiods left in which the stimulus could appear), and 100% before 600 ms (since the 
stimuli did not appear in any of the other foreperiods, it must appear at the last foreperiod).  A 
priori spatial probability shows the probability of the light appearing in each side at any given 
foreperiod; at short foreperiods, stimuli were more likely on the left side, but as time elapsed, 
presentation of the stimuli on the right became more likely.  Conditional spatiotemporal 
probability shows the likelihood of target occurrence as determined by both a priori spatial 
probability and conditional temporal probability (i.e., is the product of multiplying a priori 
spatial probability by conditional temporal probability and dividing it by 100).  As time elapses 
the probability of a target occurrence increases, and targets on the right side become more likely 
to appear.    
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Table 3.1.   
Relative probabilities of the tone and the target lights 
 
    
Foreperiod (ms) 200 200 400 500 600 
 
A Priori Temporal Probability  
(tone) 
 
20% 
 
20% 
 
20% 
 
20% 
 
20% 
 
Conditional Temporal  
Probability  
(tone) 
 
 
20% 
 
25% 
 
33% 
 
50% 
 
100% 
A Priory Spatial Probability 
(target light) 
     
                    Left  92% 67% 50% 33%   8% 
                    Right    8% 33% 50% 67%  92% 
 
Conditional Spatiotemporal 
Probability 
 (target light) 
     
                    Left  18% 17% 17% 17%   8% 
                    Right    2% 8% 17% 33%  92% 
 
 
Rats 
Number of trials per session 
(target light) 
 
 
 
24 
 
 
24 
 
 
24 
 
 
24 
 
 
24 
                    Left 22 16 12   8 2 
                    Right  2   8 12 16 22 
 
 
Humans 
Number of trials per session 
(target light) 
 
 
 
 
200 
 
 
 
200 
 
 
 
200 
 
 
 
200 
 
 
 
200 
                    Left 184 134 100   66 16 
                    Right  16   66 100 134 184 
Note.  A priori temporal probability is the likelihood of the stimuli appearing at the different 
foreperiods.  Conditional temporal probability shows that as time elapses, the likelihood of a target 
to appear increases.  A priori spatial probability shows the probability of the light to appear in each 
side at any given foreperiod; at short foreperiods, stimuli were more likely on the left side, but as 
time elapsed, presentation of the stimuli on the right became more likely.  Conditional 
spatiotemporal probability shows the likelihood of target occurrence as determined by both a priori 
spatial probability and conditional temporal probability (i.e., is the product of multiplying a priori 
spatial probability by conditional temporal probability and dividing it by 100).   
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3.2.4 Data Analysis 
Reaction time (RT).  Latency from the onset of the stimuli (tone and side hole light) to 
the start of the response (withdrawal of the nose/finger from the central hole).   
Movement time (MT).  Latency from the start of the response (withdrawal of the 
nose/finger from the central hole) to the end of the response (nose/finger poke in either side 
hole). 
Percentage of incorrect responses.  Removal of the nose/finger from the central hole 
after the onset of the target stimuli, followed by a response into the side opening that was not 
illuminated.  This was computed by dividing the number of incorrect responses by the number of 
incorrect responses and the number of correct responses, and multiplying by 100. 
Percentage of late errors.  No response on any side hole within 2 sec after successful 
removal of the nose/finger from the central hole when the target stimuli were onset.  This was 
computed by dividing the number of late errors by the total number of correct, incorrect and late 
trials, and multiplying by 100. 
Percentage of anticipatory errors.  Withdrawal of the nose/finger poke from the central 
hole before the onset of the target stimuli.  This was computed by dividing the number of 
anticipatory errors by the total number of trials (i.e., including correct, incorrect and late errors) 
and multiplying by 100.  Anticipatory errors were not influenced by the spatial location of the 
side stimuli because the nose/finger poke was withdrawn from the central hole before the onset 
of the side target stimuli; therefore, they were analysed without including the variable side.   
The results were expressed as means across the multiple sessions for each subject for 
each variable.  For reaction time both mean and mode were recorded; however, previous research 
in our laboratory has reported that the modal reaction time is a more accurate measure for the 
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central tendency of the reaction time distribution for this task, because the mean reaction time is 
more sensitive to extreme values at the high ends of the probability distribution which contained 
fewer trials (Farovik, 2007; O'Neill, 2005).  
 To show the cost/benefit of varying the spatial probability, the reaction time on the left 
side was subtracted from the reaction time on the right side for each foreperiod.  
Statistical analyses.  All analyses were conducted using IBM SPSS (v 21, SPSS Inc., 
Chicago, IL).  The criterion for significance (alpha level) was p < .05 in all cases.   
Given the difference in motor responses required to perform the task between humans and 
rats (i.e., having to move a finger to respond for humans vs. having to move the entire body to 
respond for rats) the reaction times would not be equivalent for comparison.  Therefore, the data 
for each group were analysed separately but the pattern of performance of the task was 
compared.  
A two factor, 2 x 5 within-subjects analysis of variance (ANOVA) with the variables of 
Side (Within-subjects factor with 2 levels: Left vs. Right) and Foreperiod (Within-subjects factor 
with 5 levels: 200, 300, 400, 500 or 600) was conducted to evaluate if there were significant 
differences between the two groups on each of the dependent measures.  Sidak’s-corrected 
pairwise comparisons for significant effects or interactions were performed.  When data violated 
the assumption of sphericity, Huynh-Feldt corrections were reported. 
3.3 Results 
Reaction time (RT).  Figure 3.3 shows the modal reaction time, across foreperiods, for 
humans and rats.  The upper row shows the modal RT for right and left sides across foreperiods 
for humans (left column) and rats (right column).  The lower row-left column shows the same 
data from the upper row subtracting the RT from the left side minus the right side to illustrate the 
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effect of conditional spatiotemporal probability (i.e., the probability of the stimulus on the right 
was lower at early foreperiods; but at later foreperiods, the probability of the stimulus on the 
right was greater).  The negative values on the graph at shorter foreperiods indicate that reaction 
times on the left side were faster than on the right side (at shorter foreperiods, the stimuli were 
more probable on the left).  Likewise, the positive values at longer foreperiods indicate that 
reaction times on the right side were faster than on the left side (at longer foreperiods, the right 
side stimuli became more probable).  The lower row-right column shows the RT of the average 
of the two sides to illustrate the effect of foreperiod.   
As foreperiod increased, reaction times were faster for both humans (main effect of 
Foreperiod: F(4, 136) = 5.68, p = .004, ηp
2
 = .14) and for rats (main effect of Foreperiod: F(4, 92) 
= 193.30, p < .001, ηp
2
 = .89).  Faster RTs by foreperiod was greatest for targets on the right side 
for humans (Side x Foreperiod interaction: F(4, 136) = 5.66, p = .002, ηp
2
 = .14) and for rats 
(Side x Foreperiod interaction: F(4, 92) = 6.26, p = .01, ηp
2
 = .21).  Although there was a trend, 
in both groups, showing faster RTs to the left side at shorter foreperiods and faster RTs to the 
right side at longer foreperiods (see Figure 3.3).  Sidak’s-corrected pairwise comparisons 
indicated that, for humans, RT to the right side was faster than to the left side at the longest 
foreperiod (FP 600; p = .01) and for rats, RT on the right side was faster than on the left side at 
longer foreperiods (FP 500; p = .01 and 600; p = .01).  This showed that at the longest 
foreperiods both species had faster reaction times to the right side (i.e., the side where the target 
was more likely to appear).  
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Movement time (MT).  At shorter foreperiods (FP 200 and 300) humans had faster MTs 
to the right side in comparison to the left side; but at the longest foreperiod (FP 600) they were 
faster on the left side in comparison to the right side (Side x Foreperiod interaction: F(4, 136) = 
6.70, p < .001, ηp
2
 = .17).  Overall, rats had faster MTs to the right side (main effect of Side: F(1, 
23) = 6.41, p = .02, ηp
2
 = .22), and except for the shortest foreperiod (FP 200), as foreperiod 
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Figure 3.3.  Modal reaction time (±SEM) in milliseconds across foreperiods for rats 
and humans.  The upper row shows the mode RT for right and left sides across foreperiods 
for humans (left column) and rats (right column).  The lower row shows the difference in 
reaction time to the left side minus the right side (left column) and the average of the 
reaction time to the left and the right side (right column) across foreperiods for rats and 
humans.  RT was predicted to be slower for right than left targets at shorter foreperiods 
(unexpected location), while faster for right than left targets at longer foreperiods 
(expected location).  Humans and rats had faster reaction times on the right side at the 
longest foreperiod (FP 600); RTs were also faster to the right side at FP 500 for rats (* p 
< .05). 
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increased, movement times were slower (main effect of Foreperiod: F(4, 92) = 29.18, p < .001, 
ηp
2
 = .56). 
Incorrect responses and late errors.  Figure 3.4 shows the percentage of incorrect 
responses (upper row) and the percentage of late errors (lower row) for humans (left column) and 
rats (right column).  Incorrect and late errors for humans were not affected by increasing the 
length of the foreperiod.  In addition, there were no differences in incorrect or late errors between 
the left and the right side across the different foreperiods for humans.  For rats, the percentage of 
incorrect responses was not affected by side; but incorrect responses increased as a function of 
lengthening foreperiod (main effect of Foreperiod: F(4, 92) = 4.82, p < .001, ηp
2
 = .17).  Sidak’s-
corrected pairwise comparisons indicated that there were fewer incorrect responses in the 
shortest foreperiod (FP 200) than in the longest foreperiod (FP 600; p = .05).  The percentage of 
late errors was affected by side and foreperiod for rats (Side x Foreperiod interaction: F(4, 82) = 
3.63, p = .01, ηp
2
 = .14).  Sidak’s-corrected pairwise comparisons indicated that at the shortest 
foreperiod (FP 200) there were fewer late errors to the right side than to the left side (p = .01; see 
lower row-left column from Figure 3.4). 
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Anticipatory errors.  Figure 3.5 shows that anticipatory errors increased as a function of 
lengthening foreperiod.  For humans (main effect of Foreperiod: F(4, 136) = 76.01, p < .001, ηp
2
 
= .70), Sidak’s-corrected pairwise comparisons indicated that the foreperiod (FP) 200 had fewer 
anticipatory errors than FP 400, 500 and 600; FP 300 had fewer anticipatory errors than FP 400, 
500 and 600; FP 400 had fewer anticipatory errors than FP 500 and 600, and FP 500 had fewer 
anticipatory errors than FP 600 (see Table 3.2).  For rats (main effect of Foreperiod: F(4, 92) = 
10.74, p < .001, ηp
2
 = .32), Sidak’s-corrected pairwise comparisons indicated that FP 200 had 
fewer anticipatory errors than FP 400, 500; and FP 600 had more anticipatory errors than all the 
other foreperiods (see Table 3.3). 
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Figure 3.4.  Percentage of incorrect and late errors (±SEM), upper and 
lower rows respectively, for right and left sides across foreperiods for humans (left 
column) and rats (right column).  Rats had less late errors to the right side, in 
comparison to the left side at the FP 200 (* p < .05). 
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Table 3.2.   
Foreperiod Sidak’s-corrected pairwise comparisons for 
anticipatory errors for humans.   
Foreperiod 
 
FP 200 
M =.01 
FP 300 
M =.02 
FP 400 
M =.06 
FP 500 
M =.14 
FP 600 
M =.23 
FP 200  .080 .000* .000* .000* 
FP 300   .000* .000* .000* 
FP 400    .000* .000* 
FP 500     .000* 
FP 600      
Note.  * The mean difference is significant at the .05 level. 
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Figure 3.5.  Percentage of anticipatory errors (±SEM) 
across foreperiods for humans and rats.  Insert shows an expanded 
y-axis scale for the human data.  Anticipatory responses increased 
as foreperiods increased. 
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Table 3.3.   
Foreperiod Sidak’s-corrected pairwise comparisons for anticipatory 
errors for rats. 
Foreperiod 
 
FP 200 
M =.58 
FP 300 
M =.94 
FP 400 
M =1.29 
FP 500 
M =1.89 
FP 600 
M =3.71 
FP 200  .55 .01* .03* .02* 
FP 300   .62 .20 .03* 
FP 400    .57 .04* 
FP 500     .02* 
FP 600      
Note.  *The mean difference is significant at the .05 level  
3.4 Discussion 
 The purpose of this study was to develop an implicit memory task that could be 
performed by rats and humans.  Having a task in which rats and humans show similar response 
patterns will allow the investigation of animal models of neurodegenerative diseases, such as 
HD, in which implicit memory is impaired.  The performance of rats and humans was compared 
on a modified reaction time task where the location of the target (spatial probability) changed as 
a function of the length of the foreperiod (temporal probability).  Hence, at shorter foreperiods 
targets on the left side were more probable than targets on the right side, but as the foreperiods 
increased the targets were more likely to appear on the right side than on the left side. 
One of the main measurements of the task was reaction time, if implicit learning 
occurred, it was expected that during the task, the reaction time of subjects would gradually 
become faster on the left side at shorter foreperiods, and have faster reaction times on the right 
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side at longer foreperiods (i.e., the side were the target was more likely to appear).  First, both, 
rats and humans showed faster reaction times at longer foreperiods, suggesting that both species 
were sensitive to the conditional temporal probability.  That is, if a target stimulus did not appear 
at the first foreperiod, the probability of the target appearing on the next foreperiod increased, 
this continued for the following foreperiod, until at the last foreperiod, when, if the target had 
not,  yet appeared, the probability of the stimulus appearing was 100%.  Thus, as the probability 
of the stimulus to appear increased with time, reaction times got faster.  These result are 
consistent with previous studies that observed the same effect in simple reaction time tasks in 
humans (Näätänen, 1970) and in rats (Brown and Robbins, 1991; Carli et al., 1989), and may 
reflect processes of response preparation or motor readiness (i.e., the acceleration of reaction 
time of responses as the delay elapses).  Second,  reaction times were faster on the right side at 
the longest foreperiod (the side where the stimuli were more likely to appear), suggesting that 
both rats and humans were able to learn that at longer foreperiods, the stimuli were more likely to 
appear on the right side.   
Although, humans had fewer anticipatory responses in comparison to rats, the pattern of 
anticipatory responses of both groups was similar.  Both, rats and humans had more anticipatory 
responses as the foreperiods increased, which suggested that both species were sensitive to the 
conditional temporal probability.  But in this case, motor readiness resulted in premature 
responses rather than an improved performance.  That is, as the probability of the stimulus to 
appear increased with time, the tendency to respond before the stimulus (anticipatory responses) 
also increased.   
Even though rats and humans showed a similar pattern in reaction time and anticipatory 
responses in the Spatiotemporal Target Probability Signal Reaction Time Task, there were 
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differences in their performances during the task.  For example, humans did not make incorrect 
responses or late errors.  Nevertheless, incorrect responses for rats increased as foreperiod 
increased, which suggested that rats were sensitive to the conditional temporal probability, and 
motor readiness resulted in premature responses rather than an improved performance.  In 
addition, there were no differences between the left and the right side on the number of incorrect 
responses.  It would have been expected that there would be more incorrect responses to the side 
where the stimuli were more likely to appear (i.e., on the left at short foreperiods and on the right 
at long foreperiods); however, neither rats nor humans showed this pattern, which suggested that 
even though both species prepared their responses to respond to the stimuli as the foreperiod 
increased, responses depended on the location of the light.  This was also corroborated by the late 
responses, as it would have been expected that the less probable location would have had more 
late responses (as it would take longer to move to the less expected location).  However, rats 
showed a reduced number of late errors to the right side at the shortest foreperiod, which 
suggested that, even though their reaction times were slower for the right side at the shortest 
foreperiod, they were able to respond within 2 seconds on the illuminated hole, regardless of 
whether they were expecting the stimuli to appear on that side.  
In summary, the present results showed that rats and humans can learn the Spatiotemporal 
Target Probability Signal Reaction Time Task efficiently.  Although the performance of humans 
and rats was different in the percentage of incorrect responses and on late errors (i.e., humans did 
not make incorrect responses or late errors), both groups showed a similar pattern in reaction 
times.  Both rats and humans had faster reaction times to the right side at longer foreperiods (i.e., 
the side where the stimulus was more likely to appear), which indicates that with practice both 
species were able to learn that the probability of the stimulus appearing on the left side was more 
Chapter 3 
97 
 
likely at shorter foreperiods, and at longer foreperiods, the probability of the stimulus appearing 
on the right side was more likely.  Thus, the Spatiotemporal Target Probability Signal Reaction 
Time Task provides an effective basis for evaluating implicit learning in rats and humans.  In 
addition, the task could facilitate the assessment of short acting treatments in pharmacological 
studies and the effects of lesions in rodents, these were investigated in Chapters 4 and 5 
respectively.  
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Chapter 4 
4 Selective Effects of D1 or D2 Dopamine 
Receptor Antagonism in the Spatiotemporal 
Target Probability Signal Reaction Time Task 
in Rats 
 
Previous studies have reported a loss of striatal D1 and D2 dopamine receptors in HD.  
The purpose of the experiment presented in this chapter was to investigate the effects of D1 
dopamine receptor antagonist SCH-23390 or D2 dopamine receptor antagonist raclopride on the 
execution of a reaction time task that evaluated implicit memory by manipulating the 
probabilities of the location of the stimuli as a function of the length of the foreperiod. 
 
Is implicit memory (the computation of probabilities to predict the location of a stimulus) 
affected by selective blockade of dopaminergic transmission at the D1 or D2 receptors? 
Is the performance on the Spatiotemporal Target Probability Signal Reaction Time Task 
affected differently by D1 dopamine receptor antagonist SCH-23390 or D2 dopamine receptor 
antagonist raclopride? 
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4.1 Introduction 
 The previous chapter presented the Spatiotemporal Target Probability Signal Reaction 
Time Task, a new reaction time task that requires the computation of probabilities to predict the 
location of the stimuli.  At short foreperiods, stimuli were more likely to appear on the left side, 
than on the right side; however, as the foreperiods length increased, the probability of the stimuli 
appearing on the left side decreased and the stimuli became more likely to appear on the right 
side.  Rats and humans showed faster reaction times at longer foreperiods on the right side (i.e., 
the side where the stimuli were more likely to appear), which suggests that both species were 
able to learn that the probability of the location of the stimuli changed as function of the length of 
the foreperiod.  
 This chapter investigated whether and how a selective blockade of dopamine transmission 
by means of systemically administered receptor antagonists would affect the performance of the 
Spatiotemporal Target Probability Signal Reaction Time Task.  Previous studies have shown that 
reaction times are sensitive to the blockade of dopamine receptors, and it has been suggested that 
D1 and D2 receptors have different effects in reaction time tasks (Amalric et al., 1993; Baunez et 
al., 1995; Courtière et al., 2003; Domenger and Schwarting, 2006; Mayfield et al., 1993).  For 
example, while it has been reported that D2 antagonism increases reaction times (Amalric et al., 
1993; Baunez et al., 1995; Courtière et al., 2003), the effects of D1 antagonism are not clear: 
some experiments have reported no effect on reaction time after blocking the D1 receptor 
(Amalric et al., 1993), while others have reported slower reaction times (Courtière et al., 2003) or 
even decreased response latencies (Mayfield et al., 1993).  Therefore, the functional differences 
between D1 and D2 receptors in reaction time tasks are not clear and should be investigated 
further.  In particular and for the aim of this thesis, it has been suggested that the differential loss 
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and dysfunction of the neurons that express these two dopamine receptors may contribute to the 
different symptoms of HD (see sections 1.4.1.1 and 1.8.1.1 from the General Introduction).  For 
example, HD patients and preclinical carriers of HD show cognitive deficits induced by 
reductions in D1 and D2 receptor density in the striatum (Backman et al., 1997; Berent et al., 
1988; Bohnen et al., 2000; Brandt et al., 1990; Ginovart et al., 1997; Lawrence et al., 1998b).  
Based on these studies, it was hypothesised that selective blockade of dopaminergic transmission 
at the D1 or the D2 receptor would affect the performance on a reaction time task, which require 
the computation of probabilities to predict the location of the stimuli.  Future research in HD 
could benefit by incorporating a cognitive task that detects differences between the loss of striatal 
D1 and D2 receptors to evaluate the effects of new treatments.  Thus, this experiment investigated 
if the performance on the Spatiotemporal Target Probability Signal Reaction Time Task was 
differently affected by dopamine D1 receptor antagonist SCH-23390 or D2 receptor antagonist 
raclopride. 
4.2 Method 
4.2.1 Animals 
The subjects were 8 experimentally-naïve male hooded Lister rats (Charles River, UK 
Ltd) with a mean ad libitum weight of 303 g (range = 289 - 315 g) at the beginning of the 
experiment.  The housing and husbandry conditions were described in the General Methods in 
Chapter 2.  
4.2.2 Apparatus 
The apparatus were described in the Methods section of Chapter 3. 
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4.2.3 Procedure 
Rats were tested in the Spatiotemporal Target Probability Signal Reaction Time Task.  
Training and testing procedures were described in the Methods section of Chapter 3 within the 
“Behavioural protocol for rats” subsection.  Briefly, rats had to respond to lateralised visual 
stimuli in order to receive food.  Rats were required to sustain a nose poke in the central hole 
until a stimulus on the left or the right side hole appeared after one of the 5 different foreperiods.  
Foreperiods could have durations of 200, 300, 400, 500 or 600 ms and were followed by a light 
stimulus of 100 ms on either left or right side.  At the short foreperiods, the stimuli were more 
likely on the left side, but as foreperiods increased, presentation of the stimuli became more 
likely on the right side (see figure 4.1). 
After 116 sessions in the Spatiotemporal Target Probability Signal Reaction Time Task, 
rats were able to complete 120 correct trials within 45 min. 
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Drug administration.  Rats were pseudo-randomly divided into two groups (each group 
contained four rats).  On separate sessions, the first group received one of three doses (0.005, 
0.01 and 0.02 mg/kg) of D1 antagonist receptor SCH-23390 (Sigma Aldrich, UK) or vehicle 
(0.9% saline) via subcutaneous (SC) injections.  The second group received one of three doses 
(0.05, 0.1 and 0.2 mg/kg) of D2 antagonist raclopride (Sigma Aldrich, UK) or its vehicle (0.9% 
saline) via SC injections.  Each injection day was followed by one testing day in which no drug 
was administered.  Both drugs were freshly prepared on the day of injection (dissolved in 0.9% 
saline vehicle and protected from light).  The different doses were administered in a semi-
randomised order 30 min prior to testing in the Spatiotemporal Target Probability Signal 
Reaction Time Task (each drug session assessed the three different doses and vehicle).  Once all 
the subjects received the different doses (three drug doses and vehicle) of the same drug, they 
Figure 4.1.  The probability of the stimuli on the left 
was more likely on short foreperiods; but on longer 
foreperiods, the probability of the stimuli on the right was 
more likely.  (Figure based on O'Neill, 2005) 
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were tested for one day with no injection.  Finally, the groups were tested in the alternative drug 
condition (i.e., the first group that received SCH-23390 was tested with the different doses of 
raclopride and vice versa) using the same protocol.  The DA antagonist compounds (i.e., SCH-
23390 and raclopride), doses, and method of administration used in this experiment were selected 
based on Amalric et al. (1993), which have also been previously tested in our laboratory (O'Neill, 
2005). 
4.2.4 Data Analysis 
Data analyses were the same as described in Chapter 3.  All analyses were conducted 
using IBM SPSS (v 21, SPSS Inc., Chicago, IL).  The criterion for significance (alpha level) was 
p < .05 in all cases.  The data for each drug were analysed separately with a three factor, 4 x 2 x 5 
repeated measures ANOVA with Dose, Side and Foreperiod as the within-subject factors.  
Sidak’s-corrected pairwise comparisons for significant effects or interactions were performed.  
When data violated the assumption of sphericity, Huynh-Feldt corrections were reported. 
4.3 Results 
Given that the foreperiod and target side were determined on a trial-by-trial basis 
according to a priori probabilities, there was not always precisely the same number of trials in 
every session.  Therefore, animals with incomplete data sets were discarded from the experiment.  
The final numbers (n) in each group were: SHC-23390 (n = 7), raclopride (n = 7). 
4.3.1 Raclopride  
Reaction time (RT).  Figure 4.2 shows the effect of raclopride on the modal reaction 
times across foreperiods.  Raclopride slowed reaction times (main effect of Dose: F(3, 18) = 
10.61, p < .001, ηp
2
 = .64.  Sidak’s-corrected pairwise comparisons indicated that the three doses 
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of raclopride were different from the vehicle (vehicle vs 0.05 mg/kg, p = .01; vehicle vs 0.1 
mg/kg, p = .03 and vehicle vs 0.2 mg/kg p = .003).  As foreperiod increased, reaction times were 
faster (main effect of Foreperiod: F(4, 24) = 36.74, p < .001, ηp
2
 = .86.  Sidak’s-corrected 
pairwise comparisons indicated that the foreperiod (FP) 400 had faster RT than FP 200 and 300; 
FP 500 had faster RT than FP 200 and 300; FP 600 had faster RT than FP 200, 300 and 400; see 
Table 4.1).  There was a pattern of faster reaction times to the left side at shorter foreperiods and 
faster reaction times to the right at longer foreperiods (Side x Foreperiod interaction: F(4, 24) 
6.02, p = .002, ηp
2
 = .50).  This is observed on the left column of Figure 4.2, where negative 
values represent faster reaction times on the left side and positive values represent faster reaction 
times on the right side.  Sidak’s-corrected pairwise comparisons indicated that at the shortest 
foreperiod (FP 200) reaction times were faster on the left side (p = .02), the more probable target 
location.   
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Figure 4.2.  The left column shows the effects of raclopride on 
modal reaction time (± SEM); in comparison to vehicle, all doses of 
raclopride increased RT.  The right column depicts the same information 
by side subtraction, which reflects the cost/benefit of conditional 
spatiotemporal probability.  At shorter foreperiods the subtracted values 
were negative, as RT was slower on the right compared to the left side.  
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Table 4.1.   
Foreperiod Sidak’s-corrected pairwise comparisons for 
reaction time.   
Foreperiod 
 
FP 200 
M =530 
FP 300 
M =447 
FP 400 
M =369 
FP 500 
M =325 
FP 600 
M =286 
FP 200  .482 .019* .003* .001* 
FP 300   .017* .009* .000* 
FP 400    .436 .006* 
FP 500     .172 
FP 600      
Note.  *The mean difference is significant at the .05 level. 
 
Movement time (MT).  Movement time was not affected by raclopride. 
Incorrect responses and late errors.  The percentage of incorrect responses and late 
errors were not affected by side, foreperiod or raclopride.  
Anticipatory errors.  Figure 4.3 shows the effect of raclopride on the percentage of 
anticipatory errors across foreperiods.  Anticipatory errors increased as foreperiods increased 
(main effect of Foreperiod: F(4, 24) = 5.50, p = .003, ηp
2
 = .48).  Raclopride decreased the 
percentage of anticipatory errors at the longest foreperiods, but at the shortest foreperiods, there 
were no differences in anticipatory errors between the different doses of raclopride (Dose x 
Foreperiod interaction: F(12, 72) 2.50, p = .01, ηp
2
 = .29.  Sidak’s-corrected pairwise 
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comparisons indicated that at the longest foreperiod (FP 600) anticipatory errors decreased with 
dose 0.1 mg/kg in comparison to vehicle).   
 
4.3.2 SCH-23390  
Reaction time (RT).  Figure 4.4 shows the effect of SCH-23390 on the modal reaction 
times across foreperiods.  Reaction times were slower as a function of increasing the doses of 
SCH-23390 (main effect of Dose: F(3, 18) = 7.74, p = .002, ηp
2
 = .56.  Sidak’s-corrected 
pairwise comparisons indicated that, in comparison to vehicle, 0.01 mg/kg of SCH-23390 slowed 
RT, p = .02).  Overall, as foreperiod increase, reaction time were faster (main effect of 
Foreperiod: F (4, 24) = 6.90, p = .001, ηp
2
 = .54.  Sidak’s-corrected pairwise comparisons 
indicated that FP 600 had faster reaction times than FP 200, 300 and 400; p = .05, p = .05 and p = 
.03 respectively).  
 
Figure 4.3.  Effect of raclopride on the percentage 
of anticipatory errors (±SEM) across foreperiods.  At the 
longest foreperiod (FP 600) anticipatory errors decreased 
with dose 0.1 mg/kg (* p < .05). 
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Movement time (MT).  Figure 4.5 shows the effect of SCH-23390 on movement time   
(latency from the withdrawal of the nose from the central hole, to the nose poke in either side 
hole) across foreperiods.  MTs were slower as the doses of SCH-23390 increased (main effect of 
Dose: F(3, 18) = 6.08, p = .01, ηp
2
 = .50; Sidak’s-corrected pairwise comparisons indicated that, 
in comparison to vehicle, 0.005 and 0.01 mg/kg of SCH-23390 slowed MT; p = .03 and p = .04 
respectively).  With vehicle, movement time was faster at shorter foreperiods to the left side 
(more probable target location) compared to the right side, and at longer foreperiods, MT was 
faster to the right side (more probable target location) compared to the left side.  However, with 
SCH-23390 at shorter foreperiods, MT was faster to the right side (less probable target location) 
compared to the left side, and at longer foreperiods, MT was faster to the left side (less probable 
target location) compared to the right side (Dose x Side x Foreperiod interaction: F(12, 72) 1.91, 
p = .05, ηp
2
 = .24.  Sidak’s-corrected pairwise comparisons showed that at FP 300, MT was faster 
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 Figure 4.4.  The left column shows the effects of SCH-23390 on modal 
reaction time (± SEM); in comparison to vehicle, dose 0.01 mg/kg increased 
reaction times.  The right column depicts the same information by side subtraction, 
which reflects the cost/benefit of conditional spatiotemporal probability.   
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to the left side with vehicle (p = .03; more probable location), but with 0.01 mg/kg of SCH-
23390, MT was faster to the right side (p = .04; less probable location) and at FP 200 with 0.02 
mg/kg of SCH-23390, MT was faster to the right side (p = .01; less probable location). 
 
Incorrect responses.  Figure 4.6 shows the effect of SCH-23390 on the percentage of 
incorrect responses across foreperiods.  The upper row-left column shows the percentage of 
incorrect responses with vehicle, while the different doses of SCH-23390 (0.005, 0.01 and 0.02 
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Figure 4.5.  Effects of SCH-23390 on movement time (±SEM) across 
foreperiods.  The upper row-left column shows movement time with vehicle, while the 
movement time with the different doses of SCH-23390 (0.005, 0.01 and 0.02 mg/kg) 
are shown in the upper row-right column, lower row-left column and lower row-right 
column respectively.  At FP 300, MT was faster to the left side with vehicle (more 
probable location), but with 0.01 mg/kg of SCH-23390, MT was faster on the right 
side (less probable location) and at FP 200 with 0.02 mg/kg of SCH-23390, MT was 
faster on the right side  (* p < .05). 
* 
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mg/kg) are shown in the upper row-right column, lower row-left column and lower row-right 
column respectively.  With vehicle, at shorter foreperiods, when the stimulus was more likely to 
appear on the left, there were more incorrect responses on the right side (less probable target 
location) compared to the left side, and at longer foreperiods, when the right side stimulus 
became more likely to appear, there were more incorrect responses on the left side.  However, 
0.005 mg/kg of SCH-23390 reduced the percentage of incorrect responses to the right side at the 
shortest foreperiod (FP 200; p = .03), while 0.02 mg/kg of SCH-23390 reduced incorrect 
responses on the right side at FP 300 (p = .05; Dose x Side x Foreperiod interaction: F(12, 72) 
2.07, p = .03, ηp
2
 = .26).  
 
Chapter 4 
112 
 
 
Late errors.  Figure 4.7 shows the effect of SCH-23390 on the percentage of late errors 
across foreperiods.  SCH-23390 increased the percentage of late errors (main effect of Dose: F(3, 
18) = 6.79, p = .003, ηp
2
 = .53.  Sidak’s-corrected pairwise comparisons indicated that, in 
comparison to the vehicle, doses 0.01 and 0.02 mg/kg of SCH-23390 increased the percentage of 
late errors; p = .05 and p = .01 respectively).  Overall, at shorter foreperiods there were fewer 
omissions of responses to the right side (less probable location) compared to the left side, and at 
longer foreperiods, there were fewer omissions to the left side (less probable location) compared 
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Figure 4.6.  Effects of SCH-23390 on the percentage of incorrect responses 
(±SEM) across foreperiods.  The upper row-left column shows the percentage of 
incorrect responses with vehicle, while the percentage of incorrect responses with the 
different doses of SCH-22390 (0.005, 0.01 and 0.02 mg/kg) are shown in the upper 
row-right column, lower row-left column and lower row-right column respectively. 
Incorrect responses on the right side decreased at the shortest foreperiod (FP 200) 
with 0.005 mg/kg of SCH-23390 and at FP 300 with 0.02 mg/kg of SCH-23390 (* p < 
.05). 
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to the right side (Side x Foreperiod interaction: F(4, 24) 4.45, p = .01, ηp
2
 = .43.  Sidak’s-
corrected pairwise comparisons indicated that at the shortest foreperiod (FP 200) there were 
fewer late errors to the right side in comparison to the left side, p = .03). 
 
Anticipatory errors.  Figure 4.8 shows the effect of SCH-23390 on the percentage of 
anticipatory errors across foreperiods.  Anticipatory errors increased as foreperiods increased 
(main effect of Foreperiod: F(4, 24) = 4.19, p = .01, ηp
2
 = .41).  SCH-23390 increased the 
percentage of anticipatory errors at shorter foreperiods, but at the longest foreperiod reduced 
them (Dose x Foreperiod interaction: F(12, 72) 2.07, p = .03, ηp
2
 = .26.  Sidak’s-corrected 
pairwise comparisons indicated that, in comparison to vehicle, all doses of SCH-23390 increased 
0
2
4
6
8
10
12
14
16
18
20
200 300 400 500 600
-20
-15
-10
-5
0
5
10
15
20
200 300 400 500 600
Vehicle
SCH 0.005 mg/kg
SCH 0.01 mg/kg
SCH 0.02 mg/kg
L
e
ft
 -
 R
ig
h
t 
(%
 L
a
te
) 
L
a
te
 e
rr
o
rs
 (
%
) 
Foreperiods (ms) 
Figure 4.7.  Effect of SCH-23390 on the percentage of late errors (±SEM) 
across foreperiods.  The left column shows the effects of SCH-23390 the percentage 
of late errors (± SEM); in comparison to vehicle, doses 0.01 and 0.02 mg/kg of 
SCH-23390 increased the percentage of late errors.  The right column depicts the 
same information by side subtraction.  At shorter foreperiods the subtracted values 
were positive, as there were more late errors to the right side compared to the left 
side, and at longer foreperiods the values were negative as there were more late 
errors to the left side compared to the right side.  
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anticipatory errors at foreperiod 400.  Vehicle vs 0.005 mg/kg, p = .05; Vehicle vs 0.01 mg/kg, p 
= .01; Vehicle vs 0.02 mg/kg, p = .02).   
 
 
4.4 Discussion 
 The aim of the present experiment discussed in this chapter was to test the effects of the 
D1 dopamine receptor antagonist SCH-23390 (in doses of 0.005, 0.01 and 0.02 mg/kg) or the D2 
dopamine receptor antagonist raclopride (in doses 0.05, 0.1 and 0.2 mg/kg) on the execution of 
the Spatiotemporal Target Probability Signal Reaction Time Task, a new reaction time task that 
requires the computation of probabilities to predict the location of the stimuli.  At short 
foreperiods, stimuli were more likely to appear on the left side, than on the right side; however, 
Figure 4.8.  Effect of SCH-23390 on the percentage 
of anticipatory errors (±SEM) across foreperiods.  In 
comparison to vehicle, all doses of SCH-23390 increased 
anticipatory errors at foreperiod 400 (* p < .05). 
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as the foreperiods length increased, the probability of the stimuli appearing on the left side 
decreased and the stimuli became more likely to appear on the right side.   
 As previously observed, reaction times were faster as a function of lengthening 
foreperiod.  D1 antagonist SHC-23390 or D2 antagonist raclopride did not affect this pattern.  
However, reaction times were faster on the left side at the shortest foreperiod (i.e., the side were 
the target was more likely to appear) only after administration of raclopride.  In addition, while 
all doses of raclopride (0.05, 0.1 and 0.2 mg/kg) slowed reaction times, only one of the doses of 
SCH-23390 (0.01 mg/kg) slowed reaction times in comparison to vehicle.  The highest dose of 
SCH-23390 (0.02 mg/kg) may appear to slow reaction times in comparison to vehicle; however, 
with the large variability in the responses, the effect at this dose was not significant.  These 
results may be explained as a result of the sedative effects (Christensen et al., 1984; Gessa et al., 
1985; Hoffman and Beninger, 1985) as well as catalepsy (Christensen et al., 1984; Morelli and 
Di Chiara, 1985) that have been reported with high doses of SCH-23390. 
Movement times, as well as incorrect and late errors, were differently affected by 
blocking D1 and D2 receptors.  While raclopride had no effect on movement time, incorrect 
responses or late errors, these were affected by SCH-23390.  Movement time (latency from the 
withdrawal of the nose from the central hole, to the nose poke in either side hole) was faster to 
the left side at FP 300 (the more probable side location) with vehicle, but with 0.01 mg/kg of 
SCH-23390, MT was faster to the right side at FP 300 (the less probable location), and at FP 200 
with 0.02 mg/kg of SCH-23390, MT was faster to the right side (less probable location).  This 
finding suggests that SCH-23390 reduced the response preparation bias to the more probable side 
at shorter foreperiods.   
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With vehicle, there were more incorrect responses to the right side at shorter foreperiods 
(the less probable target location), and at longer foreperiods, when the right side stimulus became 
more likely to appear, there were more incorrect responses to the left side.  However, 0.005 
mg/kg of SCH-23390 reduced the percentage of incorrect responses to the right side at the 
shortest foreperiod (FP 200), while 0.02 mg/kg of SCH-23390 reduced incorrect responses to the 
right side at FP 300.  This suggests that SCH-23390 reduce incorrect responses to the least 
probable target location.  SCH-23390 (0.01 and 0.02 mg/kg) increased late errors, which 
suggests that blocking D1 receptors impaired the rat’s ability to initiate responding.  Therefore, 
the time to respond to any side hole took more than 2 seconds after successfully removing the 
nose from the central hole when the target stimuli were onset.   
D1 and D2 antagonists had different effects on anticipatory errors; all doses of SCH-
23390 significantly increased the anticipatory responses at FP 400.  However, raclopride (0.1 
mg/kg) decreased the number of anticipatory responses at the longest foreperiod (FP 600) in 
comparison to vehicle.  Showing that with raclopride rats were more likely to respond until the 
presentation of the stimuli, yet they were able to use the information of the length of the 
foreperiod to respond.   
Slowed reaction times as a result of antagonising D2 dopamine receptors have been 
previously reported using the D2 antagonist raclopride (Amalric et al., 1993; Baunez et al., 1995; 
Domenger and Schwarting, 2006; O'Neill, 2005), the D2 antagonist eticlopride (Courtière et al., 
2003), and high doses (0.1 mg/kg) of the D2 antagonist haloperidol (Mayfield et al., 1993).  
However, it has been reported that low doses of the D2 antagonist spiperone (0.001 mg/kg) and 
haloperidol (0.01 mg/kg) decrease response latencies (Mayfield et al., 1993).  Likewise, there are 
contradictory results with regard to reaction times after blocking D1 receptors.  For example, 
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slowed reaction times have also been reported with the D1 antagonist SKF83566 (Domenger and 
Schwarting, 2006).  The D1 antagonist SCH-23390 has been reported to also slow latencies 
(Mayfield et al., 1993) or slow reaction times at short foreperiods (Courtière et al., 2003), 
although no effect on reaction times has also been reported (Amalric et al., 1993).  The results 
presented in this chapter showed that only all the doses of raclopride slowed the reaction times, 
which suggests that the D2 antagonist might be more potent than the D1 antagonist, a point which 
is in agreement with previous findings (Amalric et al., 1993; Courtière et al., 2003; Domenger 
and Schwarting, 2006; Mayfield et al., 1993).   
The results regarding accuracy after blocking D1 or D2 receptors are also contradictory.  
While some studies report impairments, others report improvements or no effects (Amalric et al., 
1993; Courtière et al., 2003; Domenger and Schwarting, 2006; Mayfield et al., 1993; O'Neill, 
2005).  Similar to the results of this chapter, Domenger and Schwarting (2006) found that a D1 
antagonist SCH-23390, but not the D2 antagonist raclopride, increased accuracy in a RT task.   
These inconsistencies in reaction times and accuracy can be attributed to the differences 
in methodology, including test paradigms, types and doses of DA antagonists, and methods of 
administration (e.g., intraperitoneal, IP, vs. subcutaneous, SC, injections).  In the case of D1, the 
ranges of doses that have been reported are broad, ranging from 0.005 to 0.15 mg/kg, IP or SC.  
In the case of D2 antagonist, they have been reported from 0.01 to 0.20 mg/kg, IP (Amalric et al., 
1993; Baunez et al., 1995; Courtière et al., 2003; Domenger and Schwarting, 2006; Mayfield et 
al., 1993).  The DA antagonist compounds (i.e., SCH-23390 and raclopride), doses, and method 
of administration used in this experiment were selected based on Amalric et al. (1993), which 
have also been previously tested in our laboratory (O'Neill, 2005).  
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In summary, D1 dopamine receptor antagonist SCH-23390 and D2 dopamine receptor 
antagonist raclopride affected the performance of the Spatiotemporal Target Probability Signal 
Reaction Time Task differently.  D1 antagonist SCH-23390 slowed the ability to initiate 
responding, which slowed reaction times, increased late responses, and slowed movement times 
but reduced the percentage of incorrect responses to the least probable target location.  These 
result could simply reflect a speed-accuracy trade off, since faster responses also produce 
relatively more errors, whilst reduced speed (like the one induced by DA antagonists) yield 
relatively fewer errors.  In contrast, D2 antagonist raclopride only slowed reaction times but did 
not affect movement time, incorrect responses or late errors, and decreased anticipatory 
responses.  These results suggested that reaction times were slower with both SCH-23390 and 
raclopride, but only D1 antagonist SCH-23390 reduced errors to the least probable target 
location.   
Changes in cognitive performance induced by reduction of dopamine binding have also 
been observed in patients with HD.  Brandt et al. (1990) showed that HD patients with reduced 
D2 receptor binding in the caudate nucleus presented impairments in tasks that required rapid 
coordination and set alternation.  Reductions in D1 and D2 receptor density in the striatum in HD 
patients have also been correlated with the severity of impairments of executive function, 
perceptual speed, visuospatial skill, verbal fluency, episodic memory, and reasoning (Backman et 
al., 1997).  These correlations between reduced D1 and D2 receptor binding and cognitive deficits 
have also been reported in preclinical carriers of HD (Lawrence et al., 1998b; Lawrence et al., 
1998c).  Therefore, having a task that is differentially affected by D1 or D2 receptors could 
evaluate cognitive impairments in patients with HD (and preclinical carriers of the disease) and 
assess selective treatments.  
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Altogether, the results presented in this chapter have important implications for the 
therapeutic use of D1 and D2 antagonists in the Spatiotemporal Target Probability Signal 
Reaction Time Task.  First, it suggested that the effects of D1 and D2 antagonists could have 
different effects, and reaction times and accuracy could be dissociated.  Second, it provided a 
new task to potentially evaluate the cognitive changes that have been reported from the reduction 
in D1 and D2 receptors density in the striatum for patients with HD and patients in the preclinical 
phase.  Finally, the task may be used to evaluate therapeutic interventions that selectively block 
D1 or D2 receptors.  Therefore, to further investigate the effects of striatal dysfunction in the 
Spatiotemporal Target Probability Signal Reaction Time Task, the next chapter evaluates an 
animal model of HD with quinolinic acid lesions of the striatum. 
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Chapter 5 
5 The Effects of Bilateral Quinolinic Acid 
Lesions of the Dorsomedial Striatum in the 
Spatiotemporal Target Probability Signal 
Reaction Time Task 
 
Deficits in implicit memory in patients with Huntington’s disease have been associated with 
loss of striatal neurons.  To examine if the neuronal loss in the dorsomedial striatum (DMS) 
affects implicit memory (the computation of probabilities to predict the location of a stimulus), 
rats with bilateral quinolinic acid lesions of the DMS were tested in the Spatiotemporal Target 
Probability Signal Reaction Time Task.  These results enabled us to evaluate the quinolinic acid 
lesioned rat as a suitable model for cognitive deficits in HD and, in addition, facilitated the 
identification of task parameters for exploring ameliorative interventions for HD.   
 
Is implicit memory (the computation of probabilities to predict the location of a stimulus) 
affected by quinolinic acid lesions of the DMS? 
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5.1 Introduction 
 The Spatiotemporal Target Probability Signal Reaction Time Task is a new reaction time 
task that requires the computation of probabilities to predict the location of stimuli.  At short 
foreperiods, stimuli are more likely to appear on the left side, than on the right side.  However, as 
the foreperiod length increases, the probability of the stimuli appearing on the left side decreases 
and the stimuli becomes more likely to appear on the right.  Previous data have shown (Chapter 
3) that both rats and humans, had faster reaction times at longer foreperiods on the right side (i.e., 
the side where the stimuli were more likely to appear), which suggested that both species were 
able to learn that the probability of the location of the stimuli changed as function of the length of 
the foreperiod (Chapter 3).  In addition, data showed that the task performance could be affected 
by selective blockade of dopaminergic transmission at the D1 or D2 receptors (Chapter 4).  
 This chapter reports on the testing of an animal model of HD to investigate the effects of 
QA lesions of the striatum in the Spatiotemporal Target Probability Signal Reaction Time Task.  
The results presented in Chapter 1, section 1.8.1, showed that patients with HD are impaired in 
acquiring new motor skills, which suggested that the striatum is necessary for learning implicit 
tasks.  However, the question of whether the striatum, once a task that requires implicit memory 
has been learned, is necessary for continuing performance in the task, has yet to be addressed.  
Therefore, the aim of this chapter was to investigate if the performance on the Spatiotemporal 
Target Probability Signal Reaction Time Task was affected by bilateral QA lesions of the 
striatum.  If the striatum is necessary for continuing performance in the task once it has been 
learned, it would be predicted that post-surgery the performance on the Spatiotemporal Target 
Probability Signal Reaction Time Task would be affected.   
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5.2 Method 
5.2.1 Animals 
The animals were the 24 male hooded Lister rats (Charles River, UK Ltd), described in 
Chapter 3. 
5.2.2 Apparatus 
All phases of the experiment were conducted in a set of four nine-hole operant chambers 
(Paul Fray Ltd, Cambridge, UK; see the Apparatus section in Chapter 3). 
5.2.3 Procedure 
Behavioural procedures.  Rats were trained and tested in the Spatiotemporal Target 
Probability Signal Reaction Time Task described in the Methods section of Chapter 3.  Briefly, 
rats had to respond to lateralised visual stimuli to receive food.  Rats were required to sustain a 
nose poke in the central hole until a stimulus on the left or the right side hole appeared after one 
of five different foreperiods.  Foreperiods could have durations of 200, 300, 400, 500 or 600 ms 
and were followed by a light stimulus of 100 ms on either left or right side.  At the short 
foreperiods, the stimuli were more likely on the left side, but as foreperiods increased, 
presentation of the stimuli became more likely on the right side (see Figure 5.1).  After 140 
sessions in the Spatiotemporal Target Probability Signal Reaction Time Task, rats were able to 
complete 120 correct trials within 45 min. 
Surgery.  Pre-surgery, rats were pseudo-randomly assigned to the sham-surgery control 
(n =8) or dorsomedial striatum (DMS) lesion (n =16) group.  Data from the two groups were 
analysed to ensure there were no differences between the groups before the surgery.  The surgery 
protocol was as described in Chapter 2 (General Methods). 
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Post-test.  12 days after surgery, rats were retested in the Spatiotemporal Target 
Probability Signal Reaction Time Task. 
Histology.  Histology was as described in Chapter 2 in the General Methods. 
 
5.2.4 Data analysis 
Reaction time, movement time, percentage of incorrect responses, percentage of late 
errors and percentage of anticipatory errors were calculated as described in Chapter 3.   
Statistical analyses.  All analyses were conducted in IBM SPSS (v 21, SPSS Inc., 
Chicago, IL) using the average data collected during the last 13 sessions of the experiment.  The 
criterion for significance was set at p < .05 in all cases.  A four factor, 2 x 2 x 5 x 2 mixed 
analysis of variance (ANOVA) with the variables of Surgery (Within-subjects factor with 2 
 Figure 5.1.  Schematic representation of the Spatiotemporal Target 
Probability Signal Reaction Time Task.  Foreperiods could have durations 
of 200, 300, 400, 500 or 600 ms and were followed by a light stimulus of 
100 ms on either left or right side.  At the early foreperiods, the stimuli 
were more likely on the left side; as time elapsed, presentation of the stimuli 
became more likely on the right.  
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levels: Pre-surgery vs. Post-surgery), Group (Between-groups factor with 2 levels: Lesion vs. 
Sham control), Foreperiod (Within-subjects factor with 5 levels: 200, 300, 400, 500, 600) and 
Side (Within-subjects factor with 2 levels: Left vs. Right), was conducted to evaluate if there 
were significant differences between the two groups on each of the dependent variables.  Sidak’s-
corrected pairwise comparisons for significant effects or interactions were performed.  When 
data violated the assumption of sphericity, Huynh-Feldt corrections were reported. 
5.3 Results 
5.3.1 Histology 
Ten out of 16 DMS lesioned rats were determined to have appropriate bilateral lesions.  
Figure 5.2 shows photomicrographs of coronal sections from sham-surgery control and DMS 
lesioned animals.  Two out of 8 sham-surgery control lesioned rats showed signs of cell damage, 
and therefore, were excluded.   
The final numbers (n) in each group were: DMS lesion (n = 10), sham-surgery control (n 
= 6).  Figure 5.3 shows a schematic diagram of a series of coronal sections of the rat brain 
(Paxinos and Watson, 2007), illustrating the extent of bilateral dorsomedial (DMS) striatum 
lesions. 
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DMS 1,000 μm Sham 
Figure 5.2.  Representative photomicrographs of coronal sections double-
stained with NeuN and Cresyl Violet from dorsomedial striatum (DMS) lesion (left), 
and sham control (right) animals.  Sham control rats showed an even distribution of 
neurons in the striatum whilst DMS lesioned rats showed cell loss.  Arrows point to 
the lesion area.  From the top, sections are +1.7, +1.2, +0.7, +0.2, and -0.3 mm from 
bregma.  Scale bar 1,000 μm. 
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Figure 5.3.  Schematic diagram of a series of coronal 
sections of the rat brain, illustrating the extent of bilateral 
dorsomedial (DMS) striatum lesions.  Darkness represents 
coincidence lesions from different animals.  From the top, 
sections are +2.2, +1.7, +1.2, +0.7, +0.2, −0.3, −0.80 and 
−0.92 mm from bregma (Paxinos and Watson, 2007). 
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5.3.2 Behavioural performances 
Reaction time (RT).  Figure 5.4 shows the modal RTs pre-surgery (upper row) and post-
surgery (middle row) for the sham-surgery control group (left column) and for the DMS lesion 
group (right column).  The lower row shows the cost/benefit of varying the spatial probability by 
subtracting the RT to the right from the RT to the left side.  At shorter foreperiods, when the 
stimulus was more probable on the left, the reaction time was slower on the right (less probable 
target location) compared to the left side; therefore, the subtracted value was negative.  However, 
at longer foreperiods, when the right side stimulus became more probable, the reaction time was 
faster to the right compared to the left side; therefore, the subtracted value was positive.   
For both groups, reaction times were faster after surgery (main effect of Surgery: F(1, 14) 
= 11.34, p = .01, ηp
2
 = .45).  Pre-surgery, there was no difference in reaction times between 
sham-surgery control and lesioned rats; however, post-surgery, reaction times of the control 
group were faster than those of the lesion group (significant interaction between Surgery x 
Group: F(1, 14) = 5.22, p = .04, ηp
2
 = .27). 
For the DMS lesioned and the control group, reaction times were faster as foreperiods 
increased (main effect of Foreperiod: F(4, 56) = 137.43, p < .001, ηp
2
 = .91.  Sidak’s-corrected 
pairwise comparisons revealed that all foreperiods were different from each other).  The lower 
row of Figure 5.4 shows that reaction times were faster to the left side at shorter foreperiods and 
faster to the right side at longer foreperiods (Side x Foreperiod interaction: F(4, 56) = 4.32, p = 
.04, ηp
2
 = .24).  Although there was this trend, Sidak’s-corrected pairwise comparisons revealed 
that reaction times to the right side (the more probable target location) were faster than the 
reaction times to the left side only at the two longest foreperiods (FP 500, p = .01; FP 600, p = 
.01).  There was a three way interaction between the variables Surgery, Side and Foreperiod (F(4, 
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56) = 3.01, p = .03, ηp
2
 = .18).  Sidak’s-corrected pairwise comparisons revealed that pre-surgery 
reaction times were faster on the right side for the two longest foreperiods (FP 500, p = .02; FP 
600, p = .02) only.  Similarly, post-surgery, reaction times were also faster to the right side for 
the two longest foreperiods (FP 500, p = .01; FP 600, p = .03) only. 
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Figure 5.4.  Modal reaction time (± SEM) to left and right targets across 
foreperiods for sham-surgery control (left column) and DMS lesioned (right column) 
animals.  The upper row shows the mode RT pre-surgery, while the middle row shows RT 
post-surgery.  RT was predicted to be slower for right than left targets at shorter 
foreperiods (unexpected location), while slower than left targets at longer foreperiods 
(expected location). The lower row depicts the same information by side subtraction, 
which reflects the cost/benefit of conditional spatiotemporal probability.  At shorter 
foreperiods the subtracted value is negative, as RT was slower to the right compared to 
the left side, while at longer foreperiods, the subtracted value is positive, as RT was 
faster to the right compared to left side. 
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Movement time (MT).  Figure 5.5 shows the mean movement times (latency of the 
withdrawal of the nose from the central hole, to the nose poke in either side hole) for the sham-
surgery control group (left column) and for the DMS lesion group (right column) pre-surgery 
(upper row) and post-surgery (lower row).  For both groups, movement time was slower after 
surgery (main effect of Surgery: F(1, 14) = 7.87, p = .01, ηp
2
 = .36); the longest foreperiods (FP 
400, 500 and 600) had the slowest movement times after surgery (Surgery x Foreperiod 
interaction: F(4, 56) = 5.22, p = .003, ηp
2
 = .27).  Overall, movement times to the right side target 
were faster than to the left side (main effect of Side: F(1, 14) = 9.07, p = .01, ηp
2
 = .39) and, as 
foreperiod increased, movement time was slower (main effect of Foreperiod: F(4, 56) = 4.32, p = 
.004, ηp
2
 = .24).  There was a four way interaction between the variables Surgery, Side, 
Foreperiod and Group (F(4, 56) = 7.42, p < .001, ηp
2
 = .35).  Sidak’s-corrected pairwise 
comparisons revealed that for the control group, pre-surgery, movement time was faster on the 
right at longer foreperiods (FP 500, p = .02 and FP 600, p = .02; see Figure 5.5 left column- 
upper row).  However, after surgery, movement time was faster on the right side at the shortest 
foreperiod (FP 200, p = .02) and at FP 400 (p = .02; see Figure 5.5 left column- lower row).  For 
the lesion group, pre-surgery there were no differences in movement times between the left and 
right side across the different foreperiods (see Figure 5.5 right column- upper row); however, 
post-surgery movement time was faster to the right side at the longest foreperiod (FP 600, p = 
.04; see Figure 5.5 right column- lower row). 
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Incorrect responses.  Figure 5.6 shows the percentage of incorrect responses pre-surgery 
(upper row) and post-surgery (lower row) for the sham-surgery control group (left column) and 
for the DMS lesion group (right column).   
Both groups made more incorrect responses to the left side (main effect of Side: F(1, 14) 
= 10.43, p = .01, ηp
2
 = .43) and for both groups, incorrect responses increased as a function of 
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Figure 5.5.  Movement time (± SEM) to left and right targets across 
foreperiods for sham-surgery control (left column) and DMS lesioned (right 
column) rats.  The upper row shows the mean MT pre-surgery, while the lower row 
shows MT post-surgery.  The left column- upper row shows that the control group, 
pre-surgery, has faster MT to the right at longer foreperiods (FP 500 and 600).  
However, after surgery, MT was faster to the right side at the shortest foreperiod 
(FP 200) and at FP 400 (left column- lower row).  The right column- upper row 
shows that for the lesion group, pre-surgery there were no differences in movement 
time between the left and right side across the different foreperiods; however, the 
right column- lower row shows that post-surgery, movement time was faster to the 
right side at the longest foreperiod (FP 600) for the lesion group (* p < .05). 
* 
* 
* 
* 
* 
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increasing the length of the foreperiod (main effect of Foreperiod: F(4, 56) = 17.14, p < .001, ηp
2
 
= .55.  Sidak’s-corrected pairwise comparisons showed that FP 200 had fewer incorrect 
responses than all the other foreperiods; FP 300 had fewer incorrect responses than FP 500 and 
600, and FP 400 had fewer incorrect responses than FP 500; see Table 5.1).  At short foreperiods 
there were no differences in the percentage of incorrect responses between the left and the right 
side, but at long foreperiods, there were more incorrect responses to the left side (Side x 
Foreperiod interaction: (F(4, 56) = 3.80, p = .01, ηp
2
 = .21).  Sidak’s-corrected pairwise 
comparisons showed that at the longest foreperiods (FP 500, p < .001 and FP 600, p = .002) there 
were more incorrect responses to the left side.  
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Figure 5.6.  Percentage of incorrect responses (± SEM) to left and right 
targets across foreperiods for sham-surgery control (left column) and DMS 
lesioned (right column) rats.  The upper row shows the percentage of incorrect 
responses pre-surgery, while the lower row shows the percentage of incorrect 
responses post-surgery. 
Chapter 5 
136 
 
Table 5.1.   
Foreperiod Sidak’s-corrected pairwise comparisons for incorrect 
responses.   
Foreperiod 
 
FP 200 
M =3.15 
FP 300 
M =4.11 
FP 400 
M =4.92 
FP 500 
M =6.89 
FP 600 
M =7.13 
FP 200  .039* .001* .000* .003* 
FP 300   .113 .000* .037* 
FP 400    .000* .184 
FP 500     1.00 
FP 600      
Note.  *The mean difference is significant at the .05 level. 
 
Late errors.  Surgery increased the percentage of late errors (main effect of Surgery: F(1, 
14) = 7.54, p = .02, ηp
2
 = .35).  Both groups made more late errors to the left side (main effect of 
Side: F(1, 14) = 7.56, p = .02, ηp
2
 = .35).  For both groups, late errors were affected by increasing 
the length of the foreperiod (main effect of Foreperiod: F(4, 56) = 3.68, p = .03, ηp
2
 = .21.  
Sidak’s-corrected pairwise comparisons indicated that FP 200 had fewer late errors than FP 400, 
p = .01 and FP 500, p = .01).  While at the longest foreperiods there were no differences in the 
percentage of late errors between the left and the right side, at the shortest foreperiods there were 
more late errors to the left side (Side x Foreperiod interaction: F(4, 56) = 3.73, p = .04, ηp
2
 = .21).  
Sidak’s-corrected pairwise comparisons indicated that at FP 200 (p = .002), FP 300 (p = .004) 
and FP 400 (p = .02) there were more late errors to the left side in comparison to the right side.  
Anticipatory errors.  Figure 5.7 shows the percentage of anticipatory errors pre-surgery 
(left column) and post-surgery (right column).  Anticipatory errors were not influenced by the 
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spatial location of the side stimuli because the nose poke was withdrawn from the central hole 
before the onset of the side target stimuli; therefore, they were analysed without including side.   
The percentage of anticipatory errors increased post-surgery (main effect of Surgery: F(1, 
14) = 10.07, p = .01, ηp
2
 = .42).  As foreperiod increased, the percentage of anticipatory errors 
increased (main effect of Foreperiod: F(4, 56) = 97.24, p < .001, ηp
2
 = .87.  Sidak’s-corrected 
pairwise comparisons revealed that all the foreperiods were different from each other).  In 
comparison to the control group, the DMS lesioned rats had higher anticipatory errors at the 
shortest foreperiods and lower anticipatory errors at the longest foreperiods (Foreperiod x Group 
interaction: F(4, 56) = 4.39, p = .004, ηp
2
 = .24).  Sidak’s-corrected pairwise comparisons showed 
that the DMS lesioned rats had more anticipatory responses than the control group only at FP 200 
(p = .03) and FP 300 (p = .04).  At the shortest foreperiods there were no differences in the 
percentage of anticipatory responses pre- and post-surgery; however, at the longest foreperiods 
the percentage of anticipatory responses increased post-surgery (Surgery x Foreperiod 
interaction: F(4, 56) = 13.74, p < .001, ηp
2
 = .50).  Sidak’s-corrected pairwise comparisons 
showed that anticipatory responses increased post-surgery at FP 500 (p = .01) and FP 600 (p < 
.001). 
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5.4 Discussion 
 The aim of this chapter was to investigate whether the performance on the Spatiotemporal 
Target Probability Signal Reaction Time Task was affected by bilateral QA lesions of the 
dorsomedial striatum. 
 Overall, reaction times were faster as foreperiods increased, which suggested that rats 
were sensitive to the conditional temporal probability of the occurrence of the stimulus.  That is, 
at the start of the delay, the stimulus could appear at any of the five foreperiods, but as the 
foreperiods elapsed, the likelihood of the stimulus appearing increased; thus general readiness to 
respond increased and reaction times were faster.  In addition, reaction times were faster to the 
left side at shorter foreperiods and faster to the right side at longer foreperiods (i.e., the 
corresponding sides where the target stimulus was more likely to appear depending on the length 
of the foreperiod), which suggested that the rats were sensitive to the conditional spatiotemporal 
probability.  Reaction times were faster after surgery, as expected, pre-surgery there were no 
Figure 5.7.  Percentage of anticipatory errors (±SEM) pre-surgery 
(left column) and post-surgery (right column) at each foreperiod for the 
DMS lesioned and the control rats.  
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differences between the lesioned and the sham-control groups.  However, post-surgery, reaction 
times were faster for the sham-control rats, which suggested that lesions of the DMS affected the 
general readiness to respond.  However, the conditional spatiotemporal probability was not 
affected by the lesions as post-surgery reaction times remained faster to the right side at the 
longest foreperiods (i.e., the side where the target was more likely to appear).   
 Movement time (i.e., the time to execute the lateralised response) was affected after 
surgery for both groups.  For the sham-control groups, the MT pre-surgery was faster to the right 
side at the longest foreperiods; but after surgery the MT to the right side was also faster on the 
shortest foreperiod.  For the lesioned group, pre-surgery, there were no differences in MT 
between the left and right side across the different foreperiods; however, post-surgery MT was 
faster to the right side at the longest foreperiod.  The faster movement times to the right side, 
across all foreperiods, could suggest a side bias to prepare movements to the right side regardless 
of the duration of the foreperiod.  The increased percentage of late responses (i.e., inability to 
respond within 2 seconds) to the left side provides evidence in favour of a possible predisposition 
to respond to the right side.     
As previously observed in Chapters 3 and 4, anticipatory responses increased as 
foreperiods increased.  After surgery, the percentage of anticipatory responses increased at the 
longest foreperiods, which suggested that surgery enhanced conditional temporal probability.  
But, in this case, motor readiness resulted in premature responses rather than in an improved 
performance.  That is, as the probability of the stimulus appearing increased with time, the 
tendency to respond before the stimulus was presented (anticipatory responses) also increased.  
Lesions of the DMS did not affect accuracy on the task; overall, incorrect responses increased as 
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a function of foreperiod and there were more incorrect responses on the left side at longest 
foreperiods.     
The results from this experiment, slowed reaction times (i.e., initiation of response) but 
not movement time (i.e., latency to execute the lateralised response), were in accord with 
previous studies that investigated the effects of striatal lesions on reaction time performance 
(Brasted et al., 1998; Brasted et al., 1997; Brown and Robbins, 1989; Hauber and Schmidt, 1994; 
Mittleman et al., 1988).  In addition, these results extend the findings that, even with minor 
differences in the lesions placements in the DMS, the different volumes of toxin infused, and 
different lesions modes (bilateral or unilateral), lesions of the DMS impaired rapid initiation of 
responses triggered by a stimulus.  
In summary, the present study showed that rats were able to learn the Spatiotemporal 
Target Probability Signal Reaction Time Task efficiently, as they had faster reaction times to the 
left side at shorter foreperiods, and faster reaction times to the right side at longer foreperiods 
(i.e., the side were the target was more likely to appear).  This conditional spatiotemporal 
probability (probability to respond to the right or the left side as a function to the length of 
foreperiod) was not affected by lesions of the DMS.  Given that, in the present study, the animals 
were trained on the Spatiotemporal Target Probability Signal Reaction Time Task prior to 
lesioning the striatum, the results suggested that once a task that requires implicit memory has 
been learned, the DMS was not involved in sustaining the performance of the task.  Further 
research could investigate if lesions of the DMS disrupt the acquisition of this implicit task; 
lesioning the animals before the probabilities are introduced on the task, would allow 
investigating if the striatum is involved in the computation of probabilities to predict the location 
of a target stimulus that changes as a function of the length of the foreperiod.  Furthermore, it 
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could also be possible that the DMS is not involved in this form of implicit task, but this should 
be further investigated.  Different human studies have suggested that the striatum is not the only 
neuronal structure that contributes to implicit learning, and various cortical areas (e.g., 
ventrolateral prefrontal cortex, ventromedial premotor area, medial prefrontal cortex) have been 
reported to be involved in various stages of implicit learning (Exner et al., 2002; van der Graaf et 
al., 2006).  Consequently, it could be possible that lesions of the prefrontal cortex may impair the 
computation of probabilities that predict the location of the stimuli in this task.  This could also 
be investigated in the future given that, in addition to the striatum, the cortex of patients with HD 
also suffers from atrophy.  Furthermore the cortical neuronal degeneration leads to excessive 
thinning of the cerebral mantle of the entire brain (Hedreen et al., 1991).  As a new task, further 
investigation is required to evaluate which neuronal structures are involved in the computation of 
probabilities to predict the location of the stimuli.  
Given that no cognitive impairments were observed in the Spatiotemporal Target 
Probability Signal Reaction Time Task after lesioning the DMS, the effectiveness of treatments 
for HD could not be evaluated using this task.  Therefore, Chapter 6 investigated another test of 
striatal function in which potential treatments for HD could be evaluated. 
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Chapter 6 
6 Goal-Directed and Habitual Responding in 
Rats with Bilateral Quinolinic Acid Lesions of 
the Dorsomedial Striatum: Implications for 
Huntington’s disease  
 
The aim of the experiment presented in this chapter was to assess the involvement of the 
DMS in habitual responding.  Using a free scan task, rats had to nose poke a row of five holes to 
find a target hole selected randomly on each trial.  There was no cue that would indicate which 
hole would produce the reward. 
The first part of the experiment used an outcome devaluation procedure to determine if 
nose poking was affected by the value of the reward or if it was habitual responding.  Rats were 
tested on this procedure pre- and post-surgery.  
The second part of the experiment investigated the effects of bilateral QA lesions of the 
DMS on habitual responding by changing the reward contingencies so that the central hole never 
produced a reward.  
Do bilateral QA lesions of the DMS induce habitual responding? 
  
 
Chapter 6 
145 
 
6.1 Introduction 
In an environment which is constantly changing, it is beneficial to have flexible, goal-
directed actions; however, monitoring every response reduces the capacity for alternative 
cognitive processes (Gehring and Knight, 2000).  Therefore, habitual, repetitive behaviours are 
also advantageous, since they reduce attention and decision making resources (Smith and 
Graybiel, 2013).  Habitual, repetitive behaviours can also bring disadvantages, for example when 
they allow predators to predict behaviour (Desrochers et al., 2010).  In this sense, optimal 
performance of everyday situations requires a balance between goal-directed and habitual 
behaviours (Balleine et al., 2009; Graybiel, 2008; Yin and Knowlton, 2006).   
It has been suggested that goal-directed and habitual behaviours are controlled by distinct 
learning processes.  While goal-directed behaviours involve the formation of action-outcome (A-
O) associations to mediate flexible, deliberated actions that are controlled by consequences, 
habits involve the integration of stimulus-response (S-R) without associating the outcome to 
those actions in order to mediate inflexible and automatic behaviour (Dickinson, 1985; Dickinson 
and Balleine, 1994). 
To evaluate if a behaviour is goal-directed or habitual, the value of that behaviour’s 
outcome could be reduced (e.g., access to the reward is given before the task).  If the 
performance of the task is unaffected after the value of the outcome is manipulated, then the 
behaviour is habitual.  Conversely, if the performance is affected after the value of the outcome 
is manipulated (e.g., the rate of responding decreases after the reward is devalued), then the 
behaviour is goal-directed (Dickinson, 1985; Dickinson and Balleine, 1994).    
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In addition to having a general role in the initiation and patterning of different behaviours, 
the striatum has also been associated with habit formation (Packard and Knowlton, 2002; Yin 
and Knowlton, 2006).  In rats, the DMS has been implicated in A-O learning and expression of 
goal-directed actions (Yin and Knowlton, 2006; Yin et al., 2004; Yin et al., 2005). 
Apart from the S-R association that characterises habitual behaviours, Graybiel (1998)  
proposed that habits are stereotypic, ritualistic behaviours which consist of sequential 
movements.  These ritualistic behaviours are one of the most common obsessions in HD (Novak 
and Tabrizi, 2010).  To study the formation of sequential habits, Desrochers et al. (2010) 
designed a free-viewing scan task in which monkeys had to scan a grid of dots, one of which was 
randomly baited.   Once the monkey fixated on the target dot, a reward became available.  Using 
this task,  Desrochers et al. (2010) found that even though the monkeys were free to move their 
eyes in any direction to find the target, despite receiving no explicit training to develop a pattern 
of saccades to scan the grid, monkeys developed a dot-looking visual habit to scan the target 
grids.  
 However, even though Desrochers et al. (2010) described the scanning pattern as a 
habitual behaviour, it remains to be investigated if the behaviour is affected by the outcome.  As 
Dickinson (1985) suggested, if the performance of the task is unaffected after the value of the 
outcome is manipulated, then the behaviour is considered habitual.  This chapter presented a task, 
adapted from that of Desrochers et al. (2010), which rats nose poked a row of five holes to find a 
target hole selected randomly on each trial (no cue would indicate which hole would produce the 
reward) to evaluate habit formation in rats with QA lesions of the DMS.   
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Changes in goal value were assessed by using a devaluation of the reward, in which rats 
had free access to the reinforcement in their home cages before testing and the reward was not 
delivered during the session.  It was hypothesised that if habits were formed, the performance on 
the task would not be affected even though the value of the reward was devalued.  In addition, to 
evaluate if lesions of the DMS would impair goal-directed behaviour (i.e., the association of an 
action and an expected outcome), in the last phase all of the conditions remained the same, but 
the central hole never produced a reward.  Since there were no cues to indicate the change, the rat 
had to learn through the task that nose poking into the central hole would never produce a 
reward.  Habit responding would consist of continuing responding to the central hole.  Thus,  it 
was hypothesised that if the DMS is required to learn goal-directed behaviours, rats with DMS 
lesions would show habit responding and would continue responding to the central hole 
regardless of no further reinforcement for that response.  Additional measures such as reaction 
time, movement time and post-reinforcement pause, were also compared between the groups to 
evaluate possible movement changes affected by lesions of the DMS.  Furthermore, since it has 
been reported that the most prominent regions where chorea manifests in HD patients are the 
orofacial regions (Berardelli et al., 1999), the rate of licking the spigot once the liquid reward 
was available was also compared between the groups. 
6.2 Method 
6.2.1 Animals 
The animals were 16 experimentally-näive male hooded Lister rats (Harlan, UK Ltd) with 
a mean ad libitum weight of 274 g (range = 256 - 321 g) at the beginning of the experiment.  The 
rats were housed in quadruplets in plastic box cages and handled five days a week.  After 
habituation to the conditions of the animal colony, water was restricted to free access of one hour 
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five days per week.  Body weight was monitored on testing days to ensure steady gain.  Weights 
did not fall below 85% of free-feeding weight.  Food was available ad libitum in the home cage.  
The experimental testing was carried out five days a week during the light portion of the cycle.  
Husbandry conditions were described in the General Methods in Chapter 2.   
6.2.2 Apparatus 
All phases of the experiment were conducted in a set of 4 five-hole nose poke wall 
operant chambers (Figure 6.1; Med Associates, Vermont, USA).  Each chamber (34 x 29 x 25 
cm) was enclosed in a ventilated, sound-attenuating cubicle and had a video camera above them 
(Santec Smart Vision, model VCA 5156; Sanyo Video Vertreib GMbH CO., Ahrensburg, 
Germany).  An extractor fan provided a constant low-level of background noise and a continuous 
airflow.  The floor of the chamber was a stainless steel grid.  The rear wall of each chamber was 
concave and had a horizontal array of five holes.  Each hole contained a vertical photocell beam 
located at the front to detect nose entries.  Liquid reinforcer was available through a metal spigot 
protruding through a hole in the lower centre of the back wall; this contained a lickometer with a 
photo beam and delivered 0.1 ml of sodium saccharine solution (0.3% w/v) per trial from a 
computer-controlled speed syringe pump (PHM-100).  A light and a tone (EW-233A) indicated 
the delivery of the reward.  The presentation of stimuli and the collection of data were controlled 
by a computer using the Medstate programming language (Med-PC-IV, MED Associates).  The 
temporal resolution of the instrumental set-up was 2 ms.   
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6.2.3 Procedure 
Three days prior to experimental testing, the rats were put in a restricted water access; 
which consisted of the following schedule: an hour of access to sodium saccharine solution 
(0.3% w/v), followed to an hour of access to plain water. 
Training.  In the initial two sessions, rats were habituated to the operant boxes during a 
30 min session, in which 0.1 ml of sodium saccharine solution was delivered every time the rat 
licked the spigot.  The delivery of the reward (accompanied by a tone and a light) was between 
10-60 sec after the onset of licking within a trial, in 10 sec increments. 
During this phase and throughout the experiment (unless specified) the rats had restricted 
access to water between 16:00-17:00 h on Monday to Friday, with free water access from 16:00 h 
on Friday to Sunday afternoon.  
Nose poke training.  During the following sessions, the animals were trained to make a 
nose poke into the illuminated holes to receive the reward.  The trial began with all the five 
holes’ lights on.  The lights from the holes were lit until the rat made a nose poke in any of the 
holes; once this occurred, the lights in the five holes were turned off and a light and a tone at the 
Figure 6.1.  Five-hole operant chamber used for training and testing. 
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spigot that delivered reward were turned on.  If the rat licked the spigot during the reward signal 
(light and tone at the spigot), the reward was pumped for 2 sec, delivering 0.1 ml of sodium 
saccharine solution.  Subsequently, the reward signal was turned off and a new trial initiated.  If 
none of the holes were poked after a variable interval of 2, 3 or 4 minutes, the reward signal was 
turned on.  This phase was conducted for a week.  
Task training and testing.  On each trial of the following sessions, only one of the holes 
was randomly selected to produce reward.  The beginning of the trial was indicated by 
illuminating the five holes and every second between 1-7 seconds one of the holes was randomly 
selected to produce a reward after a nose poke.  There was no cue that would indicate which hole 
would produce the reward.  Once the rat nose poked in the target hole the reward signal was 
turned on and the reward was given as described in the previous phase.  When the rat collected 
the reward, the reward signal was turned off and a new trial started.  Each session lasted 30 
minutes.  Figure 6.2 shows a schematic representation of the task. 
An incorrect response was registered when the animal licked the spigot before the reward 
was available or when nose pokes were produced once the reward was available.  This phase was 
conducted for 40 sessions.  Once the behaviour was stable, no difference on the trials completed 
across 5 sessions, rats were tested on the devaluation phase. 
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Devaluation phase.  An hour before testing, the animals were given 30 min of free 
access to saccharin solution in their home cages, with the solution removed 30 min before 
testing.  During this phase, testing was conducted in the same way as described before, with the 
exception that the syringe pumps were blocked so that no reward was delivered during the 
session.  However, all visual and auditory cues remained unchanged.  Sessions lasted 30 min and 
once the rats were placed back in their home cages they were given 30 min of free access of 
saccharin solution.  The volume of saccharin consumed was recorded before and after testing and 
was calculated from the weights of the bottles.  Devaluation sessions were conducted after two 
regular testing sessions and followed by an additional two regular testing sessions (i.e., Monday 
and Tuesday were regular sessions, Wednesday was a devaluation session, and Thursday and 
Friday were regular sessions).  This phase lasted 2 weeks.   
Figure 6.2.  Schematic representation of the task. 
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Surgery.  Pre-surgery, rats were pseudo-randomly assigned to the sham-surgery control 
(n =6) or dorsomedial striatum (DMS) lesion (n =10) group.  Data from the two groups were 
analysed to ensure there were no differences between the groups before the surgery.  The surgery 
protocol was as described in Chapter 2 (General Methods). 
Post-surgery testing.  After the rats recovered from the surgery (approximately 10 days), 
they were retested on the task for 17 sessions. 
Post-surgery devaluation phase.  Rats were retested on 2 sessions of the devaluation 
phase as previously described for 2 weeks (i.e., a devaluation session was conducted after two 
regular testing sessions and followed by an additional two regular testing sessions).   
Omission of reward on central hole.  After the last two regular sessions of the 
devaluation phase, the omission of the reward on the central hole phase started.  In this phase, all 
of the conditions remained the same as in the testing phase with the exception that the central 
hole never produced a reward.  There were no cues that indicated this change.  This phase was 
conducted for 32 sessions.  
Histology.  As described in the histology section of the General Methods in Chapter 2. 
6.2.4 Data analysis 
 All analyses were conducted in IBM SPSS (v 21, SPSS Inc., Chicago, IL).   
Trials completed.  Total number of trials completed by rat per session. 
Percentage of pokes in the central hole.  This was calculated by multiplying the total 
number of pokes in the central hole by 100, and dividing it by the total number of pokes in all the 
5 holes per session.  
Omission of reward on central hole phase.  The average of the percentage of pokes in 
the central hole of the last 2 sessions when the central hole was rewarded (baseline sessions) was 
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compared to the average of the percentage of pokes in the central hole of the first 2 sessions after 
the central hole was unrewarded (omission sessions). 
Reaction Time.  Time to withdraw from reward nose poke hole once reward signal has 
been presented (ms). 
Movement Time.  Time between withdrawal of nose poke from the rewarded hole to the 
first lick at reward spigot (sec).  
Post-reinforcement pause.  The time between trial onset and the first nose poke (sec). 
Lick rate.  The rate of licking the spigot once the reward was available.  
Statistical analyses.  A three factor, 2 x 2 x 2 ANOVA with the variables of Surgery 
(Within-subjects factor with 2 levels: Pre-surgery vs. Post-surgery), Group (Between-groups 
factor with 2 levels: Lesion vs. Sham-surgery control), and Session (Within-subjects factor with 
2 levels: Baseline vs Devaluation), was conducted to evaluate if there were significant 
differences between the two groups on each of the dependent measures.   
The devaluation values were the average of the two devaluation sessions; the baseline 
values were the average of the two sessions prior to the devaluation session and the second day 
following reinforcer devaluation (i.e., the average of the sessions from Monday, Tuesday and 
Friday from the devaluation phase week) of the two weeks the devaluation phase was conducted.  
The session following devaluation was not included in the analysis to avoid including skewed 
data by changes observed during the devaluation session.  These values were calculated for the 
pre-surgery and post-surgery devaluation vs baseline comparisons.  
For the omission of reward on central hole phase a two factor, 2 x 2 ANOVA with the 
variables of Group (Between-groups factor with 2 levels: Lesion vs. Sham-surgery control) and 
Session (Within-subjects factor with 2 levels: Baseline vs Omission) was conducted.  Sidak’s-
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corrected pairwise comparisons for significant effects or interactions were performed.  When 
data violated the assumption of sphericity, Huynh-Feldt corrections were reported.  The criterion 
for significance (alpha level) was p < .05 in all cases.   
6.3 Results 
6.3.1 Histology 
Nine out of 10 DMS lesion rats were determined to have appropriate bilateral lesions.  
Figure 6.3 shows photomicrographs of coronal sections from sham-surgery control and DMS 
lesioned animals.  Two out of 6 sham-surgery control lesion rats died prematurely.   
The final numbers (n) in each group were: DMS lesion (n = 9), sham-surgery control (n = 
4).  Figure 6.4 shows a schematic diagram of a series of coronal sections of the rat brain (Paxinos 
and Watson, 2007), illustrating the extent of bilateral dorsomedial (DMS) striatum lesions. 
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Figure 6.3.  Representative photomicrographs of coronal sections double-
stained with NeuN and Cresyl Violet from sham control (left), and dorsomedial 
striatum (DMS) lesion (right) animals.  Sham control rats showed an even 
distribution of neurons in the striatum whilst DMS lesioned rats showed cell loss.  
Arrows point to the lesion area.  From the top, sections are +1.7, +1.2, +0.7, +0.2, 
and -0.3 mm from bregma. Scale bar 1,000 μm. 
DMS 1,000 μm Sham 
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Figure 6.4.  Schematic diagram of a series of coronal 
sections of the rat brain illustrating the extent of bilateral 
dorsomedial (DMS) striatum lesions.  Darkness represents 
coincidence lesions from different animals.  From the top, 
sections are +2.2, +1.7, +1.2, +0.7, +0.2, −0.3, −0.80 and 
−0.92 mm from bregma (Paxinos and Watson, 2007). 
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6.3.2 Behavioural performances 
Trials completed.  Figure 6.5 shows the mean number of trials completed per session for 
DMS lesion and sham-surgery control rats, pre-surgery and post-surgery.  Figure 6.6 shows the 
mean number of the trials completed on the devaluation and baseline sessions pre-surgery and 
post-surgery for the two groups. 
Both groups completed fewer trials after surgery (main effect of Surgery: F(1, 11) = 9.12, 
p = .01, ηp
2
 = .46), and fewer trials were completed on the devaluation sessions in comparison to 
baseline sessions (main effect of Session: F(1, 11) = 462.69, p < .001, ηp
2
 = .98).  DMS lesions 
did not affect the number of trials completed on the devaluation or baseline sessions (neither 
main effect of group nor any interactions were significant). 
 
 
 
Figure 6.5.  Mean total trials completed (± SEM) for DMS lesion 
and sham-surgery control rats across all sessions of the experiment, the 
devaluation sessions are marked with a square (□) symbol. 
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Percentage of pokes in the central hole.  The percentage of pokes in the central hole 
was not affected by surgery, lesion or by the devaluation sessions (all effects and interactions 
were not significant).  Figure 6.7 shows the percentage of pokes in the central hole for the DMS 
lesion and sham-surgery control rats across all the sessions of the experiment. 
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Figure 6.6.  Mean total trials completed (± SEM) for 
DMS lesion and sham-surgery control rats on devaluation and 
baseline sessions pre-surgery and post-surgery. 
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Omission of reward on central hole phase.  Figure 6.8 shows the mean of the percentage 
of pokes in the central hole for the baseline and omission sessions.  Nose pokes in the central 
hole decreased for both groups when the hole was not rewarded (main effect of Session: F(1, 11) 
= 59.26, p < .001, ηp
2
 = .84).   
 
Figure 6.7.  Mean percentage (± SEM) of pokes in the central hole for 
DMS lesion and sham-surgery control rats across all the sessions of the 
experiment.  The devaluation sessions are marked with a square (□) symbol. 
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Reaction Time (RT).  Figure 6.9 shows the mean RTs (i.e., time to withdraw from the 
reward nose poke hole once the reward signal has been presented) per session for DMS lesion 
and sham-surgery control rats, pre-surgery and post-surgery.  Figure 6.10 shows the mean RTs 
on the devaluation and baseline sessions pre-surgery and post-surgery for DMS lesion and sham-
surgery control rats.  RTs were slower post-surgery (main effect of Surgery: F(1, 11) = 7.53, p = 
.02, ηp
2
 = .41).  Pre-surgery, there was no difference in RTs between sham-surgery control and 
lesioned rats; however, post-surgery, reaction times of the control group were slower than the 
lesion group (significant interaction between Surgery x Group: F(1, 11) = 20.49, p = .001, ηp
2
 = 
.65).  Pre-surgery, there was no difference in RTs between the devaluation and the baseline 
session; however, post-surgery, reaction times during the devaluation sessions were slower than 
the baseline sessions (significant interaction between Surgery x Session: F(1, 11) = 9.25, p = .01, 
ηp
2
 = .46).  There was a three way interaction between the variables Surgery, Session and Group 
(F(1, 11) = 21.46, p = .001, ηp
2
 = .66).  Sidak’s-corrected pairwise comparisons revealed that pre-
Figure 6.8.  Mean percentage (± SEM) of pokes in the central 
hole for DMS lesion and sham-surgery control rats on baseline and 
devaluation sessions. 
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surgery the RTs on the devaluation and the baseline sessions were not different between the 
DMS lesion and the sham-surgery control groups; however, post-surgery, the sham-surgery 
control group had slower RTs on the devaluation sessions in comparison to the DMS lesion 
group (p = .01). 
 
 
Figure 6.9.  Mean reaction times (± SEM) for DMS lesion and 
sham-surgery control rats across all the sessions of the experiment.  
The devaluation sessions are marked with a square (□) symbol. 
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Movement Time (MT).  Figure 6.11 shows the mean MTs (i.e., time between 
withdrawal of nose poke from the rewarded hole to the first lick at reward spigot) per session for 
DMS lesion and sham-surgery control rats, pre-surgery and post-surgery.  MTs were slower on 
devaluation than baseline sessions (main effect of Session: F(1, 11) = 9.43, p = .01, ηp
2
 = .46).   
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Figure 6.10.  Mean reaction time (± SEM) for DMS lesion and 
sham-surgery control rats on devaluation and baseline sessions pre-
surgery and post-surgery. 
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Post-reinforcement pause (PRP).  Figure 6.12 shows the mean PRPs (i.e., time between 
trial onset and the first nose poke) per session for DMS lesion and sham-surgery control rats, pre-
surgery and post-surgery.  Figure 6.13 shows the mean PRPs on the devaluation and baseline 
sessions pre-surgery and post-surgery for DMS lesion and sham-surgery control rats.  PRP were 
longer after surgery (main effect of Surgery: F(1, 11) = 6.35, p = .03, ηp
2
 = .37).  Devaluation 
sessions had longer PRPs than baseline sessions (main effect of Session: F(1, 11) = 13.35, p = 
.004, ηp
2
 = .55).  Pre-surgery, baseline sessions had shorter PRPs compared to devaluation 
sessions; post-surgery, devaluation sessions had longer PRPs than the baseline sessions 
(significant interaction between Surgery x Session: F(1, 11) = 5.77, p = .04, ηp
2
 = .34).   
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Figure 6.11.  Mean movement times (± SEM) for DMS lesion and 
sham-surgery control rats across all the sessions of the experiment.  The 
devaluation sessions are marked with a square (□) symbol. 
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Figure 6.12.  Mean post-reinforcement pauses (± SEM) for 
DMS lesion and sham-surgery control rats across all the sessions of 
the experiment.  The devaluation sessions are marked with a square 
(□) symbol. 
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Figure 6.13.  Mean post-reinforcement pauses (± SEM) for DMS 
lesion and sham-surgery control rats on the devaluation and the baseline 
sessions pre-surgery and post-surgery. 
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Lick rate.  Figure 6.14 shows the mean rate of licking the spigot once the reward was 
available per session for DMS lesion and sham-surgery control rats, pre-surgery and post-
surgery.  Figure 6.15 shows the mean rate of licking the spigot on devaluation and baseline 
sessions pre-surgery and post-surgery for DMS lesion and sham-surgery control rats.  The rate of 
licking the spigot was higher during the baseline than in the devaluation sessions (main effect of 
Session: F(1, 11) = 393.72, p < .001, ηp
2
 = .97).  During baseline sessions, the rate of licking the 
spigot was higher for the DMS than sham-surgery controls (p = .05); however, during the 
devaluation sessions there was no difference between the groups on the rate of licking the spigot 
(significant interaction between Session x Group: F(1, 11) = 6.90, p = .02, ηp
2
 = .39).   
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Figure 6.14.  Mean licking rate (± SEM) for DMS lesion 
and sham-surgery control rats across all the sessions of the 
experiment.  The devaluation sessions are marked with a square (□) 
symbol. 
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6.4 Discussion 
The present experiment adapted the free scan task, proposed by Desrochers et al. (2010),  
in which rats nose poked a row of five holes to find a target hole selected randomly on each trial.  
There was no cue that would indicate which hole would produce the reward or when the target 
would become bated.  The aim of this experiment was to investigate the effects of bilateral QA 
lesions of the DMS on goal-directed behaviour and habitual responding.  Changes in goal value 
were assessed by using a devaluation of the reward, in which rats had free access to the 
reinforcement in their home cages before testing, and the reward was not delivered during the 
session.  It was hypothesised that if habits were formed, the performance on the task would not 
be affected even though the value of the reward was devalued.  This was not observed, either pre-
surgery or post- surgery, both DMS lesioned and sham-surgery control rats completed fewer 
trials during the devaluation sessions, which suggested nose poking was not habitual responding.   
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Figure 6.15.  Mean licking rate (± SEM) for DMS lesion 
and sham-surgery control rats on devaluation and baseline sessions 
pre-surgery and post-surgery. 
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In addition, to evaluate if lesions of the DMS would impair goal-directed behaviour (i.e., 
the association of an action and an expected outcome), in the last phase all of the conditions 
remained the same, but the central hole never produced a reward.  Since there were no cues to 
indicate the change, rats had to learn through the task that nose poking into the central hole 
would never produce a reward.  Habitual responding would consist of continuing responding to 
the central hole.  Thus, it was hypothesised that if the DMS was required to learn goal-directed 
behaviours, rats with DMS lesions would show habitual responding and would continue 
responding to the central hole regardless of it no longer being reinforced.  This was not observed 
either, as the percentage of responses in the central hole decreased for both the DMS lesioned 
and sham-surgery control rats, when it did not produce a reward.  Given that rats with DMS 
lesions were able to learn that the central hole no longer produced a reward (i.e., their number of 
responses in the central hole decreased), it may be suggested that lesions of the DMS do not 
impair the ability to learn goal-directed behaviours.  
Additional measures such as reaction time, movement time and post-reinforcement pause, 
were compared between the groups to evaluate possible movement changes affected by lesions of 
the DMS.  Furthermore, since it has been reported that the most prominent regions where chorea 
manifests in HD patients are the orofacial regions (Berardelli et al., 1999), the rate of licking the 
spigot once the reward was available was also compared between the groups.  General motor 
impairments after DMS lesions should be expected to reduce motor activity.  This was not 
observed in the current experiment.  There were no differences between DMS lesioned and 
sham-surgery control rats in MT, PRP or licking rate; thus DMS lesions did not produce any 
evidence of general motor impairments.  During the devaluation sessions, MTs were slower, 
PRPs were longer and the licking rate decreased for both groups.  However, sham-surgery 
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control rats had slower RTs on the devaluation sessions post-surgery.  Slower RTs (i.e., time to 
withdraw from reward nose poke hole once reward signal has been presented) during the 
devaluation sessions could be explained by the fact that no reward was presented, which 
suggested that sham-surgery control rats learned that the reward signal that would indicate 
reward would no longer deliver reward during that session.   
Previous studies have reported that when the contingency between response and outcome 
delivery is weakened by using interval schedules of reinforcement, instrumental performance can 
rapidly become habitual, and also becomes insensitive to outcome devaluation (Dickinson, 1985; 
Dickinson et al., 1983).  This was not observed in the current experiment.  Even though 
uncertainty and unpredictability in the delivery of the reward over a prolonged period of training 
were used, the results from the current experiment showed that the performance of the task was 
affected after the value of the outcome was devalued, and when the reward was omitted in one of 
the holes.  These results suggested that nose poking was not habitual and lesions of the DMS did 
not affect the acquisition of goal-directed behaviours, as it has been previously suggested (Yin et 
al., 2005).   
The results from this experiment are also inconsistent with previous studies that have 
reported that inhibition of the DMS leads to a loss of behavioural flexibility and outcome 
sensitivity, and increase habitual responding (Packard, 2009; Packard and McGaugh, 1996; 
Ragozzino, 2007; Yin et al., 2005).  This inconsistency of the results in habitual responding may 
be due to the differences between the tasks that have been used, and in the operational definition 
of habit.  For example, some studies have used simple operant tasks that required pressing a lever 
to produce a reward and habits were assessed by comparing the performance once the reward 
was devalued.  Other studies have used maze learning tasks to evaluate place and response 
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strategies and habits were defined as the inflexibility of always performing the same behaviour of 
turning to the same side, regardless of where the animal was positioned to start the task (Packard 
and Knowlton, 2002; Packard and McGaugh, 1996).  The new task used in the present 
experiment, required rats to nose poked a row of five holes to find a target hole selected 
randomly on each trial.  Given that the baited hole changed every trial, it was unpredictable 
where and when the target would become baited.  Therefore, no particular response or sequence 
of responses would produce a reward, and no fixed S-R habit would be required to solve the task.  
Thus, it might be suggested that while the DMS was not required for performing the task used in 
this chapter, the DMS is required in other tasks that involve maze learning or simple operant 
tasks responses that involve S-R associations.  Similarly, studies in patients with neuronal 
degeneration in the neostriatum, such as HD, have shown impairments in the acquisition of a 
variety of tasks that require motor skills (e.g., mirror reading, pursuit-rotor tracking, adaptation 
level during weight judgements), and implicit learning (see section 1.8.1 from the General 
Introduction).  In addition,  one of the most common obsessions in HD are ritualistic behaviours 
(Novak and Tabrizi, 2010).  Hence, it was expected that rats with QA lesions of the DMS would 
present deficits in the current task that could be compared to patients with HD.   
In addition, it has been suggested that lesions of the DMS have opposing effects to 
lesions of dorsolateral striatum (DLS) for balancing habitual and goal-directed behaviours (Smith 
and Graybiel, 2014).  While it has been suggested that the DMS is involved in learning A-O 
associations, the DLS has been proposed to be involved in S-R learning (Yin and Knowlton, 
2006; Yin et al., 2004; Yin et al., 2005).  Using the devaluation procedure, Yin et al. (2004) 
observed that rats with lesions of the DLS reduced their performance after the reward was 
devalued, while the behaviour of DMS lesioned rats was not different to the sham control rats.  
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This suggests that the instrumental performance (press a lever) in the DLS lesioned rats was 
controlled by goal expectancy; therefore, when the value of the reward was decreased, the 
performance also decreased.  But rats with DMS lesions responded habitually, as the 
performance was not affected when the reward was devalued.  Thus, future research should 
investigate the involvement of the DLS in habitual responding using the task reported in this 
chapter. 
Furthermore, to evaluate if the performance is goal-directed or habitual, in addition of 
outcome devaluation, the effects of contingency degradation (i.e., rewards are delivered 
regardless of the behaviour) should be examined in the task used in this chapter to investigate the 
role of the dorsal striatum in goal-directed and habitual responding. 
In summary, this experiment presented a new task to evaluate goal-directed and habitual 
responding.  Both, DMS lesioned and sham-surgery control rats did not show habitual 
responding in the task, as their performance decreased when the value of the reward decreased.  
Lesion of the DMS did not change the sensitivity to outcome devaluation, and both sham-surgery 
control and DMS lesioned rats made fewer responses to the hole that never delivered reward 
during the last phase of the experiment, which suggested that DMS lesions did not affect the 
acquisition of a new goal-directed behaviour.  From these findings it could be concluded that rats 
with bilateral quinolinic acid lesions of the dorsomedial striatum do not present deficits as HD 
patients in goal-directed behaviours, neither showed ritualistic behaviours which are also 
considered as habits and that are one of most common obsessions in HD (Novak and Tabrizi, 
2010).   
Given that no cognitive deficits were observed in DMS lesioned rats that could be 
compared with HD patients; Chapter 7 evaluated if rats with bilateral QA lesions of the DMS 
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presented similar cognitive deficits in behavioural flexibility as those seen in HD patients in the 
ID/ED attentional set-shifting task. 
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Chapter 7 
7 Attentional Set-Shifting in Rats with Bilateral 
Quinolinic Acid Lesions of the Dorsomedial 
Striatum 
 
Patients with damage to the striatum arising from Huntington’s disease (HD) exhibit 
deficits in behavioural flexibility in the Intra-Dimensional/Extra-Dimensional (ID/ED) 
attentional set-shifting task.  Patients in early stages of HD and preclinical carriers of the HD 
mutation showed impairments in ED shift performance; whereas, patients with advanced HD 
cannot complete the earlier reversal stages and therefore rarely reach the ED stage.  To evaluate 
the QA lesioned rat as a suitable model for cognitive deficits in HD, rats with bilateral QA 
lesions of the DMS were tested in the attentional set-shifting task. 
 
Do rats with bilateral quinolinic acid lesions of the dorsomedial striatum present similar 
cognitive deficits in behavioural flexibility as those seen in HD patients in the ID/ED attentional 
set-shifting task? 
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7.1 Introduction 
One of the cognitive deficits in patients with Huntington’s disease is a decrement in 
behavioural flexibility (i.e., the ability to adjust responses according to the specified context and 
requirements of varying situations).  Attentional set-shifting, which is a process of shifting 
attention from one perceptual dimension to another, is an aspect of behavioural flexibility that 
has been assessed in humans using the Wisconsin Card Sorting Test (WCST; Berg, 1948).  
Deficits on the performance of the WCST have been reported in patients with HD.  Josiassen et 
al. (1983) compared the performance of patients with recently diagnosed HD (diagnosed for one 
year or less) with moderate HD patients (diagnosed for more than a year to eight years) on the 
WCST.  While both groups were able to infer the first sorting rule without difficulty; when the 
sorting rule changed, patients with moderate HD showed deficits in behavioural flexibility (i.e., 
they perseverated in using the past sorting rule).  Various imaging studies have suggested that the 
deficits seen in HD patients in the WCST result from changes in striatal function, rather than in 
the frontal cortex (Lawrence et al., 1998b, for a review).  For example, using high resolution 
single photon emission computerised tomography (SPECT), Hasselbalch et al. (1992) showed 
that blood flow is reduced in the caudate nucleus of patients with HD and that there is a positive 
linear relationship between blood flow in the caudate nucleus and performance of the WCST in 
patients with Huntington’s disease.  Deficits in formation, maintenance and shifting of cognitive 
sets have also been reported in the Intra-Dimensional/Extra-Dimensional (ID/ED) attentional set-
shifting task in patients with HD (Lawrence et al., 1998b).  Depending on the progression of the 
disease, patients with Huntington’s had shown different impairments in the ID/ED attentional 
set-shifting task.  Patients in the early stage of HD showed impairments in the ED shift (i.e., they 
had deficits when the task required them to shift responding from stimuli of one perceptual 
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dimension to stimuli of another dimension) and made more perseverative than non-perseverative 
errors (i.e., they kept on responding to the previous relevant stimuli dimension, when it was no 
longer relevant); but were not impaired in set-formation or reversal learning (Lawrence et al., 
1996; Lawrence et al., 1999a).  However, patients in advanced HD showed reversal impairments 
(i.e., they continued selecting the previously reinforced stimuli even though it was no longer 
correct) and fail to complete the task.  Patients in advanced stage HD cannot complete the 
reversal stages and rarely reach the ED stage (Lange et al., 1995).  Preclinical carriers of the HD 
mutation, before the onset of any clinical movement disorder, also showed specific deficits in the 
ED stage of the ID/ED attentional set-shifting task.  Therefore, the ID/ED attentional set-shifting 
task seems to be a tool that is capable of detecting subtle impairments earlier than many other 
cognitive tasks and before the development of the movement disorders in HD (Lawrence et al., 
1998a). 
Given that the ID/ED task has been able to identify cognitive deficits in HD patients even 
before any motor symptoms (Lawrence et al., 1998a), and since different studies have suggested 
that the striatum is essential for effective set-shifting (Castañé et al., 2010; Ragozzino et al., 
2002b); the aim of this chapter was to evaluate if rats with bilateral quinolinic acid lesion of the 
dorsomedial striatum, which mimics some aspects of the neural damage in HD, presented similar 
cognitive deficits in the attentional set-shifting task (Birrell and Brown, 2000) as those seen in 
patients with HD.  Based on the performance on the ED/ID task of HD patients (Josiassen et al., 
1983; Lange et al., 1995; Lawrence et al., 1998a; Lawrence et al., 1996; Lawrence et al., 1999b), 
it was hypothesised that rats with QA lesions of the DMS would show impairments in the ED 
shift (i.e., they would have deficits when the task requires them to shift responding from stimuli 
of one perceptual dimension to stimuli of another dimension), would make more perseverative 
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than non-perseverative errors (i.e., they would kept on responding to the previous relevant 
stimuli dimension, when it would no longer be relevant), and would have reversal impairments 
(i.e., they would continue selecting the previously reinforced stimuli even though it would no 
longer be correct). 
7.2 Method 
7.2.1 Animals 
The animals were the same 24 male hooded Lister rats (Charles River, UK Ltd) used in 
Chapter 5.  Testing was conducted in the light phase of a 12:12 hr. light-dark cycle.  Housing and 
husbandry conditions were described in the General Methods in Chapter 2.   
7.2.2 Apparatus 
Training and testing sessions were conducted in the attentional set-shifting box, a 69.5 x 
40.5 x 18.5 cm adapted plastic housing-cage.  The cage was divided into two sections by a 
Plexiglas panel located at one-third of the length of the cage.  The floor of the big section was 
covered with sawdust and contained a bowl with water in the back corner.  The small section was 
divided with a central divider and each section contained a ceramic bowl with an internal 
diameter of 7 cm and a depth of 4 cm.  Access to the small sections, in which the bowls were 
placed, was controlled by a removable divider (see Figure 7.1). 
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7.2.3 Procedure 
Surgery.  The surgery protocol was as described in Chapter 2 (General Methods).  
Sixteen rats received DMS lesions and eight rats received sham-surgery.  After the rats recovered 
from the surgery (approximately 10 days) testing in the attentional set-shifting task started.  In 
general, one rat was tested per day.  The order of testing the rats was counterbalanced.  
Habituation.  One day before training, rats were given a bowl filled with sawdust and six 
pieces of food reward (half of a Honey Loop cereal piece; Kellogg Company, UK) in the home 
cage overnight.   
Training.  During the following sessions, the animals were trained to dig in bowls filled 
with sawdust to retrieve the reward.  Each trial was initiated by raising the divider that allowed 
the access to the two bowls.  In the initial phase of training both of the bowls were baited.  In the 
first trial the reward was placed on top of the sawdust; once the rats retrieved the reward, the 
reward was progressively buried further down with each trial.  This phase finished when the rats 
were reliably digging the bowl to retrieve the reward, which typically required six trials in each 
bowl.  In the final stage of the training phase, rats were given two simple discriminations, one 
D. S. Tait 
Figure 7.1.  Attentional set-shifting box. 
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between two odours in sawdust, and one between two digging media with no added odour, with 
only one of the bowls being baited in each simple discrimination.  During the first four trials, the 
rats were allowed to dig in both of the bowls; this permitted the rats to dig in the baited bowl and 
learn the cue contingency regardless of whether they first dug in the incorrect bowl.  The 
criterion for a dig used through testing was defined as when the nose or paws of the rat broke the 
surface of the digging medium.  Latencies to respond were recorded and were measured using a 
stopwatch.  Time was recorded from the moment the panel that gave access to the bowls was 
lifted and stopped when the rat dug in one of the bowls.  The trial was scored as correct if the rat 
dug in the baited bowl first; if the rat dug in the incorrect bowl, the trial was recorded as an error, 
but the rat was given the opportunity to dig in the correct bowl to collect the bait.  After the 
fourth trial, once the rat dug in one of the bowls, the access to the other bowl was blocked with a 
clear plastic panel and a new trial started.  If the rat did not dig within 10 minutes, the access to 
both bowls was closed, the trial was recorded as a non-dig and a new trial started.  Each stage 
continued until six consecutive correct responses had been made; the testing phase started the 
following day. 
Testing.  In the testing phase of the task, the rats were required to perform a series of 
seven discriminations in which they had to select a bowl on the basis of a stimulus exemplar in a 
particular dimension, either odour or digging medium.  The exemplars (odour and digging 
medium pairs) are summarised in Table 7.1. 
Simple Discrimination (SD).  First rats were presented with a simple discrimination 
between either two digging media with no added scent, or between two odours mixed in sawdust.  
This stage provided an early index of general learning ability.  For example, in the SD, the only 
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relevant dimension presented was odour.  Therefore, two different odours were presented in 
sawdust, but the reward was only present in one of the odours.   
Compound Discrimination (CD).  This stage introduced a second irrelevant dimension to 
form a compound discrimination stage, but the contingencies of the discrimination remained the 
same as the SD.  This stage showed if the rat was distracted by the irrelevant dimension, and if it 
remembered the contingencies of the SD.  In the example used, digging medium was introduced 
as the irrelevant dimension, but the rewarded odour used in the SD still identified the bowl that 
was baited.    
Compound Discrimination Reversal (REV1).  In the first reversal stage, the 
discrimination contingency of the CD is switched such that the previously incorrect stimulus 
becomes correct and the correct stimulus becomes the incorrect.  This stage provided a measure 
of inhibition of responding to the previously rewarded stimuli.  In the example, the first reversal 
required the rats to respond to the bowl with the previously incorrect odour.  
Intradimensional (ID) acquisition.  In this stage two novel odours and two novel digging 
media were introduced, but the relevancy of the two dimensions remained the same as in 
previous stages (e.g., the rat was presented with two different odours and two different digging 
media but given that, in the example used, odour was the relevant dimension, one of the novel 
odours identified the baited bowl).  This stage measured the abilities to learn a new compound 
discrimination that was consistent with the attentional set from the previous stages.  
Intradimensional Reversal (REV2).  The second reversal required the rats to respond to 
the previously incorrect stimulus.  In the example used, rats had to dig in the bowl with the 
previously incorrect odour.  Improvements in reversal learning can be detected in this stage. 
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 Extradimensional (ED) shift.  This stage presented new compound stimuli, but the 
relevancy of the two dimensions was switched.  Therefore, if the rats had been required to 
respond to the odour stimuli in the SD, CD and ID stages, they would now be required to shift 
their attention, as one of the digging medium stimuli would signal reward in the ED.  This stage 
measured the abilities to learn a compound discrimination that was inconsistent with the 
attentional set from the previous stages. 
Extradimensional Reversal (REV3).  The third and final reversal required the rats to 
respond to the previously incorrect stimulus.  Thus, the bowl with the incorrect medium became 
the bowl with the bait and vice versa.  
Examples of the discriminations required to be made are found in Table 7.2.  At each 
stage, the criterion for moving to the next stage required rats to make six consecutive correct 
responses.  Rats were counterbalanced so that the initial SD would be either odour or digging 
medium. 
 
 Table 7.1.   
Exemplars used (presented in pairs within each dimension).   
 
 Digging media Odours 
Training Pairs M9-Polystyrene pieces M10-Shredded paper O9-Mint O10-Oregano 
Pairing 1 M1-Coarse tea M2-Fine tea O1-Cinnamon O2-Ginger 
Pairing 2 M3-Sand M4-Grit O3-Sage O4-Paprika 
Pairing 3 M5-Coarse shavings M6-Fine shavings O5-Turmeric O6-Cloves 
Note.  Table adapted from Birrell and Brown (2000).   
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 Table 7.2.   
Example of the testing stages and possible stimulus combinations in the 
attentional set-shifting task.   
Discriminations Dimensions Exemplar combinations 
 Relevant  Irrelevant Rewarded  Unrewarded 
Simple (SD) Medium Odour M1 M2 
Compound (CD) Medium Odour M1/O1 M2/O1 
   M1/O2 M2/O2 
Reversal 1 (REV1) Medium Odour M2/O1 M1/O1 
   M2/O2 M1/O2 
Intradimensional (ID) shift Medium Odour M3/O3 M4/O3 
   M3/O4 M4/O4 
Reversal 2 (REV2) Medium Odour M4/O3 M3/O3 
   M4/O4 M3/O4 
Extradimensional (ED) shift Odour Medium O5/M5 O6/M5 
   O5/M6 O6/M6 
Reversal 3 (REV3) Odour Medium O6/M5 O5/M5 
   O6/M6 O5/M6 
Note.  Rats were counterbalanced so that half received digging medium as the 
initial relevant dimension, whereas the other half received the odour.  Stimulus pair 
order and correct/incorrect stimuli within a pair were also counterbalanced. 
 
 
Repeat testing.  All rats were tested in the Attentional-Set-Shifting task twice.  However, 
the first test was conducted by an undergraduate experimenter and the data were not included in 
this thesis.  The stages were always in the same order while the stimuli were counterbalanced 
within rats and between tests.  The second test started seven weeks after surgery. 
Histology.  As described in the histology section of the General Methods in Chapter 2. 
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7.2.4 Data analysis 
 All analyses were conducted in IBM SPSS (v 21, SPSS Inc., Chicago, IL), using the 
General Linear Model routine.   
Total trials to criterion.  Number of trials, in each stage, until six consecutive correct 
responses were made (p = .0156 considering the six trials and assuming the rat would choose 
randomly between the two bowls). 
Mean shift-costs.  Number of trials to criterion in the ED stage minus the number of 
trials in the ID; this provides an index of the behavioural cost of shifting set that is independent 
of general learning ability. 
In addition to trials to criterion, total errors, number of non-digs and latency to dig were 
recorded in all stages.  Trials to criterion and errors often reveal the same pattern of results; 
however, trials to criterion have been suggested to be a more powerful measure (Tait and Brown, 
2007).   
Statistical analyses.  Trials to criterion were analysed using a two factor, 2 x 7 mixed 
repeated measures ANOVA with the variables of Group (Between-groups factor with 2 levels: 
DMS Lesion vs. Sham-surgery control), and Stage (Within-subjects factor with 7 levels: SD, CD, 
REV1, ID, REV2, ED, REV3).   
Mean shift-cost were analysed using a univariate ANOVA with Group as a between-
group factor. 
Sidak’s-corrected pairwise comparisons for significant effects or interactions were 
performed.  When data violated the assumption of sphericity, Huynh-Feldt corrections were 
reported, but the uncorrected degrees of freedom were reported.  The criterion for significance 
(alpha level) was p < .05 in all cases. 
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Box plot generation.  To effectively display the individual differences in shift-cost, as 
well as providing central tendency and distributional information, box plots were generated.  The 
central line in each box plot represents the median.  The lowest edge of the box is the lower 
quartile, and the top edge of the box shows the value of the upper quartile.  The whiskers on the 
box show the range between which the lowest 25% and the top 25% of scores fall (Field, 2013).  
The mean is overlaid on the box plot. 
7.3 Results 
7.3.1 Histology 
Histology was described in Chapter 5.  The final numbers in each group were 10 DMS 
lesion rats and 6 sham-surgery control rats.  
7.3.2 Behavioural performances 
Total trials to criterion.  Figure 7.2 shows the mean number of trials to reach criterion 
for the DMS lesion and sham-surgery control group in the second test.  There was no effect of 
the lesion on performance of the attentional set-shifting task (main effect of Group: F(1, 14) = 
1.52, p = .24, ηp
2
 = .10).  Although all the rats learned to discriminate at the different stages, 
showing a difference in the number of total trials to criterion in the different stages (main effect 
of Stage: F(6, 84) = 6.24, p < .001, ηp
2
 = .31); the pattern was the same for both groups (Stage x 
Group: F(6, 84) = 1.80, p = .11, ηp
2
 = .11). 
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Figure 7.2.  Mean total trials to criterion (± SEM) for DMS lesion and sham-
surgery control rats on the standard 7-stage attentional set-shifting task.   
 
Reversals.  Sidak’s-corrected pairwise comparisons indicated that DMS lesioned rats 
required fewer trials to complete the first reversal in comparison to sham-surgery controls (p = 
.03).  The second and third reversal stages in the attentional set-shifting task were not affected by 
lesions of the DMS.  Figure 7.3 shows the trials to criterion on the three reversal stages for DMS 
lesion and sham-surgery control rats.  
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Figure 7.3.  Mean of the Total Trials to Criterion (± SEM) on the three reversal 
stages (REV) for DMS lesion and sham-surgery control rats on the attentional set-shifting 
task.  DMS lesioned rats required significantly fewer trials than sham-surgery controls to 
learn the first reversal (* p < .05).  
 
Shift-cost.  Figure 7.4 displays the box plot for each group, with the mean overlaid on the 
box plot.  Although there was no difference between the groups in shift-cost (F(1,14) = 2.89, p = 
.11, ηp
2
 = .17), sham-surgery control rats showed positive shift-cost on the task (i.e., the number 
of trials required to learn the ED stage was higher than in the ID stage), which suggested that an 
attentional set was formed and then needed to be shifted.  While DMS lesioned rats showed a 
negative cost of shifting.  It also appears form the box plots that there were considerable 
individual differences within both groups of rats.   
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7.4 Discussion 
 The aim of this experiment was to evaluate if rats with bilateral quinolinic acid lesions of 
the dorsomedial striatum, which mimic some aspects of the neural damage in Huntington’s 
disease, presented similar cognitive deficits in the attentional set-shifting task as those seen in 
HD patients. 
Figure 7.4.   Box plot showing the shift-cost, ED trials minus ID trials, for DMS 
lesioned and sham-surgery control rats.  The central line in each box plot represents the 
median.  The lowest edge of the box is the lower quartile, and the top edge of the box 
shows the value of the upper quartile.  The whiskers on the box show the range between 
which the lowest 25% and the top 25% of scores fall.  The mean is overlaid on the box plot 
(●). 
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Preclinical carriers of the HD mutation, before the onset of any clinical movement 
disorder, (Lawrence et al., 1998a) and early stage HD patients showed impairments in the 
extradimensional shift stage (Lawrence et al., 1996; Lawrence et al., 1999b).  Their set-shifting 
impairments resulted from perseverative responding (i.e., inability to stop responding) to the 
stimulus dimension that was relevant in the stages before the ED (Lawrence et al., 1999b).  
Nevertheless, as the disease progresses, advanced stage HD patients showed impairments in the 
reversal stages (Lange et al., 1995).   
In an extradimensional shift, attention to compound stimuli is transferred from one 
perceptual dimension to another (e.g., from odour to digging media, in the typical rodent version 
of the task or from line to shape, in the typical human version).  Therefore, if the striatum is 
involved in different forms of flexible behaviour (Castañé et al., 2010; Ragozzino, 2007; 
Ragozzino et al., 2002b), it would have been expected that the rats' performance in the attentional 
set-shifting task following lesions of the dorsomedial striatum would have also been impaired.  In 
particular, like patients with HD, it was expected that rats with DMS lesions: 1) would show 
impaired ED shift performance by continuing to respond to the stimulus dimension that was 
relevant in the stages before the ED, but that is no longer appropriate in the ED.  Therefore, 
would need more trials than the controls to reach the criterion of six consecutive correct 
responses in the ED stage; and 2) in the reversal stages, would persist in responding to the 
previously rewarded stimulus when it is no longer appropriate.  That is, in the reversal stage, 
when the discrimination contingency was switched such that the previously incorrect stimulus 
became correct and the correct stimulus became the incorrect, the DMS lesioned rats would 
require more trials to reach criterion than the control rats. 
Chapter 7 
189 
 
Performance on the ED stage showed that DMS lesioned rats did not require more trials 
than control rats to complete the stage.  Although the difference between the groups was not 
significant, there was a trend for DMS lesioned rats to require fewer trials to complete the ED 
stage and more trials to complete the ID in comparison to the control rats; consequently showing 
diminished or absent shift-costs, which may have arisen because they did not form an attentional 
set.  Individual differences within both group of rats showed that most of the DMS lesioned rats 
(six out of ten rats) exhibited a negative shift-cost while most of the sham-surgery control rats 
(four out of six rats) displayed a positive shift-cost.  The lack of significant difference between 
the groups, even though there was a pattern, might result from the reduced number of rats used in 
this experiment after histological analysis.  These results are contrary to what is observed in HD 
patients, who require more trials than controls to complete the ED stage.  
Performance of both groups in the reversal stages showed that the number of trials to 
reach criterion increased when the stimulus-reward contingencies were reversed (i.e., the 
previously incorrect stimulus became correct and the correct stimulus became the incorrect).  
However, DMS lesioned rats did not require more trials to reach criterion in the reversal stages in 
comparison to the control rats.  On the contrary, DMS lesioned rats, required fewer trials to 
complete the first reversal.  Therefore, the results obtained in the present experiment showed that 
DMS lesioned rats do not present reversal impairments, as they did not perseverate in responding 
to the previous rewarded stimulus when it was no longer appropriate, at least when assessing 
reversal impairments under the current conditions.  These results are inconsistent with the results 
seen in patients with advanced HD.  
These results are consistent with the findings from Brooks et al. (2006) who reported no 
difference between the HD homozygous Hdh
(CAG)150
 knock-in mouse line and the Wild type mice 
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in the number of trials to criterion in the reversal stage in the attentional set-shifting task.  
Likewise, Lindgren et al. (2013) reported no difference between rats with DMS lesions and the 
controls in the number of total trials to criterion in the reversal stages.  
However, the results are inconsistent with reports of reversal learning deficits with DMS 
inactivation or lesions on other types of reversal learning tests, such as spatial, egocentric 
response, visual cues, and instrumental spatial discrimination (e.g., Castañé et al., 2010; 
Ragozzino, 2007; Ragozzino et al., 2002b).  Differences between the previous studies and the 
current study could account for the incongruent results.  One difference was that some studies 
investigated the effect of acute disruption of DMS function using pharmacological agents 
(Ragozzino et al., 2002a; Ragozzino et al., 2002b), which may be functionally different from 
excitotoxic lesions.  Another difference was that in the previous studies other types of reversal 
learning tests were used (e.g., mazes and operant boxes).  The difference in the way stimuli are 
sampled and how much can be learned in each trial could account for the incongruent results.  In 
the set-shifting task, the bowls are separated; therefore, the stimuli from the rewarded bowl and 
the unrewarded bowl are not present at the same time and therefore cannot be compared 
simultaneously.  Thus, learning will be based on the bowl sampled, and unless the rat samples 
both bowls, the characteristics of the unsampled bowl will remain unknown.   
However, in an instrumental two lever spatial discrimination task, like the one used by 
Castañé et al. (2010), both the rewarded and the non-rewarded levers are present at the same time 
and could be seen, compared, and processed simultaneously.  In each reversal session the 
previously correct lever became incorrect and the previously incorrect lever became correct.  
Therefore, after the first session of switching the rewarded lever, if pressing one of the levers was 
not rewarded, it could be inferred that pressing the other lever would be rewarded.  One of the 
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limitations of using this kind of task for evaluating behavioural flexibility is that once the 
behaviour of alternating presses on the levers is learned, flexible behaviour may no longer be 
required.  Similarly, on the reversal learning tasks that required rats to make an egocentric 
response (e.g., always make a turn to the right to receive a reinforcer) or to learn to respond to a 
visual cue discrimination (e.g., enter the visual cued arm; Ragozzino, 2007; Ragozzino et al., 
2002a; Ragozzino et al., 2002b) once the behaviour of turning to the other side or entering to the 
uncued arm to get a reinforcer is learned, flexible behaviour may not be required.  These studies 
require rats to remember a particular motor response, and stimuli are learned as a whole (i.e., 
either reinforced or unreinforced).  However, given that the baited bowl in the attentional set-
shifting task does not depend on location or a particular response, but on odour or tactile 
properties of the stimuli, learning requires attention to the components of the stimuli present in 
each bowl.  Which may involve learning the relationship between different stimuli components 
(Ragozzino, 2007).  Therefore, the difference of these tasks on the nature of sampling of the 
stimuli and the availability of the reward between the previous studies and the current study 
could account for the incongruent results.  The findings described above suggest that lesions or 
inactivation of the dorsomedial striatum impairs reversal learning in tests that require spatial, 
visual and egocentric response; but reversal learning in the attentional set-shifting task is not 
affected by quinolinic acid lesions of the DMS, which is inconsistent with the results from 
advanced stage HD patients. 
By the end of this experiment (January 2013), a review of the literature did not reveal any 
published reports of reversal impairments in DMS lesion rats using the attentional set-shifting 
task.  Therefore, the results presented new findings evaluating reversal learning, set-formation, 
and set-shifting in an animal model of HD in the attentional set-shifting task.  However, after the 
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completion of the current experiment Lindgren et al. (2013) published a paper that tested DMS 
lesion rats in the attentional set-shifting task.  Nevertheless, the lack of set-formation in the 
control rats is an important issue that should be considered when interpreting the results from 
Lindgren et al. (2013).  The ID and ED stages of the task are the critical stages for assessing 
attentional set-shifting (Birrell and Brown, 2000).  Cognitively normal rats form attentional sets 
and require more trials to complete the ED in comparison to the ID stage (i.e., show a positive 
shift-cost) because the previously relevant stimulus is now irrelevant and a stimulus in a different 
dimension must be attended to.  A positive shift-cost indicates that during the ED stage the 
animal was attending to the dimension that was relevant during the previous stages, but that is 
now irrelevant in the ED stage, which suggests that an attentional set was formed and then 
required to be shifted from.  Therefore, an essential component of the task is the presence of a 
positive shift-cost in the control animals, which was not present on Lindgren et al. (2013) report, 
but that was observed in the present experiment.  However, using a four consecutive ID stage 
(4ID) set-shifting task, Lindgren et al. (2013) showed that their control rats formed sets, but the 
DMS lesioned rats did not.  Briefly, the 4ID set-shifting task encourages the formation of an 
attentional set by removing the reversal stages and including four consecutive ID stages before 
the ED shift stage.  Performance improvements over the course of the four ID stages can provide 
a direct measure of set-formation.  In addition, like in the standard 7-stage attentional set-shifting 
task, it measures the ID/ED difference which investigates set-shifting.  Therefore, the standard 7-
stage task does not allow drawing conclusions about set-formation in the absence of a positive 
shift-cost (because it is the relationship between the ID and the ED stages that provides evidence 
of a cost in shifting and therefore allows to assume set-formation in the presence of a positive 
shift-cost); but, the relationship between the IDs in the 4ID task, plus the ID/ED difference, can 
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provide information about set-formation.  Thus, an abolished shift-cost from the DMS lesioned 
rats seen in the standard 7-stage task from this chapter and in the 4ID task from Lindgren et al. 
(2013), suggest that lesion of the DMS impair set-formation.  
Overall, the results from this experiment are inconsistent with the behaviour found in 
patients with Huntington’s disease.  Preclinical carriers of the HD mutation  (Lawrence et al., 
1998a) and patients in an early stage of HD showed impairments in ED shift performance 
(Lawrence et al., 1996; Lawrence et al., 1999b).  Their set-shifting impairments resulted from 
perseverative responding (i.e., inability to stop responding) to the stimulus dimension that was 
relevant in the stages before the ED.  Results from the current experiment showed that DMS 
lesioned rats did not require more trials than controls to complete the ED stage.  In addition, 
these results are inconsistent with the results from advanced stage HD patients who showed 
impairments in the reversals stages (Lange et al., 1995).  DMS lesioned rats did not perseverate, 
more than the control group, in a previously rewarded stimulus when it was no longer 
appropriate.  Given that impairments in set-shifting and reversal learning have been observed in 
HD patients (Josiassen et al., 1983; Lange et al., 1995; Lawrence et al., 1998a; Lawrence et al., 
1996; Lawrence et al., 1999b), DMS lesioned rats should be examined more closely with other 
procedures to evaluate if quinolinic acid lesions of the striatum is a potential animal model for 
studying cognitive and behavioural impairments of Huntington’s disease.  In addition, given that 
different striatal sub-regions may be involved in different forms of flexible behaviour (Castañé et 
al., 2010), other dorsal striatum regions should also be examined to determine if they are 
involved in the attentional set-shifting task.  
Therefore, the next chapter used a modified version of the attentional set-shifting task to 
test the hypothesis that the trend towards a diminish shift-cost observed in the DMS lesioned rats 
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represented a failure to form attentional set.  Furthermore, the next experiment evaluated if 
selective lesions of dorsomedial and dorsolateral striatum have differential effects on reversal 
learning and in set-formation in the ID/ED attentional set-shifting task in rats.  
In summary, this experiment showed that DMS lesioned rats do not have reversal 
impairments, but present a non-significant trend towards a diminished shift-cost, which is 
contrary as to what is observed in HD patients.  From these findings, it could be concluded that 
rats with bilateral quinolinic acid lesions of the dorsomedial striatum do not present the same 
deficits as HD patients in the ID/ED attentional set-shifting task. 
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Chapter 8 
8 The Effects of Lesions of the Dorsal Striatum in 
Reversal Learning, Attentional Set-Formation 
and Set-Shifting 
 
Three experiments examined the effects of QA lesions of the dorsolateral (DLS) or the 
dorsomedial (DMS) striatum in reversal learning, attentional set-formation and set-shifting.  In 
Experiment 1, rats were tested in the standard 7-stage attentional set-shifting task.  Experiment 2 
explored the relationship between reversal learning, attentional set-formation and set-shifting by 
using two modified versions of the attentional set-shifting task (that differed in the placement of 
the reversal stages).  Experiment 3 introduced a probe stage (which substituted the stimuli of the 
irrelevant dimension from the preceding stage with novel stimuli) to help identify the aspects of 
the stimuli to which the rats were attending.   
 
Do bilateral quinolinic acid lesions of the dorsal striatum impair reversal learning, 
attentional set-formation and set-shifting? 
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8.1 Introduction 
Roberts et al. (1988)  showed that distinguishing between stimuli varying along the same 
dimension (ID stage) as in previous stages requires fewer trials than distinguishing between 
stimuli varying along a different dimension (ED shift stage).  Therefore, in the standard 7-stage 
attentional set-shifting task from Birrell and Brown (2000), cognitively normal rats require more 
trials to complete the extradimensional shift stage in comparison to the intradimensional stage 
(i.e., show a positive shift-cost) because the previously relevant stimulus is now irrelevant and a 
stimulus in a different dimension must be attended to.  A positive shift-cost indicates that during 
the ED shift stage the animal was attending to the dimension that was relevant during the 
previous stages, but that is now irrelevant in the ED, which suggests that an attentional set was 
formed and then shifted from.  The experiment from the previous chapter showed that rats with 
lesions of the dorsomedial striatum had a trend towards a diminished shift-cost (i.e., they did not 
require more trials to complete the ED shift stage in comparison to the ID stage); raising the 
possibility that lesions of the DMS impair the formation of attentional set.  However, given the 
structure of the standard 7-stage attentional set-shifting task, it is not possible to make 
conclusions about set-formation impairments; it is only possible to assume that diminished shift-
costs suggest weak or absent set-formation, thus do not require shifting (i.e., change in 
attentional set).  This is because the task does not allow a direct measurement of attentional set-
formation, it only assumes that set has been formed by detecting set-shifting.  The term set has 
been defined as the property of the stimulus that is relevant in a given trial (Rushworth et al., 
2005).  When attentional set has been formed, there is a predisposition to attend to the properties 
of multidimensional stimuli that have predicted reward in the past (Esber and Haselgrove, 2011; 
Sutherland and Mackintosh, 1971).  Therefore, new discriminations that require the same 
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relevant dimension as the previous stage (e.g., from odour to odour) should be solved faster (i.e., 
should require fewer trials and less time) than those that require a shift of attentional set (e.g., 
from odour to digging medium).  In attentional set-shifting the perceptual features contained in a 
set that predicted reward are no longer relevant to the discrimination.  Therefore, the set has to be 
shifted to the new features that predict reward.  As mentioned in the previous chapter, shift-cost 
is the index of attenuated learning that occurs when the relevancy of the aspects of 
multidimensional stimuli that used to predict reward change, thus requiring a shift in attention.  
Therefore, set-shifting can be an index of behavioural flexibility, while set-formation can be an 
index of behavioural stability.  
To test if attentional set-formation is impaired in rats with lesions of the DMS this chapter 
presents a series of behavioural tasks designed to further elucidate set-shifting performance, with 
the possibility of drawing conclusions about set-formation.  In addition, given that it has been 
suggested that different striatal sub-regions may be implicated in different forms of flexible 
behaviour (Castañé et al., 2010), to assess the specificity of the role of the DMS in set-shifting 
performance, a group with lesions of the dorsolateral striatum (DLS) was added.  
The aim of this chapter was to evaluate the contributions of the DMS and the DLS in 
reversal learning, set-formation and set-shifting in rats.   
The first experiment aimed to validate the previous behavioural effects seen in rats with 
DMS lesion in the standard 7-stage attentional set-shifting task and to evaluate the behavioural 
effects of lesions in DLS in this task.  
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The second experiment used a modified version of the attentional set-shifting task to 
explore the relationship between reversal learning, attentional set-formation and set-shifting in 
rats with lesions of the dorsal striatum.  
The third experiment introduced a probe stage to help identify the aspects of the stimuli 
the animals were attending to in the intradimensional stages.  
Experiment 1.  Standard 7-stage attentional set-shifting task 
An advantage of the attentional set-shifting task is that it can be used on repeated basis 
with reproducible results and little to no effect on trials to criterion performance.  Therefore, it 
can be used to evaluate the behavioural effects of a lesion within a group over a series of tests 
(Tait et al., 2014; Tait et al., 2009; Wallace et al., 2014).  This experiment evaluated the 
behavioural effects of lesions of the dorsomedial striatum or the dorsolateral striatum in the 
attentional set-shifting task.   
8.2 Method 
8.2.1 Animals 
The animals were 36 experimentally-naïve male hooded Lister rats (Charles River, UK 
Ltd) with a mean ad libitum weight of 307 g (range = 288 - 330 g) at the beginning of the 
experiment.  Testing was conducted in the light phase of a 12:12 hr light-dark cycle.  Housing 
and husbandry conditions were described in the General Methods in Chapter 2.   
8.2.2 Apparatus 
Training and testing sessions were conducted in the attentional set-shifting task apparatus 
described in Chapter 7. 
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8.2.3 Procedure 
Pre-surgery testing.  All rats were habituated, trained and tested in the standard 7-stage 
attentional set-shifting task described in Chapter 7.  Briefly, habituation consisted of giving to the 
rats a bowl filled with sawdust and six pieces of food as a reward (half of a Honey Loop cereal 
piece; Kellogg Company, UK) in the home cage, overnight, one day before training.  The 
animals were then trained to dig in bowls filled with sawdust to retrieve the reward and were then 
given two simple discriminations stages: one between two odours in sawdust and one between 
two digging media with no added odour; with only one of the bowls being baited in each simple 
discrimination (SD).  The following day they were tested in the standard 7-stage attentional set-
shifting task. 
Standard 7-stage attentional set-shifting task.  The first stage was an SD between either 
two odours in sawdust or two digging media with no added odour.  The second stage was a 
compound discrimination (CD), where an irrelevant stimulus dimension is added, but the 
contingencies of the discrimination remained the same as in the SD.  The third stage was the 
compound discrimination reversal (REV1), where the discrimination contingency of the CD was 
switched such that the previously incorrect stimulus became correct and vice versa.  The fourth 
stage was an intradimensional (ID) acquisition stage where novel compound stimuli were 
introduced, but the relevant dimension was the same as in the previous stages.  The fifth stage 
was the intradimensional reversal (REV2), where the incorrect stimulus of the ID became 
incorrect and vice versa.  The sixth stage was the extradimensional (ED) shift, where new 
compound stimuli were presented and the relevancy of the two dimensions was switched.  
Therefore, the previously irrelevant dimension predicted reward and vice versa.  Finally, the 
seventh stage was the extradimensional reversal (REV3) where the previously incorrect stimulus 
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of the ED became incorrect and vice versa (Table 8.1 shows the different stages of this task).  
Normally, two rats were tested per day.   
Surgery.  Once all rats were tested in the attentional set-shifting task once, they were 
pseudo-randomly assigned to the sham-surgery control (n =12), dorsomedial striatum (DMS) 
lesion (n =12) or dorsolateral striatum (DLS) lesion (n =12) groups.  The surgery protocol was 
described in Chapter 2 (General Methods).  Data from the three groups were analysed to ensure 
there were no differences between the groups before the surgery.  Trials to criterion were 
analysed using a two factor, 3 x 7 ANOVA with the variables of Group (Between-groups factor 
with 3 levels: DMS Lesion vs DLS Lesion vs sham-surgery control), and Stage (Within-subjects 
factor with 7 levels: SD, CD, REV1, ID, REV2, ED, REV3).  There were no differences between 
the groups in the performance of the attentional set-shifting task pre-surgery (main effect of 
Group: F(2, 33) = 2.55, p = .09, ηp
2
 = .13).   
Post-surgery testing: standard 7-stage attentional set-shifting task.  After the rats 
recovered from the surgery (approximately 10 days) they were retested in the standard 7-stage 
attentional set-shifting task.  The stages were always in the same order and the same stimulus 
pairs were used, counterbalancing both within and between tests for direction of shift, stimulus 
pair order and correct/incorrect stimuli within a pair.  Normally, two rats were tested per day.  
The order of testing the rats was also counterbalanced. 
Histology.  This was described in the histology section of the General Methods in 
Chapter 2. 
8.2.4 Data analysis 
All analyses were conducted in IBM SPSS (v 21, SPSS Inc., Chicago, IL), using the 
General Linear Model procedure.   
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Total trials to criterion.  Number of trials, in each stage, until six consecutive correct 
responses were made (p = .0156 considering the six trials and assuming the rat would choose 
randomly between the two bowls). 
Mean shift-costs.  Number of trials to criterion in the ED shift stage minus the number of 
trials in the ID stage. 
Statistical analyses.  Trials to criterion were analysed using a three factor, 2 x 7 x 3 
ANOVA with the variables of Surgery (Within-subjects factor with 2 levels: Pre-surgery vs Post-
surgery testing), Stage (Within-subjects factor with 7 levels: SD, CD, REV1, ID, REV2, ED, 
REV3) and Group (Between-groups factor with 3 levels: DMS lesion, DLS lesion, sham-surgery 
control).   
Mean shift-costs were analysed using a univariate ANOVA with Group as a between-
group factor.  Sidak’s-corrected pairwise comparisons for significant effects or interactions were 
performed.  When data violated the assumption of sphericity, Huynh-Feldt corrections were 
reported, but the uncorrected degrees of freedom were reported.  The criterion for significance 
(alpha level) was p < .05 in all cases. 
Box plot generation.  To effectively display the individual differences in shift-cost, as 
well as providing central tendency and distributional information, box plots were generated.  The 
central line in each box plot represents the median.  The lowest edge of the box is the lower 
quartile, and the top edge of the box shows the value of the upper quartile.  The whiskers on the 
box show the range between which the lowest 25% and the top 25% of scores fall (Field, 2013). 
Outliers were defined as the values which were between one and a half and three box lengths 
from either end of the box and were represented by triangles (▲).  Extreme values were defined 
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as the scores that were more than three box lengths from either end of the box and were denoted 
by asterisks (*).  The mean is overlaid on the box plot (●). 
8.3 Results 
8.3.1 Histology 
Six out of twelve DMS lesion rats and nine out of eleven DLS lesion rats (one rat did not 
recover from surgery) were determined to have appropriate bilateral lesions.  Figure 8.1 shows a 
schematic diagram of a series of coronal sections of the rat brain (Paxinos and Watson, 2007), 
illustrating the extent of bilateral DLS lesions, and DMS lesions.  Four out of twelve of the sham-
surgery control rats showed signs of cell damage, so they were removed from the analysis.  The 
final numbers (n) in each group were: DLS lesion (n = 9), DMS lesion (n = 6) and sham-surgery 
control (n = 8).  Figure 8.2 shows photomicrographs of coronal sections from sham-surgery 
control, DMS and DLS lesioned animals.   
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Figure 8.1.  Schematic diagram of a series of coronal 
sections of the rat brain illustrating the extent of bilateral 
dorsomedial (DMS) striatum lesions (left) and dorsolateral (DLS) 
striatum lesions (right).  Darkness represents coincidence lesions 
from different animals.  From the top, sections are +2.2, +1.7, 
+1.2, +0.7, +0.2, −0.3, −0.80, and −0.92 mm from bregma 
(Paxinos and Watson, 2007). 
DLS DMS 
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DMS Sham DLS 1,000 μm 
Figure 8.2.  Representative photomicrographs of coronal sections double-
stained with NeuN and Cresyl Violet from sham control (left), dorsomedial striatum 
(DMS) lesion (middle), and dorsolateral striatum (DLS) lesion (right) animals.  Sham 
control rats showed an even distribution of neurons in the striatum whilst DMS and 
DLS lesioned rats showed cell loss.  Arrows point to the lesion area.  From the top, 
sections are +1.2, +0.7, +0.2, -0.3, and -0.80 mm from bregma. Scale bar 1,000 μm. 
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8.3.2 Behavioural performances 
Total trials to criterion.  Lesions of the DLS or the DMS affected the performance of 
the attentional set-shifting task differently (Surgery x Stage x Group interaction: F(12, 120) = 
2.58, p < .001, ηp
2
 = .21).  Sidak’s-corrected pairwise comparisons indicated that pre-surgery 
there were no differences between the groups in the performance of the task; however, post-
surgery DLS lesioned rats required fewer trials to complete the ED stage in comparison to 
controls (p = .04), and DMS lesioned rats required more trials to complete REV3 in comparison 
to DLS lesioned rats (p = .04).  Planned contrasts between the ID and the ED stages showed that 
control rats required more trials to complete the ED shift stage than the ID stage (p = .01).  There 
were no differences between the ID and ED stages for the DMS (p = .80) and the DLS (p = .59) 
rats.  Figure 8.3 shows the comparison of the mean number of trials to reach criterion for the 
DLS lesion, DMS lesion and control rats in the standard 7-stage attentional set-shifting task post-
surgery. 
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Figure 8.3.  Mean trials to criterion (± SEM) for the three groups post-surgery in the 
standard 7-stage attentional set-shifting task.  Control rats required more trials to complete 
the ED in comparison to the ID (* p < .05), DLS lesioned rats required less trials to complete 
the ED stage in comparison to the controls (■ p < .05) and rats with DMS lesions required 
more trials to complete REV3 in comparison to DLS lesioned rats († p < .05).   
Shift-costs.  Figure 8.4 displays the box plot for each group, with the mean overlaid on 
the box plot.  Although there were no differences between the groups in shift-cost (F(2,20) = 
3.13, p = .07, ηp
2
 = .24), the control rats showed positive shift-cost on the task (i.e., the number of 
trials required to learn the ED stage was higher than in the ID stage), which suggested that an 
attentional set was formed and then shifted.  While DMS and DLS lesioned rats showed a 
diminished cost of shifting.  It also appears from the box plots that there were considerable 
individual differences within both groups of rats.  Moreover, there were two outliers (values that 
were between one and a half and three box lengths from either end of the box) and an extreme 
value (value that was more than three box lengths from either end of the box) in the DLS 
lesioned group, and an outlier in the control group.  Removing these rats from the analysis did 
not change the lack of difference between the groups in shift-cost (F(2,17) = 3.10, p = .07, ηp
2
 = 
.27). 
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8.4 Discussion 
 The aim of this experiment was to evaluate the behavioural effects of lesions of the dorsal 
striatum by testing rats with lesions of the DMS and the DLS in the standard 7-stage attentional 
set-shifting task.  
Figure 8.4.  Box plot showing the shift-cost (ED trials minus ID trials) for DLS 
lesioned, DMS lesioned and control rats.  The central line in each box plot represents 
the median.  The lowest edge of the box is the lower quartile, and the top edge of the box 
shows the value of the upper quartile.  The whiskers on the box show the range between 
which the lowest 25% and the top 25% of scores fall. The values that were between one 
and a half and three box lengths from either end of the box were considered outliers (▲) 
and the scores that were more than three box lengths from either end of the box were 
extreme values (*).  The mean is overlaid on the box plot (●). 
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 On the reversal stages, there was a difference between DMS and DLS lesions of the 
performance of the last reversal.  DMS lesioned rats required more trials to complete REV3 in 
comparison to DLS lesioned rats.  However, there was no difference on the reversal stages 
between the dorsal striatal lesioned groups and the control group.  Rats with DMS or DLS lesions 
did not show an increased number of trials to complete the reversal stages in comparison to the 
control rats.  Therefore, the results obtained in the present experiment showed that DMS and 
DLS lesioned rats do not present reversal impairments, as they did not persevere in responding to 
the previously rewarded stimulus when it was no longer appropriate.  These results are 
inconsistent with the results seen in patients with advanced HD, but replicate the findings from 
the previous experiment reported in Chapter 7, which showed that DMS lesioned rats did not 
show reversal impairments (see the section 7.4 Discussion in Chapter 7).  In addition, the results 
observed in the DLS lesioned group are consistent with the results from Castañé et al. (2010), 
who found that lesions of the DLS did not impair serial reversal learning of an instrumental 
spatial discrimination task.  These findings suggest reversal learning in an instrumental two lever 
spatial discrimination task (where the correct response is associated with a particular location in 
space) or in the attentional set-shifting task (that does not depend on location or a particular 
response, but requires attention to the components of the stimuli) is not affected by lesions of the 
DLS. 
Regarding set-shifting, a greater number of trials to criterion at the ED shift stage 
compared to the ID stage (the shift-cost) indicate the flexibility with which an attentional set can 
be shifted.  In this experiment, control rats showed a positive shift-cost (i.e., required more trials 
to complete the ED in comparison to the ID stage), which suggested that an attentional set was 
formed and then shifted from.  However, the DMS and the DLS lesion groups did not require 
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more trials to complete the ED stage in comparison to the ID stage and showed no cost of 
shifting.  Therefore, there is no evidence that rats with DMS or DLS lesions either formed 
attentional set or shifted from one in the standard 7-stage attentional set-shifting task.  The 
diminished or absent shift-cost in rats with DMS lesions from this experiment is consistent with 
the pattern observed in the experiment from the previous chapter; while the absence of positive 
shift-cost observed in rats with DLS lesioned rats are the first results to suggest that DLS lesions 
impair set-formation in the attentional set-shifting task.  However, the standard 7-stage 
attentional set-shifting task does not allow a direct measurement of attentional set-formation; it 
only assumes that set-formation has been formed by detecting set-shifting.  Therefore, it is not 
possible to conclude that lesions of the dorsal striatum impair attentional set-formation; it is only 
possible to assume that the lack of positive shift-cost seen in rats with DMS or DLS lesions 
suggest deficits in attentional set-formation.  In order to evaluate if lesions of the DMS or in the 
DLS impair attentional set-formation, the next experiment used a modified version of the task 
that, in addition to measuring set-shifting, can provide more information on the formation of 
attentional set.  
 
Experiment 2.  Effects of early reversal vs late reversal stage in set-formation 
8.5 Introduction 
The results from the previous experiment suggested that lesions of the dorsal striatum 
impair attentional set-formation.  However, the standard 7-stage attentional set-shifting task does 
not allow a direct measurement of attentional set-formation (it only assumes that set-formation 
has been formed by detecting set-shifting).  To further investigate attentional set-formation in 
rats, the standard 7-stage attentional set-shifting task was modified to the four intradimensional 
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(4ID) set-shifting task (Chase et al., 2012).  Based on the task used in marmosets (Clarke et al., 
2005), the 4ID task for rats removes the reversal stages and consists of four consecutive 
intradimensional stages before the extradimensional shift stage that can measure the formation of 
attentional set in rats.  Performance over the course of these series of stages has been suggested 
to provide an index of set-formation (Clarke et al., 2005).   
However, patients with HD are impaired in shifting sets and in reversal learning 
(Josiassen et al., 1983; Lange et al., 1995; Lawrence et al., 1998a; Lawrence et al., 1996; 
Lawrence et al., 1999b).  Therefore, a task that evaluates both cognitive processes would be more 
appropriate to evaluate if lesions of the dorsal striatum impair the same cognitive processes 
observed in patients with HD.   
An alternative task that measures both set-formation and reversal learning was proposed 
by Chase (2013).  The task is based on the same structure as the 4ID task for rats, which has been 
shown to be sufficient to elicit set-formation in set-formation-impaired orbital prefrontal cortex 
lesioned rats (Chase et al., 2012), but includes a reversal stage either before or after the four 
consecutive ID stages (i.e., before or after an attentional set is likely to have been formed).  
Therefore, these tasks also allow the investigation of the relationship between reversal learning 
and attentional set-formation.  The rationale of the design of the tasks was that if it is predicted 
that the main effect of presenting four consecutive ID stages would strengthen attention to the 
relevant dimension, presenting a reversal stage after attentional set has been formed should 
require fewer trials than a reversal stage that is presented before the formation of attentional set 
(i.e., before the first ID stage).  This paradoxical effect is known as the overtraining reversal 
effect, whereby the more an animal is trained to select stimulus X and not Y, the faster it will 
learn to select stimulus Y and not X on a reversal stage.  The additional training strengthens 
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attention to the relevant cues that predict reward and the tendency to respond to other irrelevant 
cues weakens.  Therefore, during the reversal stage the overtrained animals will learn the reversal 
faster because they will continue to attend to the relevant cues and learn the new response 
required relatively quickly.  However, animals only trained to a normal criterion cease to pay 
attention to the relevant cues when they fail to receive reinforcement at the beginning of the 
reversal stage; therefore, take longer to learn the new response to that stimulus (Sutherland and 
Mackintosh, 1971). 
To test the hypothesis that a reversal stage would be completed in fewer trials after 
attentional set has been formed, two modified versions of the attentional set-shifting task were 
used.  The difference between the tasks was the placement of the reversal stage (before or after a 
series of ID stages that promote set-formation).  If rats with lesions of the dorsal striatum are 
unable to form sets after a series of ID stages, the reversal stage for the lesioned rats should 
require more trials in comparison to the control rats that can form attentional sets.   
In addition, the performance across the consecutive ID stages can provide an index of set-
formation, which allows the identification of whether the lack of shift-cost seen in rats with 
dorsal striatum lesions in the standard 7-stage attentional set-shifting task was due to attentional 
set-formation impairments. 
The aim of this experiment was to explore the relationship between reversal learning, 
attentional set-formation and set-shifting in rats with lesions of the dorsal striatum.   
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8.6 Method 
8.6.1 Procedure 
Early vs late reversal stage attentional set-shifting task.  Once all rats completed the 
standard 7-stage attentional set-shifting task, they were pseudo-randomly assigned to the early or 
late reversal set-shifting task.  Both tasks consisted of 11 stages; the difference between the tasks 
was the placement of the reversal stage.  In the early reversal stage task, the reversal was the 
third stage of the task; while for the late reversal stage task, the reversal was the seventh stage of 
the task (Table 8.1 shows the different stages for the two tasks).   
Both tasks consisted of an SD, CD, five intradimensional (ID1, ID2, ID3, ID4 and ID5) 
stages, a reversal stage (located between the CD and ID1 for the early reversal stage task or 
between the ID4 and ID5 for the late reversal stage task), an ED, ID6 (the relevant dimension 
from the ED remained relevant) and the original SD.  The original SD was presented at the end 
of the task to control against the possibility that an increase in trials associated with learning the 
ED were due to issues of fatigue, satiety or memory load, rather than the cost of shifting set.  
Table 8.2 summarises both of the tasks.  The exemplars used in these experiments are 
summarised in Table 8.3.  
 
Table 8.1.   
Stages for each of the modified versions of the attentional set-shifting tasks used in this chapter. 
Task Stages 
7-stage SD CD REV1 ID REV2 ED REV3     
Early Reversal SD CD REV ID1 ID2 ID3 ID4 ID5 ED ID6 SD 
Late Reversal SD CD ID1 ID2 ID3 ID4 REV ID5 ED ID6 SD 
Probe Task SD CD ID1 ID2 ID3 ID3Probe ID3 ID4 ED REV SD 
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Table 8.2.   
Example of the testing stages and possible stimulus combinations in the early reversal and 
late reversal stage attentional set-shifting task.   
Discriminations Dimensions Exemplar combinations 
 Relevant  Irrelevant Rewarded  Unrewarded 
Simple Discrimination (SD) Medium Odour M1 M2 
Compound Discrimination (CD) Medium Odour M1/O1 M2/O1 
   M1/O2 M2/O2 
Early Reversal (ER task only) Medium Odour M2/O1 M1/O1 
   M2/O2 M1/O2 
First Intradimensional (ID1) stage Medium Odour M3/O3 M4/O3 
   M3/O4 M4/O4 
Second Intradimensional (ID2) stage Medium Odour M5/O5 M6/O5 
   M5/O6 M6/O6 
Third Intradimensional (ID3) stage Medium Odour M7/O7 M8/O7 
   M7/O8 M8/O8 
Fourth Intradimensional (ID4) stage Medium Odour M11/O11 M12/O11 
   M11/O12 M12/O12 
Late Reversal (LR task only) Medium Odour M12/O11 M11/O11 
   M12/O12 M11/O12 
Fifth Intradimensional (ID5) stage Medium Odour M13/O13 M14/O13 
   M13/O14 M14/O14 
Extradimensional (ED) shift stage Odour Medium O15/M15 O16/M15 
   O15/M16 O16/M16 
Sixth Intradimensional (ID6) stage Odour Medium O17/M17 O18/M17 
   O17/M18 O18/M18 
Original Simple Discrimination (SD2) Medium Odour M1 M2 
Note.  The two tasks differ in the placement of the reversal stage.  In the early reversal 
stage task, the reversal was the third stage; in the late reversal stage task, the reversal 
was the seventh stage of the task.  Rats were counterbalanced so that half received 
digging medium as the initial relevant dimension, whereas the other half received 
odour.  Stimulus pair order and correct/incorrect stimuli within a pair were also 
counterbalanced. 
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Table 8.3.   
Exemplars used (presented in pairs within each dimension). 
 Digging media Odours 
Pairing 1 M1-Coarse tea M2-Fine tea O1-Cinnamon O2-Ginger 
Pairing 2 M3-Sand M4-Grit O3-Sage O4-Paprika 
Pairing 3 M5-Coarse shavings M6-Fine shavings O5-Turmeric O6-Cloves 
Pairing 4 M7-Cotton pads M8-Cigarette filters O7-Dill O8-Coriander 
Training Pairs M9-Polystyrene pieces M10-Shredded paper O9-Mint O10-Oregano 
Pairing 5 M11-Course cork M12-Fine cork O11-Fenugreek O12-Tarragon 
Pairing 6 M13-Long wire coat M14-Short wire coat O13-Cumin O14-Marjoram 
Pairing 7 M15-Beads M16-Gravel O15-Thyme O16-Caraway 
Pairing 8 M17-String M18-Knotted string O17- Fennel seeds O18-Chives 
 
8.6.2 Data Analysis 
Trials to criterion and mean shift-cost were analysed as described in the previous 
experiment (section 8.2.4).  
Statistical analyses.  Total trials to criterion for the early reversal stage task and for the 
late reversal stage task were analysed separately.  Each task was analysed using a two factor, 3 x 
11 ANOVA with the variables of Group (Between-groups factor with 3 levels) and Stage 
(Within-subjects factor with 11 levels).  Sidak’s-corrected pairwise comparisons for significant 
effects or interactions were performed.  The criterion for significance (alpha level) was p < .05 in 
all cases. 
Early reversal stage task.  For the early reversal stage task, the following planned 
contrasts were performed:  
ID2 vs ID5: to evaluate set-formation; measured by an improvement (fewer trials to 
criterion) between the first and the last ID stage.  Given that the reversal stage could affect the 
performance on the stage that preceded it, ID1 was not included in this analysis. 
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ID5 vs ED: to evaluate set-shifting; measured by requiring more trials to complete the ED 
shift stage in comparison to the ID5 stage. 
CD vs ID1: to evaluate if there was an effect of introducing a reversal stage between 
these two stages. 
SD vs SD2: to eliminate the possibility that an increase in number of trials associated 
with learning the ED shift stage were due to issues of fatigue, satiety or memory load, rather than 
the cost of shifting set. 
In addition, the difference in the performance on the ID1 stage, the ED shift stage, the 
reversal stage and shift-cost were compared between the groups. 
Late reversal stage task.  The following planned contrasts were performed: 
ID1 vs ID4: to evaluate set-formation; measured by an improvement (fewer trials to 
criterion) between the first and the last ID stage. 
ID5 vs ED: to evaluate set-shifting; measured by requiring more trials to complete the ED 
shift stage in comparison to the ID5 stage. 
ID4 vs ID5: to evaluate if there was an effect of introducing a reversal stage between 
these two stages. 
SD vs SD2: to eliminate the possibility that an increase in trials associated with learning 
the ED shift stage were due to issues of fatigue, satiety or memory load, rather than the cost of 
shifting set. 
In addition, the difference in the performance on the ID5 stage, the ED shift stage, the 
reversal stage and shift-cost were compared between the groups. 
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Early reversal vs late reversal stage.  The number of trials to complete the reversal stage 
in both tasks was compared to investigate if a reversal stage was acquired in fewer trials after 
presenting consecutive ID stages.  
8.7 Results 
8.7.1 Early reversal stage task 
After histological analysis the final numbers (n) in each group were: DLS lesion (n = 5), 
DMS lesion (n = 4) and sham-surgery control (n = 4).   
Total trials to criterion.  Figure 8.5 shows the comparison of the mean number of trials 
to reach criterion for the DLS lesion, DMS lesion and control group in the early reversal stage 
attentional set-shifting task.  There was no effect of the lesion on performance of the early 
reversal stage task (main effect of Group: F(2, 10) = 0.01, p = .99, ηp
2
 = .002).  Although the 
stages were completed differently (main effect of Stage: F (10, 100) = 3.71, p = .005, ηp
2
 = .27), 
there were no differences between the performance of DLS lesion, DMS lesion and control rats 
on the stages of the early reversal stage task (Stage x Group interaction: F(20, 120) = 0.47, p = 
.97, ηp
2
 = .09).  
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Figure 8.5.  Comparison of the mean number of total trials to reach criterion (±SEM) for 
the DLS lesion, DMS lesion and sham-surgery control group in the early reversal stage 
attentional set-shifting task. 
 
Attentional set-formation.  Planned contrast between stages ID2 and ID5, showed that 
the performance after four consecutive ID stages did not improve (i.e., the number of trials to 
complete the ID5 stage did not decrease in comparison to the trials to complete ID2) for either of 
the groups, which suggested that there were no differences between the groups in learning set.  
The groups did not show set-shifting as none of the groups required more trials to 
complete the ED shift stage in comparison to the ID5 stage.  The performance on the ED shift 
stage and the shift-cost (F(2,10) = 1.80, p = .22, ηp
2
 = .26) was not different between the groups.   
There was no difference in the performance of the first and last stage (SD and SD2), 
which suggested that the performance on the last stages were not due to issues of fatigue, satiety 
or memory load.  
Reversal.  Planned contrasts showed that although the number of trials to complete the 
reversal stage increased in comparison to the previous stage (CD) there were no differences 
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between the groups in the performance of the reversal stage.  In addition, presenting a reversal 
stage early in the task did not affect the groups differently in the ID stage that followed the 
reversal (i.e., no difference between the groups on ID1).  Finally, the reversal stage did not affect 
the stage that followed it (there were no differences between the stages presented before and after 
the reversal stage, CD vs. ID1).  
These results suggested there were no difference between the groups in the performance 
of the early reversal stage task.   
8.7.2 Late reversal stage task 
After histological analysis the final numbers (n) in each group were: DLS lesion (n = 4), 
DMS lesion (n = 2) and sham-surgery control (n = 4).   
Total trials to criterion.  Figure 8.6 shows the comparison of the mean number of total 
trials to reach criterion for the DLS lesion, DMS lesion and control group in the late reversal 
stage attentional set-shifting task.  There was an effect of lesion on performance of the task (main 
effect of Group: F(2, 7) = 8.68, p = .01, ηp
2
 = .71).  Sidak’s-corrected pairwise comparisons 
indicated that DLS lesion rats required fewer trials to complete the task than control rats (p = .03) 
or DMS lesion rats (p = .03).  Although the stages were completed differently (main effect of 
Stage: F(10, 70) = 2.34, p = .02, ηp
2
 = .25), there were no differences between the performance of 
DLS lesion, DMS lesion and control rats on the stages of the late reversal stage task (Stage x 
Group interaction: F(20, 70) = 1.07, p = .40, ηp
2
 = .23).   
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Figure 8.6.  Comparison of the mean number of total trials to reach criterion (± SEM) 
for the DLS lesion, DMS lesion and sham-surgery control group in the late reversal stage 
attentional set-shifting task.  After the reversal stage DLS lesioned rats (*p < .05) required 
fewer trials to complete ID5 in comparison to ID4 and DMS lesioned rats († p < .05) required 
more trial to complete ID5 in comparison to ID4. 
  
Attentional set formation.  Planned contrast within stages ID1 and ID4, showed that the 
performance between the first and the last pre-reversal ID stage did not improve (i.e., the number 
of trials to complete the ID4 stage did not decrease in comparison to the trials to complete ID1) 
for either of the groups, which suggested that there were no differences between the groups in 
learning set.   
DLS lesioned, DMS lesioned and control rats did not show set-shifting as none of the 
groups required more trials to complete the ED shift stage in comparison to the ID5 stage.  The 
performance on the ED shift stage and the shift-cost (F(2,7) = .06, p = .95, ηp
2
 = .02) was not 
different between the groups. 
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There was no difference in the performance of the first and last stage (SD and SD2), 
which suggested that the performance on the last stages were not due to issues of fatigue, satiety 
or memory load.  
Reversal.  Planned contrast showed that the number of trials to complete the reversal 
stage increased in comparison to the previous stage (ID4); however, there were no differences 
between the groups in the performance of the reversal stage.  Furthermore, presenting a reversal 
stage between ID4 and ID5 decreased the number of trials required to complete ID5 (in 
comparison to ID4) for the DLS lesioned rats (p = .05), but produced the opposite effect in the 
DMS lesioned rats (p = .03).  However, the performance in the ID5 stage was not significantly 
different between the groups.  
8.7.3 Early reversal vs. late reversal stage 
  The number of trials to complete the reversal stage in the early reversal task was higher in 
comparison to the late reversal stage task, which would have suggested that a reversal stage was 
completed in fewer trials after attentional set has been formed.  However, given that none of the 
groups showed a positive shift-cost, the improvement in the performance of the reversal stage in 
the late reversal stage task could have been an effect of learning.  However, the difference 
between the tasks to complete the reversal stage was not significant.  The lack of significant 
difference between the tasks, even though there was a pattern, might result from the reduced 
number of rats used in this experiment after histological analysis.  Figure 8.7 shows the mean 
trials to criterion on the reversal stage for the early and the late reversal stage task for the DLS 
lesioned, DMS lesioned and control rats.   
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Figure 8.7.  Mean trials to criterion (± SEM)) on the reversal stage for the 
three groups on the early reversal and the late reversal attentional set-shifting task.   
8.8 Discussion 
To explore the relationship between reversal learning, attentional set-formation and set-
shifting in rats with lesions of the dorsal striatum, this experiment used two modified versions of 
the attentional set-shifting task (that differed in the placement of the reversal stage). 
In the early reversal attentional set-shifting task, the reversal stage was presented before 
four consecutive ID stages (i.e., before attentional set formation could be formed); while the late 
reversal task presented the reversal stage after four consecutive ID stages (i.e., after set-formation 
could be formed).  Based on the overtraining reversal effect (Sutherland and Mackintosh, 1971), 
presenting additional ID stages before the reversal stage should strengthen attentional focus on 
the aspects of the stimuli that predict reward; thus, the performance on the reversal stage should 
be improved after attentional set has been formed (since the animal has learned the relevant cues 
to which to attend).   
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The absence of shift-cost observed in rats with DLS or DMS lesions in the standard 7-
stage attentional set-shifting task suggested that lesions of the dorsal striatum impaired 
attentional set-formation.  Thus, if the performance on a reversal stage improved after attentional 
set has been formed and rats with lesion in the dorsal striatum were unable to form sets, the 
reversal stage for the lesioned rats in the late reversal stage task should require more trials in 
comparison to the control rats that can form attentional sets.   
In the early reversal stage task, although the DLS lesioned and the DMS lesioned group 
needed more trials, in comparison to the controls, to complete the reversal stage, the difference 
between the groups was not significant.  Therefore, there is no evidence that suggested that 
lesions of the dorsal striatum impair reversal learning when the reversal stage is presented before 
4 consecutive ID stages.  
In addition, the reversal stage did not affect the performance of any of the groups on the 
ID stage that followed the reversal (ID1).  These results are consistent with the results from 
Chase (2013) who showed that when comparing ID1 vs CD (the stages before and after the 
reversal stage), the performance on the ID1 was not affected by the reversal stage for the sham-
surgery control rats. 
There was no evidence of attentional set-formation, as the number of trials to complete 
ID1 and ID5 did not decrease for any of the groups.  Although Chase (2013) did not present an 
analysis of these stages, the graph suggests that there was no difference between ID1 and ID5 for 
the control group.  
Finally, the number of trials to complete the ED shift stage was not higher than the trials 
to complete the previous ID, which suggested that the groups did not form set, and therefore did 
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not show a cost of shifting set.  These results are inconsistent with the results from Chase (2013) 
who found that control rats show a shift-cost in this task.  
In summary, there were no significant differences between the performance of DLS 
lesioned, DMS lesioned and control rats on any stage of the early reversal stage attentional set 
shifting task. 
In the late reversal stage task, although the DLS lesioned rats completed the task in fewer 
trials, there were no significant differences between the performance of DLS lesioned, DMS 
lesioned and control rats on any specific stages of the task.  Although reversing the correct 
stimulus to the incorrect stimulus and vice versa from the ID4 stage in the reversal stage 
increased the number of trials for completing the reversal stage, there were no differences in the 
performance of the reversal stage between the groups.  Therefore, there is no evidence that 
suggested that lesions of the dorsal striatum impair reversal learning after presenting four 
consecutive ID stages.  However, the reversal stage could affect the acquisition of the subsequent 
stage for the DLS lesioned and the DMS lesioned rats.  DLS lesioned rats required fewer trials to 
complete the ID5 stage in comparison to the ID4 stage (ID prior and post the reversal stage) and 
DMS lesioned rats required more trials to complete the ID5 stage in comparison to the ID4 stage.  
Nevertheless, these results cannot be conclusive given the reduced number of rats that were 
analysed in this experiment after histological analysis.  The performance on the ID5 stage 
showed no statistical difference between the lesioned groups and the control group.   
The results from the control group from the current experiment are consistent with the 
performance of the control rats from the experiment from Chase (2013), where attentional set 
was not affected after presenting a late reversal stage. 
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There was no evidence of learning set, as the number of trials to complete the ID1 and the 
ID4 stages did not decreased for any of the groups and there was no evidence of set-shifting in 
any of the groups, as the number of trials to complete the ED shift stage was not higher than the 
trials to complete the previous ID stage.  These results are inconsistent with Chase (2013) who 
found that sham-surgery control rats showed a shift-cost in the late reversal stage task. 
To summarise, the results from the late reversal stage task showed there were no 
differences in the performance of the stages of this task between the DLS lesioned, DMS 
lesioned and control rats. 
Altogether, the results from this experiment showed that there were no differences 
between the DLS lesioned, DMS lesioned and the control group in set-formation, set-shifting or 
reversal learning in the early reversal or in the late reversal stage tasks.  However, the 
performance of the control group on the ED shift stage was unexpected as they did not show 
evidence of an attentional set.  Therefore, the lack of difference between the control and dorsal 
striatum lesion groups cannot be conclusive.  In addition, one of the limitations was the number 
of rats that were eliminated from the analysis since they did not have bilateral lesions, or because 
they showed signs of cell damage (in the case of the control group).  The reduced number of rats 
that could be analysed compromised the statistical power; therefore, a larger sample size should 
be evaluated to support the results found in this experiment. 
The absence of attentional set-shifting from the control group on the early and late 
reversal stage tasks is inconsistent with the previous results from Experiment 1 of this chapter; 
where the same rats were tested in the standard 7-stage attentional set-shifting task and showed a 
positive shift-cost.  The discrepancy in results might be accounted for by the difference in the 
Chapter 8 
226 
 
number of stages and the characteristics of the stages employed in each task before the ED shift 
stage.  While the standard 7-stage attentional set-shifting task only uses two different pairs of 
stimuli before the ED shift stage; the early/late reversal stage attentional set-shifting task uses six 
different stimuli pairs.  As every ID stage contains novel stimuli with relevant and irrelevant 
dimensions, increasing the number of ID stages, each one with novel stimuli, might facilitate the 
learning of the relevant and irrelevant dimension.  Given that the stimuli in the irrelevant 
dimension are rewarded half of the time (i.e., when they are paired with the correct stimuli), they 
will likely also gain salience relative to other irrelevant cues (e.g., spatial location).  Therefore, 
when the previously relevant dimension no longer predicts reward on the ED stage, the next most 
salient cue is the irrelevant dimension (which had previously predicted reward half of the time).  
Thus the number of trials to complete the ED shift stage may have decreased as the tendency to 
respond to other irrelevant cues has been weakened.  It is possible that the standard 7-stage 
attentional set-shifting task does not provide enough stages and enough pairs of stimuli to 
structure the salience of the relevant cues; so the performance on the ED shift stage does not 
improve even for the control rats.  Therefore, the standard 7-stage attentional set-shifting task 
might be a more sensitive task to detect attentional set-shifting deficits.   
Also, the absence of attentional set-shifting from the control group on the early and late 
reversal stage attentional set-shifting tasks from this experiment are inconsistent with the results 
on these two tasks reported by Chase (2013).  The discrepant results may be explained by the 
different stimuli that were used in this experiment and the ones that Chase (2013) used.  
Although some of the stimuli have not being changed, some of the pair stimuli have been 
substituted for different reasons (e.g., some odours were aversive for the rats and they refused to 
dig or some of the digging media were too heavy for the rat to dig or some stimuli were too easy 
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to discriminate) and none of the stimuli used by Chase (2013) or in this experiment have been 
validated in the standard 7-stage attentional set-shifting task, which is a limitation of these tasks.  
It is also important to mention that the early and late reversal stage attentional set-shifting tasks 
have only been used twice.  First by Chase (2013) who found set-shifting evidence in sham-
surgery control rats (n =8), and the present experiment which did not find attentional set-shifting 
evidence in sham-surgery control rats (n =8).  Given that normal rats, without being exposed to 
sham-surgery, have not been tested in these two tasks, further research should test unoperated 
control rats, to validate these two tasks.  
  The lack of difference between the early and late reversal attentional set-shifting tasks in 
control rats from this experiment are consistent with the results from Chase (2013) who did not 
find difference in the performance between these two tasks in control rats.  Since the 
performance of the reversal stage did not improve when rats formed sets (Chase, 2013) or when 
rats did not form sets (this experiment), there is no evidence to  support that there is a 
relationship between reversal learning and attentional set formation in control rats. 
Finally, the reversal stages from both tasks were compared to evaluate if the performance 
on the reversal stage improved after presenting multiple ID stages.  Although there was a trend 
towards requiring fewer trials to complete the reversal in the late stage reversal task, the 
difference between the tasks to complete the reversal stage was not significantly different.  Thus, 
presenting multiple consecutive ID stages before the reversal stage did not strengthen attention to 
the relevant cues that predicted reward and the performance on the reversal stage was not 
improved.  Also, the multiple ID stages did not hinder the learning of the relevant dimension on 
the ED stage.  Both of these results are inconsistent with the predictions of the overtraining 
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theory, where the more overtraining, the faster the reversal, but the slower a non-reversal shift 
discrimination is learned (Mackintosh, 1962).  
Although these results are inconsistent with the overtraining predictions; these are not the 
only ones.  Since Reid (1953) showed that the more overtraining trials were given to rats on a 
brightness discrimination task the faster they learned the reversal of the original discrimination, 
several experiments have tried to study this effect, but the results have been controversial.  While 
some experimental studies have found the same findings from Reid, there are some other studies 
that have found that overtraining has significantly retarded reversal learning.  Nevertheless, the 
majority of experimental studies have found that overtraining has had no significant effect on 
reversal learning (Mackintosh, 1969), just like the results found in the present experiment. 
A possible explanation for the inconsistency of results from the present experiment and 
the experiment from Mackintosh (1962) might be the difference in experimental design used for 
overtraining.  Although presenting multiple ID stages could be considered as “overtraining” the 
relevant dimension, it is important to note that each stage used different stimuli.  Therefore, it is 
not the same design of overtraining used by Mackintosh (1962) where the same stimulus was 
presented for multiple trials (100% or 200% more trials of the overall mean number of trials to 
learn the original discrimination).  To evaluate if the overtraining reversal effect is observed in 
the attentional set-shifting task, further research should investigate if presenting the same stimuli 
for multiple trials on the same stage improves the performance on the reversal stage that follows 
it.   
Overall, the results from this experiment showed that there were no differences between 
the DLS lesioned, DMS lesioned and the control group in set-formation, set-shifting or reversal 
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learning in the early reversal attentional set-shifting task or in the late reversal attentional set-
shifting task.  The absence of set-shifting observed in the DLS lesioned and DMS lesioned rats in 
the standard 7-stage attentional set-shifting task and the early and late stage attentional set-
shifting task could be explained if the rats were performing each stage as novel discriminations.  
To test this hypothesis, the next experiment used a modified version of the task to help identify 
the aspects of the stimuli the animals were attending in the intradimensional stages. 
 
Experiment 3.  The probe stage attentional set-formation task 
8.9 Introduction 
The previous experiments showed that in the standard 7-stage attentional set-shifting task, 
as well as in the early reversal and late reversal stage attentional set-shifting task, when the 
relevant dimension changed at the ED shift stage, the DLS lesioned and DMS lesioned rats did 
not require more trials to complete the ED shift stage in comparison to the ID stage; therefore, 
they did not show a positive shift-cost.  Although these results suggested that the dorsal striatum 
might be involved in attentional set-formation and set-shifting, the specific impairments induced 
by the dorsal striatum lesions remain unknown.  It is possible that the lesioned rats were 
performing each stage as novel discriminations, which could explain the absence of set-shifting 
and set-formation.  To test this hypothesis, the next experiment, based on the task from Dias et al. 
(1996b), used a series of intradimensional stages followed by a probe stage to help identify the 
aspects of the stimuli the animals were attending to in the ID stages.  The probe stage consisted 
of presenting the relevant dimension stimuli from the previous ID, with a new pair of stimuli in 
the irrelevant dimension (e.g., for medium being the relevant dimension, ID stage: M1,O1; 
Chapter 8 
230 
 
M1,O2; M2,O1; M2,O2; probe stage: M1,O11; M1,O12; M2,O11; M2,O12), with the reward 
contingencies of the relevant stimuli remaining the same as the previous ID stage.  Therefore, if 
the rats have learned to distinguish that the compound stimuli are formed by correct and incorrect 
stimuli (e.g., M1, regardless if it is presented with O1 or O2), then presenting the correct stimuli 
with new stimuli in the irrelevant dimension (M1,O11 or M1,O12) should not require new 
learning.  Hence, the probe stage should be completed in fewer trials, as the animal should not 
require additional trials to learn the correct stimulus (i.e., should continue choosing M1 
regardless of whether it was presented with O11 or O12).  On the contrary, if the rats have 
completed the stages by learning the stimuli as a compound (e.g., M1,O1 and M1,O2 as 
rewarded), pairing the correct stimulus with a new exemplar from the irrelevant dimension 
should require a novel discrimination, and any benefit from learning at the preceding stage 
should not carry over.  Learning the correct stimuli as a compound does not allow a distinction 
between relevant and irrelevant dimensions.  Therefore, a difference between the ID stage and 
the ED shift stage would not be expected.  This might explain the absence of shift-cost that has 
been observed in rats with DLS lesions and DMS lesion.   
To help identify the aspects of the stimuli the animals were attending in the 
intradimensional stages, a probe stage was incorporated to form a new version of the attentional 
set-shifting task.  If DLS lesioned and DMS lesioned rats perform each stage as an individual 
stage, without focussing on the relevant stimulus, the probe stage should be solved as a novel ID 
stage where novel stimuli were presented for the first time.  Therefore, the stage will not be 
completed in fewer trials (as the ‘correct’ stimulus from the previous stage would not be 
considered such for completing the current stage).  
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In addition to identifying the aspects of the stimuli attended in the ID stages, this task also 
evaluated set-formation, set-shifting and reversal learning to help identify possible impairments 
in the dorsal striatum lesioned animals.  
8.10 Method 
8.10.1 Procedure 
 Unlike the standard 7-stage attentional set-shifting task, in which each stage is followed 
by a reversal stage, the early and late reversal stage attentional set-shifting tasks only have one 
reversal stage; therefore, some of the exemplars within the stimulus pairs that were used in the 
preceding early/late reversal stage task were never associated with reward (even partially as 
irrelevant stimuli).  To control against the effects of previous rewarded and unrewarded stimuli 
associations on the performance of subsequent tasks, the rats were pre-exposed to all the stimuli.  
Rats were presented twice with each of the digging media (unscented) and with each of the 
odours (mixed in sawdust) until they retrieved the reward from both of the bowls. 
 In addition, before testing the rats in the probe stage attentional set-shifting task, all the 
animals were retested in the standard 7-stage attentional set-shifting task, to ensure there had not 
been learning effects after the early and late reversal stage attentional set-shifting tasks.  
Standard 7-stage attentional set-shifting task.  Rats were retested in the standard 7-
stage attentional set-shifting task (Table 8.1).  The stages were always in the same order and the 
same stimulus pairs were used as in the first 7-stage attentional set-shifting task, with 
counterbalancing both within and between tests for direction of shift, stimulus pair order and 
correct/incorrect stimuli within a pair. 
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Probe stage attentional set-shifting task.  Once all rats completed the standard 7-stage 
attentional set-shifting task, they were tested in the modified version of the task that included a 
probe stage (Table 8.1).  The task consisted of an SD, CD, three intradimensional (ID1, ID2, 
ID3) stages, a probe stage of ID3, the original ID3, ID4, an ED, a reversal of the ED (REV) stage 
and the original SD.  Table 8.4 summarises this task.  The original SD was presented at the end 
of the task to control against the possibility that an increase in trials associated with learning the 
ED shift stage or the reversal stage were due to issues of fatigue, satiety or memory load, rather 
than the cost of shifting set or reversal learning.  The original ID3 was presented after the probe 
stage, to control for any possible effect of the probe stage on the subsequent ID stage.  The 
exemplars used in these experiments were the same as in the previous experiment, which are 
summarised in Table 8.3.  The stimuli from pair five were always used in the probe stage to 
substitute the irrelevant dimension.  
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Table 8.4.   
Example of the testing stages and possible stimulus combinations in the probe stage 
attentional set-shifting task.   
Discriminations Dimensions Exemplar combinations 
 Relevant  Irrelevant Rewarded  Unrewarded 
Simple Discrimination (SD) Medium Odour M1 M2 
Compound Discrimination (CD) Medium Odour M1/O1 M2/O1 
   M1/O2 M2/O2 
First Intradimensional (ID1) stage Medium Odour M3/O3 M4/O3 
   M3/O4 M4/O4 
Second Intradimensional (ID2) stage Medium Odour M5/O5 M6/O5 
   M5/O6 M6/O6 
Third Intradimensional (ID3) stage Medium Odour M7/O7 M8/O7 
   M7/O8 M8/O8 
Probe third Intradimensional  Medium Odour M7/O11 M8/O11 
            (ID3Probe) stage   M7/O12 M8/O12 
Third Intradimensional (ID3) stage Medium Odour M7/O7 M8/O7 
   M7/O8 M8/O8 
Fourth Intradimensional (ID4) stage Medium Odour M13/O13 M14/O13 
   M13/O14 M14/O14 
Fifth Intradimensional (ID5) stage Medium Odour M15/O15 M16/O15 
   M15/O16 M16/O16 
Extradimensional (ED) shift Odour Medium O17/M17 O18/M17 
   O17/M18 O18/M18 
Reversal (REV) Odour Medium O18/M17 O17/M17 
   O18/M18 O17/M18 
Original Simple Discrimination (SD2) Medium Odour M1 M2 
Note.  The probe tasks consist of replacing the stimuli in the irrelevant dimension with two 
novel stimuli, whereas the stimuli from the relevant dimension and the reward contingencies 
remained the same.  Rats were counterbalanced so that half received digging medium as the 
initial relevant dimension, whereas the other half received odour.  Stimulus pair order and 
correct/incorrect stimuli within a pair were also counterbalanced. 
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8.10.2 Data analysis 
Standard 7-stage attentional set-shifting task.  Trials to criterion and mean shift-cost 
were analysed as described in the first experiment from this chapter.  
Statistical analyses.  Trials to criterion were analysed using a three factor, 2 x 7 x 3 
ANOVA with the variables of Test (Within-subjects factor with 2 levels: Post-surgery First Test 
vs. Post-surgery Repeat Test), Stage (Within-subjects factor with 7 levels: SD, CD, REV1, ID, 
REV2, ED, REV3) and Group (Between-groups factor with 3 levels: DMS lesion, DLS lesion, 
sham-surgery control).  The rest of the analyses were conducted as described before.  
Probe stage attentional set-shifting task.  Trials to criterion and mean shift-cost were 
analysed as described in the first experiment from this chapter.  
Statistical analyses.  Total trials to criterion for the probe stage task were analysed using 
a two factor, 3 x 11 ANOVA with the variables of Group (Between-groups factor with 3 levels) 
and Stage (Within-subjects factor with 11 levels).  Sidak’s-corrected pairwise comparisons for 
significant effects or interactions were performed.   
Planned contrasts.   
ID3 vs ID3Probe: to evaluate if the relevant and irrelevant dimensions were identified; 
measured by an improvement (fewer trials to criterion) between the ID3 and the ID3Probe stage. 
ID1 vs ID4: to evaluate set-formation; measured by an improvement (fewer trials to 
criterion) between the first and the last ID stage. 
ID4 vs ED: to evaluate set-shifting; measured by requiring more trials to complete the ED 
shift stage in comparison to the ID4 stage. 
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SD vs SD2: to eliminate the possibility that an increase in trials associated with learning 
the ED shift stage or the reversal stage were due to issues of fatigue, satiety or memory load, 
rather than the cost of shifting set or reversal learning. 
In addition, the difference in the performance on the ID3Probe stage, the ED shift stage, 
the reversal stage and shift-cost were compared between the groups. 
8.11 Results 
8.11.1 Effects of repeated testing in the standard 7-stage attentional set-shifting task 
Total trials to criterion.  There were no differences between the first and the second test 
(main effect of Test: F(1,20) = 3.42, p = .08, ηp
2
 = .15; Test x Group: F(2, 20) = 2.20, p = .14, ηp
2
 
= .18; Test x Stage F(6, 120) = 2.17, p = .06, ηp
2
 = .10).  The effect of lesion on the performance 
of the task was still present the second time the rats were tested in the standard 7-stage attentional 
set-shifting task (main effect of Group: F(2, 20) = 6.75, p = .01, ηp
2
 = .40).  The DLS lesioned 
rats still required fewer trials to complete the task than the controls (p = .02) and the DMS 
lesioned (p = .02) rats. 
Figure 8.8 shows the mean of the performance of the first and second test on the standard 
7-stage attentional set-shifting task post-surgery.  Planned contrasts between the ID and the ED 
stages, of the average of the two tests, showed that control rats required more trials to complete 
the ED shift stage than the ID stage (p = .01).  There were no differences between the ID and ED 
stages for the DMS (p = .97) and the DLS (p = .72) lesioned rats.  DLS lesioned rats required 
fewer trials to complete the ED stage in comparison to the controls (p = .02), and DMS lesioned 
rats required more trials to complete REV3 in comparison to DLS lesioned rats (p = .03). 
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Figure 8.8.  Mean trials to criterion (± SEM) for DLS lesion, DMS lesion and 
control group in the standard 7-stage attentional set-shifting task (mean of the two tests 
post-surgery).  Sham-surgery control rats required more trials to complete the ED in 
comparison to the ID (* p < .05), DLS lesioned rats required less trials to complete the 
ED stage in comparison to the controls (■ p < .05) and rats with DMS lesions required 
more trials to complete REV3 in comparison to DLS lesioned rats († p < .05).   
8.11.2 Probe stage attentional set-shifting task   
Total trials to criterion.  Figure 8.9 shows the comparison of the mean number of total 
trials to reach criterion for the DLS lesion, DMS lesion and control groups on the probe test stage 
attentional set-shifting task.  Lesions of the dorsal striatum did not affect the performance of the 
task (main effect of Group: F(2, 20) = 0.40, p = .67, ηp
2
 = .04).  Although the stages were 
completed differently (main effect of Stage: F(10, 200) = 6.88, p < .001, ηp
2
 = .26), there were no 
differences between the performance of DLS lesion, DMS lesion and control rats on the stages of 
the task (Stage x Group interaction: F(20, 200) = 0.70, p = .82, ηp
2
 = .07).   
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Figure 8.9.  Mean trials to criterion (± SEM) for DLS lesion, DMS lesion and 
control group in the probe stage attentional set-shifting task.  Control rats required 
more trials to complete the ED shift stage in comparison to the ID4 stage (* p < .05). 
Attentional set formation.  Although the number of trials between the first and the last 
ID stages (ID1 vs ID4) decreased for the control rats and the DLS lesioned rats, the difference 
was not significant for either of the groups; which suggested that there were no differences 
between the groups in learning set.   
Control rats needed more trials to acquire the discrimination requiring an ED shift 
compared with the immediately preceding discrimination requiring an ID (p = .05), which 
suggested that they had formed an attentional set and, therefore, required to shift attentional set at 
the ED shift stage on the test.  However, the DLS lesioned and the DMS lesioned rats did not 
show attentional set-shifting.  While the DLS lesioned rats required more trials to complete the 
ED shift stage in comparison to the ID4 stage, the difference between these stages was not 
significant.  Though, the DMS lesioned rats showed a non-significant trend to complete the ED 
shift stage in fewer trials in comparison to the ID4 stage (see Figure 8.9).  The performance on 
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the ED shift stage and the shift-cost (main effect of Group: F(2, 20) = 1.94, p = .17, ηp
2
 = .16) 
was not different among the groups. 
All three groups required fewer trials to complete the last stage in comparison to the first 
stage (SD vs. SD2), which suggested that the performance on the last stages were not due to 
issues of fatigue, satiety or memory load.  
Probe test.  Substituting the irrelevant dimension with novel exemplars had no effect on 
performance in either control or dorsal striatum lesioned rats.  The three groups continued to 
respond to the previously correct stimulus in the relevant dimension, therefore the ID3Probe 
stage was completed in fewer trials in comparison to the ID3 stage (see Figure 8.9).  Figure 8.10 
shows a comparison of the errors made on the previous ID stage and the probe stage.  The errors 
on the probe stage significantly decreased in comparison to the ID3 stage for the three groups, 
but the difference was only significant for the lesioned groups (DLS: p = .04; DMS: p = .01).   
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Figure 8.10.  Mean errors to criterion (± SEM) for DLS lesion, DMS lesion 
and control group on the ID3 and the ID3 Probe stage.  The number of errors on the 
ID3 Probe stage was significantly lower than on the ID3 stage (DLS*, DMS † p < 
.05). 
 
Reversal.  DLS lesioned, DMS lesioned and control rats did not show perseveration on 
the reversal stage.  Planned contrast showed there were no differences between the groups in the 
reversal stage.  
8.12 Discussion 
The aim of Experiment 3 was to introduce a probe stage after a series of ID stages to 
investigate the aspects of the stimuli that the animals were attending to in the attentional set-
shifting task. 
Before testing the rats in the modified version of the task, the three groups were retested 
in the standard 7-stage attentional set-shifting task.  In both tasks the pattern of performance did 
not change.  That is, the control group required more trials to complete the ED shift stage in 
comparison to the ID stage, which suggested that they formed an attentional set to one perceptual 
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dimension of a compound stimulus and then had to shift from that attentional set to complete the 
ED shift stage.  On the contrary, DLS lesioned and DMS lesioned rats did not require more trials 
to complete the ED shift stage in comparison to the ID stage and therefore showed a 
diminished/absent cost of shifting.  Therefore, there was no evidence that rats with DMS or DLS 
lesions formed attentional set in the standard 7-stage attentional set-shifting task.  The replication 
of results confirms that the standard 7-stage attentional set-shifting task can be used on repeated 
basis with reproducible results and having no learning effects (Tait et al., 2014; Tait et al., 2009; 
Wallace et al., 2014). 
Instead of forming an attentional set to the relevant dimension and learning which of the 
stimuli within that perceptual dimension was rewarded.  It could be possible that the DLS 
lesioned and the DMS lesioned rats could be solving the discrimination of each stage by 
combining odour and medium exemplars to form compound discriminations and learn which of 
the two, out of the four possible compounds, were rewarded (Dias et al., 1996b; Roberts et al., 
1988).  To test this hypothesis, Experiment 3 introduced a probe stage where the stimuli of the 
irrelevant dimension were substituted for novel ones.  
DLS lesioned and DMS lesioned rats, as well as the control rats, were able to remember 
the rewarded stimulus, within the relevant dimension, when it was presented with novel stimuli 
in the irrelevant dimension.  This suggests that none of the three groups were solving the stages 
by learning the two compound discriminations that predicted reward.  In addition, the 
performance of the three groups on the ID stages across the task was very similar.  However, the 
DMS lesioned rats showed a diminished shift-cost, as it was observed on the standard 7-stage 
attentional set-shifting task, which suggested they were not forming sets. 
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Shifting an attentional set requires a subject to transfer attention away from the relevant 
dimension and reengage attention to the previously irrelevant dimension.  So it might be possible 
that the lesioned rats have a limited attentional selectivity and were only able to learn that a 
dimension is relevant, but might be less capable of learning that a dimension is irrelevant.  
Therefore, when the irrelevant dimension becomes relevant on the ED shift stage, lesioned 
animals might only need to learn the new dimension that is relevant, which allowed them to solve 
the ED shift stage faster.  The ability to inhibit a previously learned association in the lesioned 
animals was observed on the reversal stage, where DLS and DMS were able to learn the new 
stimulus-reinforcement associations like the control group.  
The results from this experiment suggested that the diminished shift-cost observed in rats 
with DLS or DMS lesions did not result from solving the discrimination of each stage by 
learning which of the two, out of four, possible compound discriminations (i.e., the combination 
of odour and medium exemplars) were rewarded.  
Overall summary and conclusion 
It has been reported that in the attentional set-shifting task, preclinical carriers of HD 
mutation and HD patients on an early stage show perseveration responding on the ED shift stage 
(i.e., are unable to stop responding to the stimulus dimension that was relevant in the stages 
before the ED stage).  In addition, advance stage HD patients also show impairments in the 
reversal stages (Lange et al., 1995; Lawrence et al., 1996; Lawrence et al., 1998b; Lawrence et 
al., 1999b).   
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The purpose of this chapter was to test rats with bilateral quinolinic acid lesions of the 
dorsolateral or dorsomedial striatum in a series of attentional set-shifting tasks to investigate the 
role of the dorsal striatum in reversal learning, attentional set-formation and set-shifting.   
In Experiment 1, rats were tested in the standard 7-stage attentional set-shifting task.  On 
the reversal stages, there were no differences between the DLS or the DMS lesioned rats and the 
control rats, which suggested that lesions of the dorsal striatum do not affect reversal learning as 
measured by this task.  However, as opposed to the control rats, there was no evidence that the 
DMS and the DLS lesioned groups formed attentional set, as they showed a diminished/absent 
shift-cost (did not require more trials to complete the ED shift stage in comparison to the ID 
stage).   
Given that the standard 7-stage attentional set-shifting task does not allow a direct 
measurement of attentional set-formation, it only assumes that set-formation has been formed by 
detecting set-shifting, Experiment 2 used two modified versions of the attentional set-shifting 
task (that differed in the placement of the reversal stages) that, in addition of measuring set-
shifting, can provide a better measure of the formation of attentional set.  In the early reversal 
attentional set-shifting task, the reversal stage was presented before four consecutive ID stages 
(i.e., before attentional set is likely to have been formed); while the late reversal task presented 
the reversal stage after four consecutive ID stages (i.e., after set-formation is likely to have been 
formed).  The results from the early and late reversal stage attentional set-shifting tasks showed 
that there were no differences in the performance of DLS lesioned, DMS lesioned and control 
rats in any stage of these two tasks. 
The absence of set-shifting observed in the DLS lesioned and DMS lesioned rats in the 
standard 7-stage attentional set-shifting task and the early and late stage attentional set-shifting 
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task could be explained if the rats were performing each stage as novel discriminations.  To test 
this hypothesis, Experiment 3 used a probe stage to help identify the aspects of the stimuli the 
animals were attending to in the intradimensional stages.  First, the three groups were retested in 
the standard 7-stage attentional set-shifting task.  The results were consistent with the results 
from the first time the rats were tested post-surgery (i.e., dorsal striatum lesioned rats did not 
show reversal impairments and showed no difference between the number of trials to complete 
the ID stage and the ED shift stage).  When the rats were tested in the modified version of the 
attentional set-shifting task that included a probe stage (which substituted the stimuli of the 
irrelevant dimension from the previous ID with novel stimuli) after three consecutive ID stages, 
DLS and DMS lesioned rats showed no reversal learning impairments, but they did not appear to 
have formed attentional set (as there was no difference between the number of trials to complete 
the last ID stage and the ED shift stage).  The performance of the three groups was not affected 
in the probe stage.  When the stimuli of the irrelevant dimension were substituted, all of the rats 
continued responding to the rewarded stimulus from the relevant dimension of the previous ID 
stage.  Therefore, the three groups did not take as many trials to complete the probe stage as they 
did on the ID stages, which suggested that the rats were not treating the probe stage as if it was 
an entirely new discrimination.  The results from this experiment suggested that the diminished 
shift-cost observed in rats with DLS or DMS lesions did not derive from solving the 
discrimination of each stage by learning the two compound discriminations that were rewarded.   
Overall, the results from the three experiments presented in this chapter, and the results 
from Chapter 7, showed that dorsal striatum lesioned rats were not impaired in the acquisition of 
discriminations; they were able to inhibit responding to previously rewarded stimuli, showing 
that they were not impaired in reversal learning.  These results are contrary to what is observed in 
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patients with advanced HD, who show reversal impairments.  Given that dorsal striatum lesioned 
rats did not require more trials to complete the ED shift stage than the ID stage, the ability to set-
shift could not be measured, but the results suggested that there was no evidence that they were 
forming set.  These results were consistent across the four different tasks on which the rats were 
tested.   
In summary, the series of experiments presented in this chapter showed that there were no 
differences between the DLS and DMS lesioned rats in the attentional set-shifting task.  Lesions 
of the dorsal striatum did not impair reversal learning but impaired the formation of attentional 
set.  These results are inconsistent with the results observed in HD patients, who showed reversal 
impairments and impaired ability to shift attentional set from a previously relevant dimension to 
previously irrelevant dimension (Lange et al., 1995; Lawrence et al., 1996; Lawrence et al., 
1998b; Lawrence et al., 1999b).  Therefore, the results from this chapter and the previous 
chapter, suggested that even though bilateral quinolinic acid lesions of the dorsal striatum in rats 
mimic some aspects of the neural damage in HD, they do not presented similar cognitive deficits 
in behavioural flexibility as those seen in HD patients in the ID/ED attentional set-shifting task. 
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9.1 Introduction 
The purpose of this thesis was to develop methodology by which treatments for the 
cognitive impairments in HD could be tested.  As such, the thesis focused mainly on evaluating 
rats with quinolinic acid lesions of the striatum, as this manipulation mimics some aspects of the 
neural damage in Huntington’s disease, to try to identify cognitive deficits of HD resulting from 
cell loss in the striatum.  The animal models of HD based on genetic manipulations have, 
understandably, resulted in a research emphasis on the motor impairments of the models, while – 
in part because these tend to be mice – the characterisation of the cognitive impairments remains 
poorly investigated.  The reduced number of tasks available for evaluating cognitive impairments 
in animal models of HD, which are caused by cell loss in the striatum, has slowed the progress 
for testing treatments for the disease.  Currently, the only treatments available for HD ameliorate 
the motor and psychiatric symptoms, but there are no treatments available for the cognitive 
decline observed in HD.  This suggests there is a necessity to develop and validate new tests of 
striatal function in which the effectiveness of treatments for HD could be evaluated.  Accordingly 
and based on the cognitive deficits that have been previously reported in patients with HD, this 
thesis examined the following: implicit memory (Chapters 3-5), habit formation (Chapter 6), 
reversal learning, attentional set-formation and set-shifting (Chapters 7-8) in rats with QA lesions 
of the striatum in order, to assess the validity and translatability of these tasks as well as to 
evaluate the effectiveness of potential treatments for HD.  In this concluding chapter, the findings 
from this thesis will be summarised briefly.  Because the results have already been discussed in 
Chapters 3-8 this chapter considers the implications of these findings in a wider context in order 
to suggest future avenues of research.  
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9.2 Summary of results 
9.2.1 Role of the dorsomedial striatum in implicit memory  
In the first part of this thesis (Chapters 3-5), the role of the striatum in implicit memory 
was investigated. 
The basal ganglia have been reported as a critical brain structure for implicit learning 
(Paulsen et al., 1995a).  In effect, patients with HD, who have neuronal loss of the striatum, 
exhibit deficits in implicit learning (Knowlton et al., 1996b).  Research on implicit learning in 
animal models of HD has been restricted given that the tasks to evaluate implicit memory have 
been designed for humans, and thus the behavioural abilities required to perform the tasks cannot 
easily be tested in animals.   
The aim of Chapter 3 was to develop a task that could be performed by rats and humans 
as a means of evaluating implicit memory.  It has been suggested that the striatum is involved in 
the calculation of probabilities that predict an outcome (Knowlton et al., 1996b); accordingly, a 
reaction time task was modified in order to allow the study of implicit memory by incorporating 
the computation of probabilities to predict the location of the stimuli.  In this reaction time task, 
called the Spatiotemporal Target Probability Signal Reaction Time Task, the location of the 
target (spatial probability) changed as a function of the length of the foreperiod (temporal 
probability).  At shorter foreperiods, targets on the left side were more probable than targets on 
the right side, but at longer foreperiods, targets on the right side became more probable than the 
targets on the left side.  If implicit learning occurred, it was expected that during the task 
participants would gradually have faster reaction times on the left side at shorter foreperiods and 
have faster reaction times on the right side at longer foreperiods (the more probable location of 
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the targets), even though they would not have conscious knowledge of the location where the 
stimuli were more likely to appear.  The results from Chapter 3 showed that rats and humans can 
learn the Spatiotemporal Target Probability Signal Reaction Time Task efficiently.  Although the 
performance of humans and rats differed in the percentage of incorrect responses and late errors 
(i.e., humans did not make incorrect responses or late errors), both groups showed a similar 
pattern in reaction times.  Both rats and humans had faster reaction times to the right side at 
longer foreperiods (i.e., the side where the stimulus was more likely to appear), which indicates 
that with practice both species were able to learn that the probability of the stimulus appearing on 
the left side was more likely at early foreperiods, and at later foreperiods, the probability of the 
stimulus appearing on the right side was more likely.  Chapter 3 showed that the Spatiotemporal 
Target Probability Signal Reaction Time Task was an effective task for evaluating implicit 
learning in rats and humans.  Given that the task could facilitate the assessment of short acting 
treatments in pharmacological studies and the effects of lesions in rodents, these were 
investigated in Chapters 4 and 5 respectively.  
Previous studies have reported a loss of striatal D1 and D2 dopamine receptors in HD 
(Backman et al., 1997; Brandt et al., 1990; Lawrence et al., 1998b; Lawrence et al., 1998c).  
Chapter 4 investigated if implicit memory (the computation of probabilities to predict the 
location of a stimulus) was affected by selective blockade of dopaminergic transmission at the D1 
or D2 receptors by SCH-23390 and raclopride, respectively.  These results suggested that reaction 
times were slower with both SCH-23390 and raclopride, but only D1 antagonist SCH-23390 
reduced errors to the least probable target location.  These results suggested that selective 
blockade of dopaminergic transmission at the dopamine D1 and D2 receptors could have different 
effects in tasks that require implicit memory, and that reaction times and accuracy could be 
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dissociated.  To further investigate the role of the striatum in implicit memory, Chapter 5 
evaluated rats with QA lesions of the striatum, through the use of the Spatiotemporal Target 
Probability Signal Reaction Time Task.  Implicit memory was not affected by QA lesions of the 
DMS as reaction times remained faster to the right side at the longest foreperiods (i.e., the side 
were the target was more likely to appear), which suggests that once a task that requires implicit 
memory has been learned, the DMS is not involved in sustaining the performance of the task.   
Given that no cognitive impairments were induced by lesions of the DMS in the 
Spatiotemporal Target Probability Signal Reaction Time Task, the effectiveness of treatments for 
HD could not be evaluated using this task.  Hence, Chapter 6 investigated another test of striatal 
function in which potential treatments for HD could be evaluated. 
9.2.2 Role of the dorsomedial striatum in goal-directed and habitual responding 
The second part of this thesis (Chapter 6), explored the contribution of the DMS in habit 
formation.  
In addition to having a general role in the initiation and patterning of different behaviours, 
the striatum has also been associated with habit formation (Packard and Knowlton, 2002; Yin 
and Knowlton, 2006).  Ritualistic behaviours, which are considered as habits (Graybiel, 1998), 
are one of the most common obsessions in HD (Novak and Tabrizi, 2010).  Chapter 6 
implemented a task, adapted from that of Desrochers et al. (2010), as means of evaluating habit 
formation in rats with QA lesions of the DMS.   
Using a free scan task, rats had to nose poke a row of five holes to find a target hole 
selected randomly on each trial.  There was no cue that would indicate which hole would produce 
the reward or when the target would become bated.  Changes in goal value were assessed by 
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using a devaluation of the reward, in which rats had free access to the reinforcement in their 
home cages before testing, and the reward was not delivered during the session.  It was 
hypothesised that if habits were formed, the performance on the task would not be affected even 
though the value of the reward was devalued.  This was not observed, neither DMS lesioned nor 
sham-surgery control rats showed habitual responding in the task, as their performance decreased 
when the value of the reward decreased.   
In order, to evaluate if lesions of the DMS would impair goal-directed behaviour (i.e., the 
association of an action and an expected outcome), in the last phase of the experiment all of the 
conditions remained the same, but the central hole never produced a reward.  Since there were no 
cues to indicate the change, rats had to learn through the task that nose poking into the central 
hole would never produce a reward.  Habitual responding would consist of continuing 
responding to the central hole.  Thus, it was hypothesised that if the DMS was required to learn 
goal-directed behaviours, rats with DMS lesions would show habitual responding and would 
continue responding to the central hole regardless of it no longer being reinforced.  Lesion of the 
DMS did not change the sensitivity to outcome devaluation, and both sham-surgery control and 
DMS lesioned rats made fewer responses to the hole that never delivered reward during the last 
phase of the experiment, which suggested that DMS lesions did not affect the acquisition of a 
new goal-directed behaviour.   
Because no cognitive deficits were observed in DMS lesioned rats that could be 
compared with HD patients, Chapter 7 evaluated if rats with bilateral QA lesions of the DMS 
presented similar cognitive deficits in behavioural flexibility as those seen in HD patients in the 
ID/ED attentional set-shifting task. 
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9.2.3 Role of the dorsal striatum in attentional set-shifting, set-formation and reversal 
learning 
The third part of this thesis (Chapters 7 and 8) investigated the role of the dorsal striatum 
in attentional set-shifting. 
Patients with damage to the striatum arising from HD exhibit deficits in behavioural 
flexibility in the ID/ED attentional set-shifting task.  Preclinical carriers of the HD mutation 
(Lawrence et al., 1998a), and early stage HD patients showed impairments in the 
extradimensional shift stage (Lawrence et al., 1996; Lawrence et al., 1999b).  Their set-shifting 
impairments resulted from perseverative responding (i.e., an inability to stop responding) to the 
stimulus dimension that was relevant in the stages before the ED (Lawrence et al., 1999b).  As 
the disease progresses, advanced stage HD patients showed impairments in the reversal stages 
(failing to complete those stages) and therefore rarely reach the ED stage (Lange et al., 1995).   
Chapter 7 investigated if rats with bilateral quinolinic acid lesions of the dorsomedial 
striatum, which mimic some aspects of the neural damage in HD, presented similar cognitive 
deficits in behavioural flexibility as those seen in HD patients in the ID/ED attentional set-
shifting task.  DMS lesioned rats and sham-surgery control rats were tested in the ID/ED 
attentional set-shifting task for rodents, which consists of 7 stages that are analogous to those in 
the human task.  Rats with lesions of the DMS did not show reversal impairments and showed a 
trend towards a diminished shift-cost suggesting that no sets were formed, which is contrary to 
what is observed in HD patients.  To test if attentional set-formation was impaired in rats with 
lesions in the DMS, Chapter 8 presented a series of behavioural tasks designed to further 
elucidate set-shifting performance, with the possibility of drawing conclusions on the set-
formation.   
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In Chapter 8, three experiments examined the effects of QA lesions of the dorsolateral or 
the dorsomedial striatum in reversal learning, attentional set-formation and set-shifting.  In 
Experiment 1, rats were tested on the standard 7-stage attentional set-shifting task.  DLS and 
DMS lesioned rats did not have reversal learning impairments, but showed a diminished shift-
cost (they did not require more trials to complete the ED shift stage in comparison to the ID 
stage), which may occur if no set has been formed.  Experiment 2 explored the relationship 
between reversal learning, attentional set-formation, and set-shifting by using two modified 
versions of the attentional set-shifting task (that differed in the placement of the reversal stages).  
There were no differences between the DLS lesioned, DMS lesioned and the control groups in 
the performance of these two tasks.  Experiment 3 introduced a probe stage (which substituted 
the stimuli of the irrelevant dimension from the preceding stage with novel stimuli) to help 
identify the aspects of the stimuli to which the rats were attending.  The three groups continued 
responding to the rewarded stimulus in the relevant dimension from the previous stage, which 
suggested that the diminished shift-cost observed in rats with DLS or DMS lesions was not 
caused by solving the discrimination of each stage by learning the two compound discriminations 
that were rewarded.  Altogether, the four different attentional set-shifting tasks used in Chapter 8 
showed that the DLS lesioned and the DMS lesioned rats were not impaired in reversal learning, 
but they had a diminished shift-cost, which suggests that dorsal striatum lesions disable the 
formation of attentional sets.   
The results from Chapter 7 and 8 suggest that even though bilateral quinolinic acid lesions 
of the dorsal striatum in rats mimic some aspects of the neural damage in HD, they do not present 
similar cognitive deficits in behavioural flexibility as those seen in HD patients in the ID/ED 
attentional set-shifting task. 
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9.3 Contributions, limitations and future research directions 
9.3.1 Spatiotemporal Target Probability Signal Reaction Time Task 
This thesis presented a new task that measured implicit memory that could be performed 
by both humans and rats.  Both species were able to learn that the probability of a stimulus 
appearing on the left side was more likely at early foreperiods; at later foreperiods, however, the 
probability of the stimulus appearing on the right side was more likely.  Consequently, the 
Spatiotemporal Target Probability Signal Reaction Time Task could be used in future research to 
evaluate cognitive deficits in implicit learning in patients with HD or in other animal models of 
HD. 
Previous studies have reported that in HD, the cognitive deficits start before the motor 
symptoms appear, and that subtle cognitive impairments could be among the earliest 
manifestations of HD (Aylward, 2007; Aylward et al., 2000; Hahn-Barma et al., 1998; Paulsen, 
2011; Paulsen et al., 2006; Paulsen et al., 2008; Paulsen et al., 2001b).  Deficits in implicit 
learning and the inability to learn new motor skills or procedures are some of the cognitive 
changes that have been reported in HD patients (Paulsen et al., 1995a).  Future research could 
evaluate HD patients at different stages of the disease using the Spatiotemporal Target 
Probability Signal Reaction Time Task.  For example, if the task is sensitive in detecting early 
cognitive deficits in implicit learning in patients at the prodromal stage of HD, the task could be 
used as a tool for diagnosing and potentially starting treatment that could prevent the decline of 
cognitive deficits.  Conversely, this task could also test patients that have been diagnosed with 
HD in order to monitor the progression of the cognitive deficits in implicit learning.  In addition, 
the task is not only restricted for evaluating patients with HD, it could also be used to evaluate 
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implicit learning in diseases or disorders in which implicit learning has been reported to be 
impaired, such as Parkinson’s disease (Heindel et al., 1989) or autism (Kriete and Noelle, 2009). 
By showing that rats and humans have a similar pattern of reaction times in the 
Spatiotemporal Target Probability Signal Reaction Time Task, the task could be used to evaluate 
implicit learning in different animal models.  Although different animal models of HD have been 
proposed, there are only few tasks available for evaluating cognitive impairments that could be 
performed by both rats and humans, which have resulted in a slow testing process for treatments 
for patients with HD.  Therefore, the Spatiotemporal Target Probability Signal Reaction Time 
Task provides a tool for initiating the evaluation of cognitive deficits in HD, which could prove 
valuable in future investigations of this disease.  
Additionally, the results presented in Chapter 4 have important implications for the 
therapeutic use of D1 and D2 antagonists in the Spatiotemporal Target Probability Signal 
Reaction Time Task.  Firstly, because the data presented in this thesis suggest that D1 and D2 
antagonists could have different effects, and that reaction times and accuracy could be 
dissociated.  Secondly, it provides a new task to potentially evaluate the cognitive changes that 
have been reported from the reduction in D1 and D2 receptor density in the striatum in patients 
with HD and in preclinical carriers.  Finally, the task may be used to evaluate therapeutic 
interventions that selectively block D1 or D2 receptors.   
Furthermore, the results from Chapter 5 suggested that once a task which requires 
implicit memory has been learned, the DMS is not involved in sustaining the performance of the 
task.  However, it remains to be investigated if the DMS is involved in the acquisition of this 
type of implicit memory task.  Lesioning the DMS before the probabilities are introduced in the 
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task would allow investigation on whether the striatum is involved in the computation of 
probabilities to predict the location of a target stimulus, which changes as a function of the length 
of the foreperiod.   
Before discussing the implementation of the task, it is necessary to address some 
methodological points of concern.  During the experiments reported in this thesis, for example, 
the side of stimulus presentation was not counterbalanced.  Throughout the experiments, the 
stimuli at shorter foreperiods, were more likely to appear on the left side, and at longer 
foreperiods, the stimuli were more likely to appear on the right side.  Although there is no 
evidence to suggest that the results would have been different if the stimuli at shorter foreperiods 
would have been more likely to appear on the right side and at longer foreperiods on the left side, 
laterality in rats cannot be ruled out.  Therefore, future research should counterbalance the side 
on which the stimuli are presented at both short and long foreperiods.  Another limitation of the 
task was that the foreperiod and target side were determined on a trial-by-trial basis according to 
a priori probabilities; therefore, there was not always precisely the same number of trials in 
every session.  Methodologically, this concern was not an issue when the data were collected for 
repeated sessions (like on Chapters 3 and 5) because there were enough trials for all the 
foreperiods and target sides.  However, this was a limitation when the data was collected for a 
single session, such as in the experiment described in Chapter 4, where data on the effect of each 
dose were collected only once.  Given that there were cases in which a rat did not receive all the 
targets at all the possible locations/foreperiods, the data could not be included in the analysis, 
which reduced the power of the experiment.  This could have been addressed by having more 
than one session to test each drug dose.  However, the main issue could be addressed by having a 
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fixed number of stimuli per foreperiod and target side.  This would ensure that even within one 
session all the rats would receive a reasonable number of trials at each foreperiod and side.  
Furthermore, future research should investigate other neuronal structures in this form of 
implicit learning task.  Different human studies have suggested that the striatum is not the only 
neuronal structure that contributes to implicit learning, and various cortical areas (e.g., 
ventrolateral prefrontal cortex, ventromedial premotor area, medial prefrontal cortex) have been 
reported to be involved in various stages of implicit learning (Exner et al., 2002; van der Graaf et 
al., 2006).  Consequently, it could be possible that lesions in the prefrontal cortex may impair the 
computation of probabilities that predict the location of the stimuli in this task.  This could also 
be investigated in the future given that, in addition to the striatum, the cortex of patients with HD 
also suffers from atrophy.  Furthermore, cortical neuronal degeneration leads to excessive 
thinning of the cerebral mantle of the entire brain (Hedreen et al., 1991).  As a new task, further 
investigation is required to evaluate which neuronal structures are involved in the computation of 
probabilities to predict the location of the stimuli, which could ultimately become a useful task 
for testing rats and humans. 
9.3.2 Goal-directed and habit formation 
In order to continue addressing the issue of the reduced number of tasks available for 
evaluating cognitive impairment in animal models of HD, Chapter 6 presented a new task to 
evaluate goal-directed and habitual responding.     
The results from Chapter 6 showed that lesions of the DMS did not induce habitual 
responses (as the performance in the task decreased when the value of the reward decreased), and 
they did not affect the acquisition of a new goal-directed behaviour (as the responses to the 
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central hole decreased when it never delivered reward).  However, for any given behaviour to be 
established as goal-directed it should be tested using outcome revaluation (i.e., decrease or 
increase the value of the outcome) and by evaluating the effects of contingency degradation (i.e., 
deliver rewards regardless of the behaviour).  Behaviours would be considered goal-directed if 
the performance is affected by these two manipulations (Eilan et al., 1993).   Therefore, in 
addition of outcome devaluation, the effects of contingency degradation should be examined in 
the task used in Chapter 6 in order to investigate the role of the dorsal striatum in goal-directed 
and habitual responding. 
Furthermore, lesions of the DMS have opposing effects to lesions of the DLS for 
balancing habitual and goal-directed behaviours (Smith and Graybiel, 2014).  While it has been 
suggested that the DMS is involved in learning A-O associations, the DLS has been proposed to 
be involved in S-R learning (Yin and Knowlton, 2006; Yin et al., 2004; Yin et al., 2005).  Future 
research could therefore investigate the role of the DLS in goal-directed and habitual responding 
in this task. 
As habitual behaviour has been proposed as a symptom of HD (Novak and Tabrizi, 
2010), the task presented in Chapter 6 has the potential to evaluate goal-directed and habitual 
responding in different animal models of HD.  
9.3.3 Attentional Set-shifting task 
Patients with HD show impairments in set-shifting and reversal learning in the ID/ED 
attentional set-shifting task (Josiassen et al., 1983; Lange et al., 1995; Lawrence et al., 1998a; 
Lawrence et al., 1996; Lawrence et al., 1999b).  The series of experiments presented in Chapters 
7 and 8 investigated if rats with bilateral QA lesions of the dorsal striatum, not only mimicked 
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some aspects of the neural damage in HD, but also presented similar cognitive deficits in 
behavioural flexibility as those seen in HD patients.   
In addition to the standard 7-stage attentional set-shifting task for rodents, Chapter 8 
presented three modified versions of the task to test different hypothesis about reversal learning, 
attentional set-formation, and set-shifting.  These tasks are not limited to the evaluation of animal 
models of HD; rather, they provide alternative tools for testing specific hypothesis based on 
particular behavioural flexibility deficits, which require further investigation. 
Although the different modifications of the attentional set-shifting task have several 
advantages for investigating reversal learning, attentional set-formation, and set-shifting, they 
also have limitations that should be addressed in future research.  
An advantage of the attentional set-shifting task is that it can be used on repeated basis 
with reproducible results and without having learning effects (i.e., the ED shift-cost and the 
reversal costs are consistent between tests).  However, the effects of counterbalancing on 
retesting should be considered.  Even though the design for repeated testing tries to 
counterbalance for direction of shift, stimulus pair order and correct/incorrect stimuli within a 
pair, the design has some limitations.  For example, on the tasks that have multiple ID stages 
with no reversal stages, only limited combinations for the stimulus pairs order can be used, and 
the pairs are always followed or preceded (most of the times both) by the same pairs even in 
different tasks.  As a result, there will be cases where some cues will never be rewarded which 
might affect the performance on following tests. 
In addition, increasing the number of stages in the task to test different hypotheses 
reduced the pairs of stimuli that were tested in this laboratory.  The limited number of stimulus 
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pairs available is also a limitation of the task.  The tasks used in Experiment 2 and 3 as presented 
in Chapter 8, have an increased number of stages that require multiple stimuli.  Unfortunately, 
some of the pairs that were used are relatively new to our laboratory and have not been tested 
enough to validate them.  Because the standard 7-stage attentional set-shifting task always uses 
the same three pairs of stimuli (pair 1-3 from Table 8.3), and it has not been established if the 
different stimuli (pair 4-8 from Table 8.3), that are only used in tasks that require multiple ID 
stages, would produce the same results in the standard task.  Before using novel stimulus pairs in 
other tasks, then, further research should be conducted to determine if the stimulus pairs used in 
the tasks with multiple ID stages are equivalent to the pairs of stimuli used in the standard 7-
stage attentional set-shifting task.  In particular, it is important to evaluate that there are no pairs 
of stimuli that are more difficult to discriminate than others.  Having pairs that are harder to 
discriminate in the ED shift would require more trials to learn than the ID stage; but this would 
lead to erroneous conclusions about performance shifts because the cost was not associated with 
attentional set-shifting.  In the tasks used in Chapter 8, the stimuli in the same dimension 
presented as pairs differed as little as possible from each other.  Furthermore, the digging media 
were sufficiently dense to mask the scent of the reward, and the reward was buried sufficiently 
deep.  The results from the reversal stages showed that rats required more trials to complete the 
reversal stage than the preceding stage; therefore, they were not solving the stages by detecting 
the scent of the reward.  
It is also important to mention that the early and late reversal stage attentional set-shifting 
tasks have only been used twice.  First by Chase (2013) who found set-shifting intact (i.e., an 
ID/ED difference) in sham-surgery control rats.  The experiment presented in Chapter 8 did not 
find an ID/ED difference in in sham-surgery control rats.  The difference in results might be 
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accounted for by the different pairs of stimulus that were used.  As previously mentioned, some 
of the stimulus pair that Chase (2013) used have been replaced because the rats found them 
aversive or easy to discriminate.  However, these new stimulus pairs should first be validated.  In 
addition, cognitively normal rats (without being submitted to surgery) should be tested in these 
tasks to establish a baseline and to determine if these tasks are valid as a means of measuring 
reversal learning, attentional set-formation, and set-shifting.  This also applies for the probe task 
attentional set-shifting task used in Experiment 3 from Chapter 8, which is a new task used in our 
laboratory.   
Another fact that should be considered is that in comparison to the automated CANTAB 
ID/ED task for humans and nonhuman primates, in the rodent attentional set-shifting task, 
currently a human observer scores and classifies the behaviour of the rat.  Therefore, there is 
possibility for human error, bias or subjectivity.  Although the ambiguity of interpretation of 
behaviour can be reduced by a standard training system within a research group, there will still 
be differences between different laboratories.  Therefore, the observer bias may contribute to the 
difference in findings and effect sizes.  Although an automated version of the task would 
eliminate these subjective elements, there are elements in the human ID/ED task that cannot be 
replicated in rodents.  For example, the stimuli presented in bowls in the rodent version are 
presented in separate compartments and the rat/mouse needs to explore each bowl individually.  
Comparatively, the visual stimuli in the task for humans are presented simultaneously on the 
touch screen and can be compared at the same time.  In addition, while the rat task requires the 
discrimination of two perceptual dimensions using different sensory modalities (olfactory, 
somatosensory and possibly visual), the human task only requires one modality (visual) to solve 
the discriminations.  There have been some attempts to automate the rodent task.  Brigman et al. 
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(2005) used a visual discrimination protocol similar to the one used in the primate version of the 
ID/ED task where compound visual stimuli were presented on a touch screen.  However, the 
mice tested on the task did not require more trials to complete the ED in comparison to the ID 
stage (i.e., did not show a positive shift-cost), which suggests that visual stimuli in general may 
not be generalised by mice to form attentional sets.  Likewise, the different tasks in rodents that 
have used visual stimuli have suggested that texture and odour stimuli are discriminated more 
easily and are learned in fewer trials in comparison to visual stimuli (Brigman et al., 2005; 
Izquierdo et al., 2006).  Although the current version of the attentional set-shifting presents some 
limitations, it is nevertheless one of the best tasks available to measure behavioural flexibility in 
rats. 
Given that impairments in set-shifting and reversal learning have been observed in HD 
patients (Josiassen et al., 1983; Lange et al., 1995; Lawrence et al., 1998a; Lawrence et al., 1996; 
Lawrence et al., 1999b), DMS lesioned rats should be examined more closely with other 
procedures to evaluate if QA lesions of the striatum are a potential animal model for studying 
cognitive and behavioural impairments of HD.   
9.3.4 Quinolinic acid lesions of the rat striatum as an animal model of Huntington’s 
disease 
Although there is no animal model which simulates all the aspects of a disease such as 
HD, a model needs to present only some aspects of the disease to be an appropriate model 
(Willner, 1991).  The validity of animal models has been evaluated using three main criteria: 
face, predictive, and construct validity (Willner, 1986).  More specifically, an adequate model of 
HD should resemble the fundamental motor, psychiatric and cognitive symptoms, as well as the 
pathophysiology, found in HD patients (face validity), conform to a theoretical rationale, such as 
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the known genetics of HD (construct validity), and allow us to make predictions about HD, based 
on the performance of the model (predictive validity).  From a pharmacological perspective, 
predictive validity is the ability of an animal model to respond to treatments in the same manner 
that humans respond to the treatment, and vice versa (Willner, 1984).  Given that currently there 
are no effective treatments available for HD, this criterion cannot be used to validate the existing 
animal models of HD.   
In rats, excitotoxic lesions of the striatum produce anatomical changes that resemble the 
pathology of HD (face validity; Brasted et al., 1998; Dunnett et al., 2012; Shear et al., 1998).  In 
addition, it has been suggested that striatal lesions produce behavioural changes that, even though 
might not be identical to all of the symptoms observed in HD, are analogous (Brasted et al., 
1998).  In this sense, the face validity of the model has focused on similarly impaired behaviours 
that have been established as behaviours affected in HD.  The results from this thesis showed that 
contrary to HD patients, DMS lesioned rats did not have cognitive deficits in implicit memory 
(Chapter 5), and they did not show habitual responding (Chapter 6).  In addition, DLS lesioned 
and the DMS lesioned rats did not present similar cognitive deficits in behavioural flexibility as 
those seen in HD patients in the ID/ED attentional set-shifting task (Chapter 7 and 8).  While 
patients with HD show reversal impairments and impaired ability to shift attentional set from a 
previously relevant dimension to previously irrelevant dimension (Lange et al., 1995; Lawrence 
et al., 1996; Lawrence et al., 1998b; Lawrence et al., 1999b), rats with lesions of the dorsal 
striatum were not impaired in reversal learning but were impaired forming attentional sets.  
Consequently, the results from this thesis showed that although QA lesions of the dorsal striatum 
mimic some aspects of the neural damage in HD, they did not result in the same cognitive 
deficits observed in patients with HD, at least using the tasks presented in this thesis.  Therefore, 
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future research should evaluate rats with quinolinic acid lesions of the dorsal striatum using other 
procedures to determine if the model presents the same cognitive and behavioural impairments of 
Huntington’s disease.   
Another point that should be consider when using QA lesions of the rat striatum as an 
animal model of HD, is that even though lesions of the striatum are a controlled and rapid 
method to induce HD neuropathology, in some occasions the number of lesioned subjects is 
reduced if they do not have appropriate bilateral lesions, which cannot be determined until the 
behavioural testing is completed and the histology is finalised.  This was a limitation of the 
present thesis as subjects that did not have bilateral lesions were excluded and the number of 
lesioned animals used in the analyses was reduced.  In addition, it was unexpected to observe that 
some of the sham-surgery control rats showed signs of cell damage; thus, they were also 
excluded from the analyses.  This damage was unusual, and although the surgery protocol for the 
control rats has been previously used in this laboratory with no cell damage observed, it could 
have been possible that the sham-surgery control rats presented cell damage because the needles 
were contaminated with QA.  Thus, future research could avoid this problem by using different 
syringes and needles for the lesion and the control groups and by making sure the equipment is 
sterilised between surgeries to avoid cross contamination between the groups.   
Furthermore, other animal models of HD (see section 1.7 from the General Introduction) 
could be evaluated using the different tasks presented in this thesis to continue the search of a 
reliable animal model of HD in which treatments for the disease could be evaluated. 
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9.4 Conclusion 
Despite the numerous animal models of HD available, most research has evaluated the 
motor impairments of the models, while the characterisation of the cognitive impairments 
remains poorly investigated.  The low number of tasks available for evaluating cognitive 
impairments in animal models of HD has slowed the progress for testing treatments for the 
disease.  The new tasks presented in this thesis provide several alternatives that should prove 
valuable in future investigations.  First, the Spatiotemporal Target Probability Signal Reaction 
Time Task could evaluate patients with potential cognitive deficits in implicit learning, and it 
could also assess cognitive deficits in animal models in order to potentially test different 
treatments.  Second, the new task presented in Chapter 6 has the potential to evaluate goal-
directed and habitual responding in different animal models of HD.  Third, in addition to the 
standard 7-stage attentional set-shifting task for rodents, Chapter 8 presented three modified 
versions of the task to test different hypotheses about reversal learning, attentional set-formation, 
and set-shifting.  The tasks presented in this thesis not only contribute to the research on animal 
models of HD; they provide alternative tools for testing specific hypothesis based on particular 
cognitive deficits in implicit memory, habits, and behavioural flexibility in different diseases or 
disorders that require further investigation.   
Finally, the research from this thesis did not find support for validating rats with QA 
lesions of the dorsal striatum as a model of HD.  Contrary to HD patients, DMS lesioned rats did 
not have cognitive deficits in implicit memory, and they did not show habitual responding.  In 
addition, DLS lesioned and the DMS lesioned rats did not present similar cognitive deficits in 
behavioural flexibility as those seen in HD patients in the ID/ED attentional set-shifting task.  
Similarly to patients with HD, the severity of cognitive deficits in the animal models of a disease 
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is not universal across individuals; rather, it is dependent on the task.  Hence, concluding that a 
specific animal model is inappropriate for studying HD based simply on the results from the 
tasks presented in this thesis is perhaps incorrect.  This animal model should be examined more 
closely with other procedures to evaluate if rats with quinolinic acid lesions of the dorsal striatum 
are a potential animal model for studying cognitive and behavioural impairments of Huntington’s 
disease.   
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